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The femtosecond laser (FL) has been introduced into cataract surgery within the 
last 10 years and continues to provoke much interest, with strong opinions on 
either side of the debate concerning its value; both potential and real. It offers 
automation and precision for several steps of cataract surgery but at a significant 
financial cost. 
 
Many case series and cohort studies have been published in the academic 
literature, but there are only a few randomised controlled trials comparing FL 
assisted cataract surgery (FLACS) with the gold standard of conventional 
phacoemulsification cataract surgery (CPS), and these are generally 
underpowered. Some National Health Service (NHS) hospitals are adopting this 
technology but at significant financial cost and there is yet a lack of convincing 
evidence for any clinical benefit of this technology.  
 
The aim of this MD(Res) project was to investigate whether FLACS technology 
can offer clinical benefit or with differing models of service delivery provide cost-
effectiveness to public sector cataract services. The primary hypothesis was 
whether a FL incorporated into a ‘hub-and-spoke’ pathway (whereby one FL 
treats patients and feeds them into multiple operating theatres) would improve 
productivity, and whether these productivity gains are sufficient to offset the 
additional costs associated with the technology itself. 
 
In order to address these questions this thesis comprises six studies: 
 
1. To fully understand the running of NHS cataract theatre lists, time-motion studies 
(TMS) were conducted at cataract theatre lists in 5 different institutions (four NHS 
hospitals, one private hospital). Individual tasks, and their timings, of every 
member of staff were recorded. This study represents the first published TMS of 
cataract surgery and showed significant variability in the number of cases 
performed and the efficiency of patient flow between different institutions. 
Hypotheses were made as to factors supporting or hindering productivity, 




2. A hypothetical financial model was designed to compare FLACS with CPS for the 
provision of cataract surgery within the NHS. This study highlighted the 
significance of the cost of the disposable patient interfaces (PI) over the capital 
cost of the femtosecond laser itself. It concluded that there would need to be a 
significant improvement in productivity offered by FLACS over CPS, as well as 
significant discounting from the manufacturers of the PI, to offset the associated 
costs associated with this technology. 
 
3. To evaluate the learning curve of the first 288 consecutive FLACS operations 
among 3 surgeons of differing grades of experience, who were naïve to the 
FLACS procedure. Surgical outcomes were analysed using a risk-adjusted 
cumulative sum method (CUSUM) to estimate the length of the learning curve for 
each surgeon, with regards to all complications and specifically posterior capsular 
rupture (PCR). The results of the pooled suggest stability in the rate of PCR after 
the first 16 cases. 
 
4. A randomised controlled trial (RCT) was conducted to compare FLACS with CPS 
in 400 eyes of 400 consecutive patients. The analysis of the results found no 
statistically significant differences between the treatment arms in unaided or 
corrected visual acuity, refractive outcomes, phacoemulsification energy, 
endothelial cell loss, macular oedema, or patient reported outcome measures. 
The only statistically significant difference found was in the rates of posterior 
capsular rupture (FLACS 0%, CPS 3% p=0.03). 
 
5. Surgeries within the RCT, described above, were performed within a high-volume 
surgery model. The FLACS arm was performed within a 2:1 hub and spoke 
model, while the CPS arm was performed with 2 theatres operating in parallel. 
This is the only study to date to evaluate the productivity of FLACS within a hub 
and spoke setting. FLACS with a hub-and-spoke model was significantly faster 
than CPS, with patients spending less time in theatre. This enabled a slight 
improvement in productivity, but not sufficient to meaningfully offset the additional 
costs relating to FLACS. 
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6. A sub-analysis of the FLACS RCT was undertaken to compare the effectiveness 
of manual limbal relaxing incisions (LRI) with femtosecond laser arcuate 
keratotomies (FS-AK) in the management of corneal astigmatism at the time of 
cataract surgery. All patients with corneal astigmatism greater than 0.9 dioptres 
(D) were offered treatment with either LRI (n=51) or FS-AK (n=53). Visual acuity, 
post-operative refraction, and corneal topography were recorded as well as any 
surgical complications. Analysis was performed according to the Alpins method. 
The FS-AK group had a significantly lower difference vector and higher correction 
index than the LRI group. 44% of patients treated with FS-AK attained a post-
operative astigmatism of <0.5D compared with 20% in the LRI group. 
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Chapter 1. Introduction 
1.1. Background 
 
In the current economic climate, the need to severely limit public sector spending 
to reduce national budget deficits has become of overriding importance. 
However, despite the best efforts of most societies, expenditure within the public 
health sector continues to increase at an unsustainable rate (Monitor, 2015b). 
Cataract surgery is one of the commonest and most successful surgical 
interventions undertaken in modern medicine (Department of Health, 2015a; Day, 
Donachie, et al., 2015; Allen and Vasavada, 2006). Within the National Health 
Service (NHS) in the UK alone, an estimated 370,000 cataract surgeries are 
undertaken per annum at a cost of over £300 million.(Department of Health, 
2015b) There is clearly a need to limit such costs. It may be difficult in any 
democratic society to ration the provision of cataract surgery, but expenditure can 
be curtailed by improving productivity (Monitor, 2015a). This may be achieved by 
improving the efficiency of the cataract surgery service, by treating more patients 
with the same resources, and by minimising additional costs, such as those 
sustained from providing care and resources for complications of surgery 
(Qatarneh et al., 2012; Schmier et al., 2007). 
 
Femtosecond laser (FL) technology has been recently introduced into cataract 
surgery in an attempt to automate and improve the efficacy of some of the 
surgical steps within this procedure (Nagy et al., 2009). Within the scientific 
literature there are numerous studies supporting its usage and continued 
development as more surgeons are adopting this technology and publishing their 
results, often in comparison with conventional phacoemulsification (CPS). 
However, most of its uptake, until recently, has been within the private healthcare 
sector because of the additional associated financial costs. To the knowledge of 
the author, less than ten FL systems are in service within the NHS at the time of 
writing. Whilst FL technology is undoubtedly initially expensive to purchase and 
maintain, by its very nature it offers the potential to automate some of the surgical 
steps. This automation has the potential, with hub and spoke delivery models, to 
reduce actual surgeon operating time, while maintaining and possibly improving 
patient safety and outcomes. Reduced surgeon operating time could lead to 
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improved efficiency with an increase the quantity of cases undergoing cataract 
surgery within the same period of time. Increasing patient numbers may have the 
potential to offset the initial expenditure and additional costs associated with FL 
technology. Indeed it may have the potential to  reduce overall costs if the number 
of patients treated can be sufficiently increased, as well as the incidence of 
complications are equivalent or reduced (Abell and Vote, 2014). 
 
1.2.  Epidemiology of cataracts 
 
In 2002, the World Health Organization (WHO) calculated that there were 161 
million people living with visual impairment worldwide, of which cataract 
accounted for 48% (Resnikoff et al., 2004). They estimated that cataract was the 
most common cause of blindness worldwide, affecting over 17 million people 
across the globe (Foster and Resnikoff, 2005). It is expected that over the next 
20 years there will be an approximate doubling in the incidence of cataract and 
need for cataract surgery, as the world’s population is estimated to increase by 
one third, especially in developing countries (Pascolini and Mariotti, 2012; Brian 
and Taylor, 2001). 
 
Cataract surgery is the most common surgical procedure performed in the 
developed world (Allen and Vasavada, 2006), where the prevalence of cataract 
is very high among elderly people (20% with unoperated disease at age 70, rising 
to 50% in over 80s) (Reidy et al., 1998). In 2014-15 over 370,000 cataract 
operations were performed in the National Health Service (NHS) of the UK 
(Department of Health, 2015a), which represents an increase by a factor of 3.7 
since 1989 (Black et al., 2008). The tariff paid to an NHS hospital for a routine 
elective day case cataract surgery is approximately £850 (Department of Health, 
2015b). Based on these figures, the annual cost of cataract surgery itself within 
the NHS can be crudely estimated at more than £300million. It is important to 
note that these values do not include the costs of the pre- and post-operative 
clinic appointments and the management of any intra- or post-operative 
complications, so that the total burden of cataract disease to the NHS will be 
much higher. In addition, it is important to consider in any disease process, other 
direct healthcare costs such as the cost of hospitalization from falls associated 
with visual impairment (Harwood et al., 2005) and societal costs, such as lost 
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productivity from both affected individuals and carers (Harwood et al., 2005; Sach 
et al., 2007). 
 
The requirement for cataract surgery is expected to rise considerably over the 
next decades with increasing life expectancy, population size, patient 
expectations, and age-related chronic diseases associated with cataracts, such 
as diabetes (Minassian and Reidy, 2009). Using the rate of provision of cataract 
surgery from 2011 Hospital Episode Statistics data as a crude estimate of 
demand, average expected rates of cataract surgery are approximately 530 per 
100,000 population or 3200 per 100,000 for those over 65 years old per year 
(Day, Wormald, et al., 2016). Historical data from the North London Eye Study 
estimated that 30% of people 65 years or older had visually impairing cataract in 
one or both eyes (Reidy et al., 1998). Ten percent of individuals in this age group 
in this study had already had cataract surgery. However, this is likely to be less 
than our current patient cohort due to the increase in the provision of cataract 
surgery within the NHS over the past 20 years (Keenan et al., 2007). 
 
Improvements in technology, changing expectations of the public, greater 
confidence of surgeons in their ability to deliver a quality outcome and politically 
driven initiatives to reduce waiting times have contributed to the increase in 
provision of cataract surgery in the NHS (Sparrow, 2007). In the UK, thresholds 
for listing for surgery have generally become increasingly lenient in visual acuity 
terms. In 1990 less than 9% of eyes undergoing cataract surgery had an acuity 
6/12 or better (Desai, 1993), while the Royal College of Ophthalmologists’ 
(RCOphth) National Ophthalmology Database (NOD) (August 2006 – November 
2010) showed that 3%, 5% and 36% of eyes undergoing cataract surgery had 
preoperative visual acuities of better than or equal to 6/6, 6/9 and 6/12 
respectively (Day, Donachie, et al., 2015). As well as increasing the demands for 
cataract surgery, this lowering the visual threshold for cataract surgery also 
reduces the potential amount of possible visual improvement and raises the 
possibility of patients complaining that they are ‘worse off’ following surgery 
(Black et al., 2008). 
 
Cataract surgery is reported to be one of the most cost-effective operations, and 
comparable to hip replacement surgery (Lansingh et al., 2007). Even in 
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developed countries, which as discussed above, undertake a significant 
proportion of surgery for only mildly visually impairing cataract, it is estimated to 
be cost effective with an incremental cost per quality adjusted life year (QALY) of 
£13,172 over an individual’s lifetime (assuming an anticipated lifespan of 10 
years following surgery) (Sach et al., 2007). This is significantly below the £20k-
£30k per QALY benchmark set by the National Institute for Health and Care 
Excellence (NICE) for a medical intervention to be cost effective. 
 
Approximately 40% of patients eventually undergo cataract surgery on both eyes 
(Jaycock et al., 2009; Day, Donachie, et al., 2015). A recent systematic review 
funded by the National Institute for Health Research (NIHR) concluded that 
second eye cataract surgery was associated with a clinically meaningful 
improvement in depth perception, binocular visual acuity was slightly improved 
but perhaps of limited clinical value, there was no significant improvement in self-
reported visual function or health related quality of life (Frampton et al., 2014). 
Second eye cataract surgery is thought to be less cost-effective than first eye 
surgery, but still worthwhile and cost-effective, as the systematic review 
estimated the probability of cost effectiveness at willingness-to-pay thresholds of 
£10,000 and £20,000 to be 100% (and therefore within the threshold set by 
NICE). A Swedish National Cataract Register study demonstrated better self-
assessed visual outcomes and satisfaction after second eye cataract surgery in 
comparison to a comparable group of unilateral surgery only patients(Lundstrom 
et al., 2001). A national study in the U.S. found that a group of 243 patients having 
second eye surgery within 12 months, demonstrated a 61% increase in VF-14 
score(Javitt et al., 1995). Despite this, second eye cataract surgery has been one 
of several areas where clinical commissioning groups have recently tried to ration 
surgery to cut costs. A report by RCOphth highlights the impact that recent 
efficiency savings expected from the NHS has had on cataract surgery (The 
Royal College of OphthalmologistsThe Royal National Institute of the Blind, 
2011). A recent report by Monitor, the Government’s regulator for healthcare in 
England, states, “Elective care services across England are generally under 
pressure to do more with less. Their costs are increasing and demand is growing. 
Similar pressures affect all NHS care: they are the source of the £30 billion gap 
between NHS funding and the projected costs of care in 2021 that the NHS Five 
Year Forward View highlights and new care models seek to address. For these 
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reasons, improving productivity in elective care is critical for NHS providers…. 
Improving productivity does not mean simple cost cutting: it means increasing the 
efficiency of elective care while at the same time improving or maintaining its 
quality.”(Monitor, 2015a). 
 
1.3. History of cataract management 
 
Mark 8:22-25-“And He cometh to Bethsaida; and they brought a blind man unto 
Him, and besought Him to touch him. And He took the blind man by the hand, 
and led him out of the town; and when He had spit on his eyes, and put His hands 
upon him, He asked him if he saw ought. And he looked up, and said, “I see men 
as trees, walking.” After that He put His hands again upon his eyes, and made 
his look up: and he was restored, and saw every man clearly” 
 
1.3.1. Couching to extracapsular cataract surgery 
The oldest documented case of cataract was in a statue from the 5th dynasty of 
Ancient Egypt. The cataract is represented by a statue of a male priest with a 
white pupillary reflex in one eye (Ascaso and Cristóbal, 2001). The most plausible 
hypothesis for the first cataract treatment was in Ancient Egypt based on a mural 
(c. 1200 BC) demonstrating an oculist treating the eye of a workman, using a long 
instrument, by couching the cataract into the vitreous cavity (Ascaso et al., 2009). 
However the first description of the couching technique was in an Indian medical 
treatise dating around 800 BC (Duke-Elder1969, n.d.). The text describes using 
a curved needle to push the lens into the rear of the eye, out of the visual axis. 
The eye would later be soaked in warm clarified butter and then bandaged. This 
method was described as successful but with caution that it should only be 
performed when absolutely necessary! 
 
The longevity of couching of thousands of years far eclipses any of the newer 
methods for treating cataracts, as it was the procedure of choice until the first 
documented cataract extraction was performed in 1748 in France by Jacques 
Daviel (Dolezalová, 2005). Indeed it is still used in some parts of Africa (Savage-
Smith, 2000). Daviel was the oculist to King Louis XV. His extracapsular 
technique marked the beginning of the modern era in cataract surgery 
(Dolezalová, 2005). Interestingly, the advent of a rival technique to couching 
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divided opinions with vocal proponents on each side. During this phase, two 
famous composers Johann Sebastian Bach and George Frideric Handel both 
elected to undergo couching by the same surgeon, John Taylor (1703-1772); 
unfortunately both went blind (Zegers, 2005). Albrech von Graefe (1828-1870) 
refined the technique of extracapsular cataract surgery, with his eponymous knife 
and ‘modified linear extraction’. 
 
1.3.2. Intraocular lenses 
The era of intraocular lenses began with Sir Harold Ridley (1906-2001) who 
worked at both Moorfields Eye Hospital and St Thomas’ Hospital. His interest in 
developing an artificial lens was allegedly catalysed by a medical student, who, 
while watching a cataract operation questioned why the lens was not replaced. 
He was inspired to choose polymethylmethacrylate (PMMA) as the material for 
the IOL as he had observed that it was an inert material in the eyes of Royal Air 
Force pilots in World War II who had sustained intraocular foreign bodies from 
shards of their PMMA cockpit canopy (Ridley, 1952). On 29th November 1949, 
Ridley implanted the first IOL at St Thomas’ Hospital. The first IOL was 
manufactured by Rayner company of Brighton & Hove (Spalton, 2009), yet it was 
many decades until IOL implantation became commonplace. It was in 1981 that 
the US Food and Drug Administration approved Peter Choyce’s Choyce Mark IX 
IOL as the first IOL to be approved in the United States. Today, approximately 14 
million IOLs per annum are implanted worldwide.  
 
1.3.3. Phacoemulsification 
In a 1994 paper, Charles D Kelman recalls how he was inspired to reduce the 
size of the incision needed for cataract surgery to improve post-surgical 
rehabilitation and the amount of surgically induced astigmatism (Kelman, 1994). 
In the 1960s, Kelman was awarded a grant to explore his hypotheses. He first 
searched for a chemical which would dissolve the crystalline lens, however there 
were none which did not also destroy the corneal endothelium. After spending 
most of the research funds on various surgical instruments including drills and 
vibrators, Kelman concluded that the movement of the lens and the denuding of 
the endothelium were the two greatest challenges to overcome. Kelman 
hypothesized that only a rapidly accelerating instrument could move through lens 
matter without pushing it away, and was subsequently inspired while in the 
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dentist’s chair by the ultrasonic probe. After years of experiments on animals, the 
first human phacoemulsification operation was performed on an already blind eye 
scheduled for enucleation; the operation lasted 76 minutes (Kelman, 1967). It 
was not until many years later that phacoemulsification became mainstream. 
Refinements which enabled phacoemulsification to become the technique used 
for 99.7% of cataract operations in the UK in 2001-2006 included improvements 
in the phacoemulsification machine (including smaller handpieces and better 
fluidics), the advent of foldable IOLs (allowing smaller incisions), the invention of 
the continuous curvilinear capsulorrhexis (CCC) (allowing more reliable 
implantation of the IOL in the bag), and the development of viscoelastic 
substances (to facilitate the operation and protect the endothelium) (Jaycock et 
al., 2009). 
 
1.3.4. An Overview of Modern Phacoemulsification 
There are variations on surgical technique, but the fundamental steps of 
conventional cataract surgery are as follows. The patient receives pre-operative 
dilating drops to widen the pupillary aperture to allow access to the cataract and 
topical iodine onto the conjunctiva and eyelashes for infection prophylaxis. The 
operation is conducted in an operating theatre under sterile conditions. The 
operation is generally performed under local anaesthesia, with general 
anaesthesia accounting for less than 5% of cases in the UK (Jaycock et al., 
2009). A sterile drape is placed over the patient’s face, a slit is made in the drape 
to allow access to the eye and a speculum is inserted to open the eyelids. 
 
Figure 1.3.4-A Anatomy of a phacoemulsification operation 
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One main incision, usually no more than 3mm wide, is made in clear corneal 
tissue, at the limbus or within the sclera, accompanied by one or two smaller 
adjacent incisions to allow a second instrument into the anterior chamber. A 
circular opening is made in the anterior lens capsule, the continuous curvilinear 
capsulorhexis (CCC). This is generally done with forceps or a needle. The 
cataract is then separated from its capsule by an injection of saline solution 
between the anterior lens capsule and the lens substrate. This injection, known 
as hydro-dissection, circulates around the lens and breaks any adhesions 
allowing the cataract to be rotated freely within its capsule. The 
phacoemulsification probe can then be inserted through the main incision (Figure 
1.3.4-A). Controlled by a multi-axial foot-pedal, this probe allows irrigation of fluid 
into the anterior chamber to maintain the intraocular pressure. A second aperture 
on the instrument allows vacuum aspiration from inside the eye. Finally, the tip of 
the probe is able to oscillate at ultrasonic frequencies (40,000 times a second). 
The energy delivered by this vibration emulsifies the hard nuclear lens matter. 
Often with the assistance of a second instrument to manipulate the cataract, the 
lens is broken into several smaller pieces, which can then be aspirated from the 
eye by the phacoemulsification probe. Once the cataract has been removed from 
the eye, the phacoemulsification probe is withdrawn, and an irrigation-aspiration 
probe can be inserted into the anterior chamber. The functions of this probe are 
the same, with the exception of the high frequency vibration. This probe allows 
the surgeon to remove the softer peripheral remnants of the lens epithelium (the 
cortex) from inside the capsular bag with minimal risk of trauma to the capsule. 
Once the last remnants of the cataract have been removed, the intraocular lens 
can be inserted into the eye. Modern materials allow IOLs to be folded and 
inserted via forceps or an injector through the original wound. The IOL is generally 
placed into the capsular bag, unless it has been damaged during the course of 
the operation, which occurs with an expected frequency of about 2% (Day, 
Donachie, et al., 2015). This is the most common significant intraoperative 
complication and is known as posterior capsule rupture (PCR) or tear. The small 
size of the corneoscleral wound means that it is generally watertight under 
physiological conditions and does not require a suture, although the wound can 
be sutured if there are doubts as to its competency. Finally, an antibiotic is 
injected into the anterior chamber to reduce the risk of post-operative 
endophthalmitis (ESCRS Endophthalmitis Study Group, 2007). 
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Postoperatively, most surgeons treat their patients with prophylactic topical 
antibiotics and anti-inflammatory agents, such as corticosteroids, either in 
separate formulations or in combination (The Royal College of Ophthamologists, 
2010). Patients apply the drops several times a day for several weeks, depending 
on the postoperative course.  
 
1.4. Overview of Use of Femtosecond Lasers in Cataract 
Surgery  
 
1.4.1. Device Description  
Applying laser energy within transparent tissues requires high irradiances, and a 
tightly focussed and short-pulsed spot size. This mechanism, called dielectric 
breakdown, allows for a highly localised delivery of laser energy within a 
transparent tissue, such as the cornea. The absorption of the photon energy 
ionises the tissue, producing plasma with a temperature between 100-300°C, 
which in turn, vapourises the tissue at the focus of the laser. This process is 
known as photodisruption. Rapidly expanding and contracting bubbles of tissue 
vapour can rupture adjacent tissue. When applied to the cornea as a series of 
adjacent laser spots, these bubbles cleave planes between adjacent collagen 
fibrils (T. V. Roberts et al., 2012).  
 
The femtosecond laser can be focused precisely at a given depth within the 
cornea or crystalline lens as the infrared wavelengths (1053 nanometres (nm)) 
emitted are not absorbed by the tissues of the cornea or anterior lens capsule 
(Schumacher et al., 2008). Due to the ultrashort pulse (10-15 seconds), the laser 
can create multiple gas bubbles side by side, with minimal collateral tissue 
damage. This effectively allows the laser to cut through tissue with micrometre 
accuracy. The laser energy delivery and subsequent micro-cavitation bubble 
creation, can be linked to real-time anterior segment optical coherence 
tomography (OCT) or Scheimpflug imaging to accurately and safely perform pre-
planned cuts within the anterior segment, without damage to important ocular 
structures such as the corneal endothelium and posterior lens capsule. 
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1.4.2.  Femtosecond laser assisted cataract surgery (FLACS) 
Currently, there are five femtosecond laser platforms which are approved for use 
in cataract surgery: Catalys (Abbott Medical Optics, Santa Ana, California), 
Femto LDV Z8 (Ziemer Ophthalmic Systems AG, Switzerland), LensAR (LensAR, 
Orlando, Florida), the LenSx (Alcon Laboratories, Inc., Fort Worth, Texas) (Figure 
1.4.2-A), and VICTUS (Bausch & Lomb, Rochester, New York). As of January 
2015, over 400,000 cataract procedures have been performed with the LenSx 
laser in 67 countries with over 780 laser machines (Data from Alcon).  
 
All femtosecond lasers provide the laser operator with an image of the target 
tissue. The LenSx device (Figure 1.4.2-A) is directed by means of an integrated 
video microscope for a real-time ‘en-face’ view of the tissues and an OCT scanner 
which allows cross-sectional views through the cornea and lens. A disposable 
applanating contact lens and suction ring are used to dock the subject’s eye to 
the laser via an arm which extends from the body of the machine and can be 
controlled by a joystick. A vacuum is applied to the tear film to fixate and 
applanate the globe to the patient interface allowing for the precise placements 
of the laser spots. While the applanating contact lens is docked onto the eye, 
there is usually an accompanying rise in the intraocular pressure within the 
anterior chamber (Ebner et al., 2017). 
 




The femtosecond laser can be used to precisely automate 4 stages of the 
cataract operation. At the level of the cornea, the laser can create the main 
incisions and side ports needed for access to the anterior chamber. In addition, 
by making arcuate cuts within the corneal stroma at its periphery, the laser can 
effect changes in the curvature of the corneal to change the cylindrical 
component of the cornea’s refractive power, allowing the surgeon to reduce 
corneal astigmatism. The FL can also be used to  mark the cornea at its steep 
axis for the subsequent alignment of a toric IOL (Dick and Schultz, 2016). At the 
level of the crystalline lens, the laser can create a precise circular opening on the 
anterior capsule, the capsulotomy. Finally, the laser can be used to assist in the 
fragmentation or softening of the lens by cutting the lens into sections or even a 
grid pattern. Real time OCT imaging of the anterior segment allows for the 
automated planning of safe zones, to avoid laser application from a pre-
determined distance from the pupillary margin or posterior capsule. 
 
Following the application of the laser energy to the tissues, the vacuum is release 
and the patient is ‘undocked’ from the machine. The surgeon can then commence 
the manual portion of the intraocular surgery. If the laser was used to create the 
clear corneal incisions (CCI) the surgeon will usually need to open these wounds 
with a blunt spatula. Once a viscoelastic device has been injected into the anterior 
chamber, the next task is to remove the disc of anterior capsule which has been 
cut away from the capsulotomy rim. Hydrodissection and hydrodelineation are 
facilitated by the presence of intra-lenticular gas bubbles formed by the laser. 
Balloting the cataract will induce a partial pneumodissection as the gas bubbles 
escape anteriorly and less fluid is required to complete the dissection/delineation. 
The phacoemulsification probe can then be used to remove the remaining lens 
matter with a combination of phacoemulsification and aspiration, this stage 
having been facilitated by the lens segmentation pattern. The removal of cortical 
strands is often more challenging than CPS because of the increased adherence 
of the cortex to the capsule and the lack of freely floating filaments. From this 







1.4.3. Published Clinical Experience with FLACS 
 
1.4.3.1. CLEAR CORNEAL INCISIONS 
The clear corneal (micro-) incision (CCI), used by most cataract surgeons to gain 
access to the anterior chamber during cataract surgery is one aspect which the 
femtosecond laser can automate. The length and shape of the incisions are 
important factors in corneal wound stability. A cadaveric study demonstrated 
greater architectural stability and reproducibility with FL CCIs compared to CCI 
wounds made manually with a disposable keratome (Masket et al., 2010). In vivo, 
a study performing corneal wave-front analysis on groups of CPS and FLACS 
patients showed that the CCIs created with a keratome knife induced greater high 
order aberrations at one month post operatively compared to the laser incisions 
(Serrao et al., 2017; Serrao, Lombardo, Schiano-Lomoriello, et al., 2014). There 
also appears to be a lower incidence of ragged Descemet’s membrane (DM) 
morphology at the inner aspect of the wound and DM tear/detachment in FL-
created CCIs compared with those created manually with keratomes (Titiyal et 
al., 2017). It has also been postulated that a FL CCI may result in less endothelial 
cell loss (ECL) at the wound site than a manual CCI with less of an increase in 
local corneal thickness at one month (L. Mastropasqua, Toto, A. Mastropasqua, 
et al., 2014). However, occasionally  the FL CCI may be incompletely formed 
which results in difficulty entering the anterior chamber (T. V. Roberts et al., 
2013). An in vitro study of 16 human corneo-scleral buttons found that FL CCIs 
in human corneas showed no differences in stromal inflammatory cell response 
but a significantly higher cell death rate than manually performed incisions, 
indicating an upregulated postoperative wound-healing response (Mayer, 
Klaproth, Hengerer, Kook, et al., 2014). Another cadaveric study including 90 
human corneas demonstrated increased interleukin-18 positive cells in the 
adjacent stroma of FL-CCIs compared to manually created wounds, but no 
increase in interferon gamma, when low energy spot settings were used (Toto et 
al., 2016). 
 
The femtosecond laser does allow for the creation of custom CCI profiles, with 
more customisation than is practically possible with a manual keratome. Using a 
Catalys platform, tri-planar CCIs created with a reverse angle for the first plane 
(Figure 1.4.3-A) withstood greater IOPs before leaking peri-operatively and had 
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lower incidence of day 1 post op wound leakage on applying pressure (Seidel 
positivity) than traditionally constructed tri-planar femtosecond or manually 
created tri-planar CCIs (Donnenfeld et al., 2018). There were no significant 
differences in mean IOP before leakage between the conventional CCIs whether 
constructed by laser or keratome. However, the inherent differences between a 
FL which creates an incision plane by ablating corneal tissue and a manual 
keratome which cleaves through tissue are borne out in a study examining wound 
architecture using optical coherence tomography (OCT) demonstrating FL CCIs 
had a higher incidence of posterior wound retraction at one and three months (X. 
Wang et al., 2018). 
 
 
Figure 1.4.3-A Architecture of a femtosecond triplanar CCI with a reverse side cut of 110 degrees (From 
Donnenfeld et al. JCRS. 2018) 
 
1.4.3.2. ARCUATE/ASTIGMATIC KERATOTOMIES 
Corneal astigmatism in patients undergoing cataract surgery is common. In one 
study approximately 40% of patients were reported as having more than 1 dioptre 
(D) and 10% more than 2D of corneal astigmatism (Khan and Muhtaseb, 2011). 
Similarly, in other studies, corneal astigmatism between 0.25D and 1.25D was 
observed in 64.4% and in 22.2% was greater than 1.50D (Ferrer-Blasco and 
Montés-Micó, 2009). Therefore, failing to address corneal astigmatism at the time 
of cataract surgery can clearly result in unaided distance visual acuity (UDVA) 
significantly less than the visual potential. This has been shown to be associated 
with reduced quality of life (Tahhan et al., 2013; Nejima et al., 2015). 
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To reduce post-operative spectacle dependence and maximize unaided distance 
visual acuity UDVA, various techniques have been introduced to reduce corneal 
astigmatism at the time of cataract surgery. These include on-axis incisions with 
or without opposite clear corneal incisions, limbal relaxing incisions (LRIs), 
femtosecond laser assisted arcuate keratotomies (FS-AK), toric IOLs, and post 
cataract surgery excimer laser refractive surgery (bioptics) (Titiyal et al., 2014; 
Javier Mendicute et al., 2009; Qammar and Mullaney, 2005; Abbey et al., 2009; 
T. C. Y. Chan et al., 2015).  
 
The main drawbacks of LRIs are the lack of reproducibility of incision length and 
depth leading to often unpredictable results (Lim et al., 2014; Kaufmann et al., 
2005). There may also be a degree of increased post-operative discomfort and 
although complications are rare, infection within the LRI, corneal melt and 
perforation have been described. 
  
Femtosecond laser-arcuate keratotomy (FS-AK) can relax and effectively flatten 
the steepest meridian of corneal astigmatism by precisely incising the corneal 
stroma. Indeed, it is possible to create intra-stromal FS-AKs which avoid incising 
the epithelium, negating additional post-operative ocular surface symptoms and 
risks of infection.(Day, N. M. Lau, et al., 2016; Day and Stevens, 2016a) When 
FLACS is being performed, the inclusion of FS-AKs can be accomplished in a 
matter of only a few additional seconds as the laser performs its other functions. 
Due to the automated nature of the technique, the incisions are precise and 
reproducible with several studies showing a benefit in post-operative corneal 
astigmatism and unaided visual acuity (T. C. Y. Chan et al., 2015; Nejima et al., 
2015; Rückl et al., 2013; Day, N. M. Lau, et al., 2016). However, the management 
of large amounts of corneal astigmatism, greater than 1.5D, may still require the 
use of a toric intraocular lens due to the inherent limitations of astigmatic 
keratotomy techniques. 
 
1.4.3.3. ANTERIOR CAPSULOTOMY 
Potential benefits of laser-delivered capsulotomy instead of manually created 
CCC include a more centred and more circular opening, which in turn may allow 
better IOL centration (L. Mastropasqua, Toto, Mattei, et al., 2014; Nagy et al., 
2011). Several studies have demonstrated less IOL decentration after FLACS 
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compared with manually created CCC (Kránitz et al., 2011; Nagy et al., 2011; 
Kránitz et al., 2012). This is promoted as one of the main benefits of FLACS, 
especially for patients where lens position is of increased importance, such as 
when multi-focal IOLs are used. However, this is perhaps a contentious benefit. 
In a prospective case study series of 255 eyes undergoing manual CCC, there 
was no difference in IOL tilt or decentration between well centred or eccentric 
CCCs (Findl et al., 2017). In addition, a case-control study which investigated the 
use of premium IOLs in patients undergoing CPS and FLACS showed no 
significant difference in mean postoperative spherical equivalent refractive error 
or mean absolute refractive prediction error, although higher order aberrations 
were not investigated (Lawless et al., 2012). Similarly, a randomised intra-
individual comparison of 50 patients receiving FLACS and CPS to each eye 
showed no differences in terms of visual acuity, central corneal thickness, 
macular thickness, or lens decentration at 1 week and months 1, 3 and 6 (Mursch-
Edlmayr et al., 2017). Interestingly, a one year follow up study of 33 patients 
undergoing FLACS in one eye and CPS in the other eye showed less deviation 
in the size of the anterior capsulotomy in the FLACS group, but this did not 
translate to a difference in corrected distance visual acuity (CDVA), ELP or 
refractive error (Panthier et al., 2017).  
 
A major concern of FL capsulotomy creation are reports of an increased risk of 
anterior capsular tears compared with manual CCC. Anterior capsular tears may 
occur in relation to, or independent of, incomplete capsulotomies or where focal 
tags exist. A dimple down technique has been described in the management of 
focal tags (Arbisser et al., 2013). In a study of over 4000 eyes in a single centre, 
an incidence of anterior capsular tears of 1.84% with FLACS versus 0.22% in 
manual CCC was reported (Abell et al., 2015). Other studies have shown 
conflicting results, with a case series of 1,000 FLACS (using the same device as 
the study described above) having an anterior capsular tear rate of only 0.1% 
(Day et al., 2014). A number of hypotheses have been proposed to account for 
the increased rate of capsular tears associated with FLACS, including patient 
movement during capsulotomy formation and irregularities at the capsulotomy 
edge. Studies have aimed to evaluate the capsulotomy edge using scanning 
electron microscopy (SEM). A SEM study comparing the removed anterior 
capsule of 12 manual CCCs with 48 FL capsulotomies of varying energy settings 
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demonstrated increasing irregularity of the capsulotomy edge (Figure 1.4.3-A) 
with increasing FL energy settings (L. Mastropasqua et al., 2013). The irregularity 
seems to be independent of which FL device is used (Harthi MD et al., 2014). 
Another SEM study examined the capsulotomy edges compared with manual 
CCC edges using objective metrics such as arithmetic mean deviation of the 
surface and found increased irregularities in the FLACS groups (Serrao, 
Lombardo, Desiderio, et al., 2014). A SEM and atomic force microscopy 
evaluation of FL capsulotomies and manual CCCs modelled that the smooth 
edge of CCCs result in the uniform distribution of forces compared with focal high 
stress concentrations in frayed or notched portions of FL capsulotomies (Lua et 
al., 2016). However, this has not been fully  borne out in mechanical testing  
(Auffarth et al., 2013; Sándor et al., 2014). Indeed, a prospective inter-eye 
comparison tested the breaking force and breaking strain of capsulotomy 
samples of 39 patients with bilateral cataracts having CPS in one eye and FLACS 
in the other and found no differences in the mean breaking force or breaking 
strain between the CPS and FLACS group (T. Chan MBBS et al., 2017). It 
appears that there is a degree of irregularity in the FL capsulotomy edges 
compared to manual CCC, the precise nature of which varies with the laser 
platform and settings used but is present in all currently used devices,. This 
irregularity may be responsible for some degree of weakness of FL created CCCs 




Figure 1.4.3-A Scanning electron microscopy images of (B) manual CCC and (D) FL capsulotomy edge. From Lua, 
M. R., Oertle, P., Camenzind, L., Goz, A., Meyer, C. H., Konieczka, K., et al. IOVS (2016).  
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It is important to note, that the femtosecond laser is not the only device available 
for creating automated CCCs. Indeed, the advent of the FL in cataract surgery 
has appeared to generate interest in exploring alternative, single-use, disposable, 
and portable technologies for CCC in order to automate this step within cataract 
surgery whilst obviating the substantial capital outlay costs for a FL device. In late 
2015, the Zepto device (Mynosys Cellular Devices, Inc.) was given Conformité 
Européene (CE) approval. This device consists of a disposable handpiece with 
an elastic circular nitinol element at its tip, encased in a soft silicone suction cup 
(D. F. Chang et al., 2016). The tip is inserted into the anterior chamber through a 
2.2mm corneal incision. Once inside, the silicone cup is placed centrally and 
suction is applied to oppose the capsulotomy ring to the capsule. Brief pulses of 
electricity are discharged through the nitinol ring to create the capsulotomy, after 
which the suction cup is released. The disposable handpiece is connected to an 
external control console operated by an assistant for applying suction, energy, 
and releasing. However in the largest case series of 100 consecutive patients 
treated with this device there was a reported 28% incomplete capsulotomy rate 
(focal tags 18%, broad attachments 10%) (Hooshmand et al., 2018).  
 
Similarly, the Capsulaser (Capsulaser) is a microscope-mountable device 
featuring a laser focused on a trypan blue–stained anterior capsule delivering a 
singular circular pattern to create a CCC. The Capsulaser’s application to the 
capsule is continuous, unlike the femtosecond laser’s postage stamp 
perforations. It is understood that the irradiation causes the conversion of type IV 
collagen to amorphous collagen at the edge of the capsulotomy which may offer 
more elasticity and tear strength. As yet no peer reviewed studies exist for this 
device, although initial reports are encouraging (personal correspondence, 
Richard Packard). 
 
Another potential benefit of a more circular capsulotomy and a more centred 
intraocular lens is a more consistent overlap between the edge of the 
capsulotomy and the edge of the IOL (Nagy et al., 2011; Kránitz et al., 2011). 
Better overlap between the lens edge and the capsulotomy may reduce the 
incidence of posterior capsular opacification (PCO) post operatively (Kovacs et 
al., 2014).  
 27 
 
PCO is one of the most common post-operative complications after cataract 
surgery. Theoretically, by creating a better overlap of the capsulotomy edge and 
IOL optic, FLACS could reduce need for subsequent posterior capsulotomy by 
reducing migration of lens epithelial cells (when used in conjunction with a 
square-edged optic design) (Findl et al., 2010). Although Nd:YAG capsulotomies 
are a relatively low cost, low risk procedure, it does require  additional visits of 
the patient to their ophthalmology service, which leads to patient and societal 
costs. A retrospective study of 39 CPS and 40 FLACS eyes showed an increased 
PCO level on digital retro-illumination photographs of the posterior capsule in the 
CPS group between 18 – 26 months after surgery (Kovacs et al., 2014). A 
retrospective cohort study of 1534 eyes showed FLACS Nd:YAG capsulotomy 
rate of 11.6% compared with 15.2% in CPS over 3 years (p=0.04) (Tran et al., 
2016). 
 
1.4.3.4.  FL-ASSISTED NUCLEAR FRAGMENTATION 
In vitro and animal studies have demonstrated that phacoemulsification energy 
causes oxidative stress and free radical production which lead to cellular injury to 
the corneal endothelium.(Murano et al., 2008; Shin et al., 2009) Adopting 
techniques to reduce the effective phacoemulsification time (EPT) is considered 
good practice among cataract surgeons to limit such effects. FLACS has been 
designed to pre-treat the lens, using linear or fragmentation patterns to segment 
the nucleus or soften harder cataracts with the intention of reducing thermal or 
ultrasound energy delivered to the corneal endothelium (Conrad-Hengerer, 
Hengerer, Schultz, and Dick, 2012a; 2012b). Different patterns of laser grids 
applied to the lens nucleus may influence the amount of ultrasound energy 
delivered to the cataract (Conrad-Hengerer, Hengerer, Schultz, and Dick, 2012b; 
Ahn et al., 2016). EPT correlated with density of lens opacity (LO) in 150 eyes 
undergoing cataract surgery but was significantly reduced in the FLACS group of 
88 eyes for all grades of LO compared with CPS (Mayer, Klaproth, Hengerer, and 
Kohnen, 2014). In another series of 124 eyes the positive correlation between 
Scheimpflug densitometry of the lens and cumulative dissipated energy (CDE) in 
FLACS was confirmed (Al-Khateeb et al., 2017). 
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In a case-control study, the amount of phacoemulsification energy delivered 
intraocularly to cataracts pre-treated with femtosecond laser was reduced by an 
average of 84%, with 30% of patients not requiring any phacoemulsification 
energy whatsoever to remove the cataract (Abell, Kerr, and Vote, 2013b). In a 
randomised controlled study (RCT), Palanker et al found that phacoemulsification 
energy was reduced by 39% in eyes treated with FLACS compared with PES 
(Palanker et al., 2010). Interestingly, in a RCT of 400 patients (200 CPS, 200 
FLACS) treated with an active fluidics phacoemulsification machine, there was a 
reduction in CDE in the FLACS group but this did not translate into a difference 
in ECL (Hida et al., 2017). 
 
Reduced phacoemulsification energy may translate into reduced ECL, which 
reduces the risk of post-operative corneal decompensation and bullous 
keratopathy. Several studies have shown reduced ECL after FLACS compared 
with CPS (Conrad-Hengerer et al., 2013; Krarup et al., 2014; Abell, Kerr, et al., 
2014). One intra-individual study showed no difference between FLACS and CPS 
in ECL at 3 months (Krarup et al., 2014). There are many difficulties in trying to 
conclusively demonstrate whether FLACS is less traumatic for the endothelium 
compared to CPS. Pseudophakic bullous keratopathy (PBK) is sufficiently rare 
that a prospective RCT to investigate for this would require a vast number of 
operations to be sufficiently powered and need to correct for many confounding 
variables. A 2016 Cochrane review found no difference in ECL in 1638 cases 
(Day, Gore, et al., 2016). A 2016 Canadian meta-analysis of 14,567 eyes showed 
a difference of 55cells/mm2 in favour of FLACS but whether this is of clinical 
significance is debatable. Perhaps the best way to tease out an effect is to 
examine the effects of FLACS on the endothelium of high risk groups, namely 
mature cataracts or patients with endothelial compromise. A prospective 
nonrandomised cohort study comparing FLACS with CPS in grade 4-5 hard 
nuclei demonstrated reduced EPT, and reduced ECL in the FLACS group (11.4% 
± 12.1 in FLACS, 25.7% ± 18.9 in CPS at one month, p<0.001) (Xinyi Chen MD 
et al., 2017). However, a single-centre retrospective series of 207 eyes (FLACS 
n=64, CPS n= 143) with Fuch’s endothelial dystrophy did not show a statistically 
significant differences in rates of corneal decompensation (FLACS 17%, CPS 
10%, p=0.18) (Zhu et al., 2018). 
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1.4.3.5. USE OF FLACS IN COMPLICATED CATARACT SURGERY 
The speed of capsulotomy formation by the FL is dependent on the specific 
platform, but commonly occurs in less than 3 seconds. This can facilitate opening 
the capsule of intumescent white cataracts reducing the risk of complications of 
posterior extension (Conrad-Hengerer, Hengerer, Joachim, et al., 2014; Titiyal et 
al., 2016). Case reports of FL capsulotomy completion in other anterior capsular 
anomalies, such as Alport’s syndrome, have been published (Barnes and Roth, 
2017). A technique for rescuing an emigrating CCC using a FL has been 
described (Dick and Schultz, 2014a). Postoperatively, there have been several 
case reports published on its use in anterior capsule contraction/phimosis 
(Schweitzer et al., 2015; Gerten et al., 2016; Ibarz et al., 2017). A small case 
series demonstrated the safety of FLACS in patients with previous radial 
keratotomies, including successful anterior capsulotomies with no capsular tags 
(Noristani et al., 2016). 
 
The FL has been showed to be a useful and safe adjunct in a series of 47 eyes 
subluxed cataracts selected for FLACS where manual CCC can be especially 
problematic due to lack of lens support to allow countertraction, with over 90% of 
capsular bags successfully retained (Chee et al., 2017). 
 
The FL has been used to transect IOLs which require exchange (Anisimova et 
al., 2017) and can be used without adverse effect in cataract surgery with 
coexisting phakic IOLs and low endothelial counts before phakic IOL removal 
(Lee et al., 2017). The FL can also be used to perform a primary laser posterior 
capsulotomy just prior to or just after IOL insertion (Haeussler-Sinangin et al., 
2016; Schojai et al., 2017). It has also been used to this effect in paediatric 
congenital cataract cases (Bordin and Vizzari, 2016).  
 
1.4.3.6. COMPLICATIONS OF FLACS 
The risks of anterior capsular tear are discussed above. Fortunately for all 
stakeholders, the rates of complications of cataract surgery are low. Therefore, 
large studies are required to be adequately powered to investigate differences in 
safety between FLACS and CPS. One meta-analysis of RCTs and cohort studies 
of 14,567 eyes found an increased rate of posterior capsular rupture (PCR) in 
FLACS (RR, 3.73; 95% CI, 1.50-9.25; p<0.005) (Popovic et al., 2016). The largest 
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RCT to investigate complication rates with FLACS compared to CPS published 
to date included 200 eyes and reported one anterior capsular tear in the FLACS 
group and no events of PCR in either group (Conrad-Hengerer et al., 2015). 
Within the published RCTs the rates of PCR are cumulatively lower than expected 
(overall rate 1/976, 0.1%). This perhaps reflects patient selection for FLACS 
studies and/or the senior expertise of the surgeons undertaking them. In many 
such published studies, included patients are often within the private sector and 
self-paying, further increasing bias and limiting relevance of these studies in 
public health sector cataract surgery. With such low rates of complications, many 
studies are simply underpowered to detect differences in safety, requiring many 
thousands of cases to detect such differences. A retrospective review of 3371 
FLACS and 3784 CPS in the public sector in the US found increased risk of 
vitreous loss in the CPS group compared to FLACS (1.4% vs 0.8%, p<0.05) 
(Scott et al., 2016), while Abell et al.’s case-control study of over 4000 surgeries 
did not find a difference in the rate of PCR (0.43% vs 0.18%, N.S.)(Abell et al., 
2015). The EUREQUO case control study compared 2814 FLACS cases with 
4987 CPS and found no significant difference in the PCR rates of 0.4% and 0.7% 
(p=0.79) respectively (Manning et al., 2016). 
 
A single case report describes a limited supra-choroidal haemorrhage in a myopic 
patient (AL 27.57mm) after multiple failed docking attempts (Bozkurt and Miller, 
2016). 
 
1.4.3.7. FUTURE APPLICATIONS OF FLACS UNDER CURRENT INVESTIGATION 
A consistently sized and very reproducible sized capsulotomy allows for the 
design of intraocular lenses which are secured within the plane of the CCC, with 
haptics either side of the anterior capsular edge (Figure 1.4.3-A) (Thompson, 
2018). Theoretical benefits of such IOLs could include better refractive outcomes 
from a more consistent effective lens position (ELP) and less long-term 
decentration or subluxation, yet these perceived benefits have yet to be borne 





Figure 1.4.3-A The FEMTIS IOL (Oculentis) which features a plate haptic design for intracapsular fixation and 
four smaller haptics which are enclavated in front of the capsulotomy. Figure from Next Frontier in IOL Designs, 
Supplement to Cataract & Refractive Surgery Today Europe, October 2017. 
 
A laboratory study has demonstrated the use of a femtosecond lens to change 
the refractive properties of an intraocular lens ex vivo (Nguyen et al., 2018). The 
femtosecond laser device used in this study operated at an energy level below 
the threshold for ablation or cutting. It appears to induces chemical changes in 
the IOL substrate which affect its refractive index, without affecting the overall 
modulation transfer function of the IOL and is biocompatible in a rabbit model 
(Bille et al., 2017; Sahler et al., 2016; Werner et al., 2017). This application of FL 
technology has yet to be performed in vivo on a human, but may allow refining 
the post-operative refraction including toricity or multifocality. 
 
As discussed above, FLs have been used to perform a primary posterior 
capsulotomy at the end of FLACS (Schojai et al., 2017; Dick and Schultz, 2014b). 
Advantages of this technique would include definitively superseding the previous 
attempts to limit PCO in the visual axis by changing IOL material or design. This 
study reported this technique to be safe with no increased rates of CSMO or other 
complications. However, the requirement to redock the globe with the FL at the 
end of the procedure, could lead to unforeseen complications when vacuum is 
reapplied if the CCIs are not watertight (although this did not occur within the trial) 
(F. S. Lau et al., 2017). Furthermore, long term IOL tilt or decentration were not 
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evaluated, but would be a theoretical risk, considering the architecture of the 
capsular bag is altered before its fibrotic contraction in the postoperative period. 
However, an in vitro study on cadaver lens capsules did not demonstrate a 
difference in the post-operative fibrotic response, either by growth of lens 
epithelial cells or quantity of fibronectin, actin or collagen type I (Wetheimer et al., 
2018). 
 
1.4.3.8. META-ANALYSES AND REVIEWS 
A meta-analysis of FLACS vs CPS RCTs performed by Chen et al, identified 9 
RCTs (Xiaoyun Chen et al., 2015). Overall, they found that FLACS significantly 
reduced EPT compared to CPS. This did not translate into a difference in central 
corneal thickness or endothelial cell count at one week or beyond. The rates of 
surgical complications were similar. The post-operative corrected visual acuity 
was statistically superior in FLACS at 1 week and 6 months post-operatively but 
not at 1-3 months. There was no statistically significant difference in uncorrected 
visual acuity at any time point.  
 
A 2016 Cochrane Review analysed data from 16 RCTs including 1638 eyes. 
They rated all RCTs as having an unclear or high risk of bias with 11/16 authored 
by investigators with financial links to the manufacturer of the laser used. Due to 
the low level of evidence, they concluded, ‘There is currently not enough 
evidence to determine the benefits and harms of laser-assisted cataract surgery 
compared with standard ultrasound cataract surgery. The evidence is uncertain 
because current studies have not been large enough to provide a reliable answer 
to this question’ (Day, Gore, et al., 2016). 
 
A 2016 meta-analysis of RCTs and cohort studies found no difference between 
FLACS and CPS in terms of unaided or corrected visual acuity or refractive 
outcomes. FLACS was found to be beneficial in terms of EPT, ECL and post-
operative central corneal thickness (CCT) but appeared to have a greater rate of 
PCR (Popovic et al., 2016). 
 
1.5. Rationale for proposed study 
The average number of cataract cases performed on one NHS ophthalmic 
theatre half-day long list/session (3.5 - 4 hours) is unknown. ‘Action on cataracts’, 
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published in 2000, estimated the average to be between 6 and 7.(The Royal 
College of Ophthalmologists, 2000) The report stated that a benchmark of half 
an hour per case was a reasonable expectation. 15 years after the report, 6 cases 
on a theatre list remains typical. Due to the ubiquitous nature of cataract surgery, 
any gains in operational efficiency may have far reaching consequences. For 
example, if the average number of cataract operations were to be permanently 
increased from 6 to 7 per session this would represent a 17% increase in 
productivity. These theatre lists act as a source of income to the hospital as the 
NHS trust is reimbursed a fee for all operations performed. The current tariff for 
cataract surgery in 2015-2016 was £718 plus an additional market forces 
factor.(Department of Health, 2015b) Adding more cases to a theatre list creates 
more revenue, yet the overhead costs will remain largely similar and are unlikely 
to increase by as much. By improving efficiency of the running of the theatre, the 
hospital can provide more value for money to the NHS. 
 
The femtosecond laser can perform the 4 steps of cataract surgery (corneal 
incisions, arcuate keratotomies, capsulotomy and nucleus fragmentation) in less 
than one minute leaving only removal of lens fragments and insertion of the IOL 
to be performed by the surgeon. The potential benefits of automating several 
steps of the cataract operation may include better visual outcomes through 
greater precision and improved safety. These systems are expensive, both in the 
initial purchase and also the running costs, however to date the current highest 
level of evidence available shows no advantage in terms of safety of one method 
over the other hence the very limited adoption by the NHS so far (Day, Gore, et 
al., 2016). Despite these obvious costs, the laser removes several steps of the 
cataract extraction from needing to be performed by a trained surgeon, and from 
needing to be performed in an operating theatre (OR). In a hub and spoke model 
with the FL application being performed outside the OR and then feeding cases 
into multiple ORs, there is the potential to improve productivity and patient 
throughput in the operating theatre. By reducing the amount of time each patient 
spends in the actual OR, the volume of surgical cases may be increased per 
given time. If the number of cases within one theatre session can be increased 
sufficiently then the initial expenditure and additional costs associated with FL 
technology might be offset. The extra efficiency required to offset these costs 
remains unknown and is the focus of this research. 
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This thesis centres on the introduction of a FL to an inner-city teaching hospital 
cataract service to better understand its possible role within public health service 
high volume cataract surgery. Time motion studies of cataract lists and 
hypothetical financial modelling were completed before its introduction. The 
learning curve of 3 surgeons previously unfamiliar with this technology was 
studied in the lead up to a randomised clinical trial. A randomised controlled trial 
was designed which aimed to further resolve uncertainty about the clinical 
differences of femtosecond laser assisted cataract surgery (FLACS) compared 
with CPS. Within this trial, the cataract service was run as high-volume model 
involving the use of a FL as part of a hub-and-spoke model. The efficacy of such 
a service had not been previously evaluated in the peer-reviewed literature. 
Efficiency parameters of both the FLACS and CPS services were evaluated and 
used as inputs for a hypothetical financial model examining the cost of FLACS 
within the NHS. Clinical parameters including vision related outcomes, rates of 
complications, patient reported outcome measures (PROMs) and management 
of corneal astigmatism were recorded to ensure that there was no difference in 
clinical outcome or patient perceptions between the two groups. The primary 
hypothesis was to test whether FLACS can improve theatre efficiency sufficiently 
to offset the initial cost of the machine, with no disadvantage to the patients in 
terms of poorer clinical outcomes or patient satisfaction, and therefore comment 




Chapter 2. Time and motion studies of National 
Health Service Cataract Theatre lists to determine 
strategies to improve efficiency. 
Supplementary material #1. Roberts, H., Myerscough, J., Borsci, S., Ni, M., & O'Brart, D. P. S. (2017). 
Time and motion studies of National Health Service cataract theatre lists to determine strategies to 




2.1.  Introduction 
 
With current financial constraints, the increased future demand for cataract 
surgery within the NHS is liable to be problematic. Meeting an ever-greater 
demand with a constrained budget requires an improvement in efficiency while, 
ensuring that standards of patient care are maintained or improved. A recent 
report from Monitor (Department of Health) estimated that 13-20% productivity 
gains might be made in elective ophthalmology if practices were optimized 
(Monitor, 2015a). The recently published The Way Forward report, found a 
median of 7 cases scheduled per theatre list (Range 4-12) (Royal College of 
Ophthalmologists Cataract Surgery Commissioning Guidance Development 
Group, 2017), which represents an almost three-fold difference in productivity 
between minimum and maximum values. Why this three-fold difference in 
productivity between minimum and maximum values exists in public sector 
cataract surgery has not received the due attention it should. 
 
In 1911, F.W. Taylor introduced the time and motion study (TMS) as an 
application of the scientific method to the management of workers to improve 
productivity. Historically, TMS was applied to the manufacturing industry. 
However, it is has also been shown to have useful applications within healthcare 
(Burke et al., 2000; Finkler et al., 1993). A century after the introduction of 
scientific management method, there is genuine interest in aggregating 
knowledge in healthcare workflow, inefficiencies, patient safety and quality. 
Among several approaches commonly used to date, TMS, which involves 
continuous and independent observation of clinicians’ work, is generally regarded 
as a more reliable methodology compared to alternative approaches such as 
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work sampling and time efficiency questionnaires (Burke et al., 2000; Finkler et 
al., 1993). 
 
To provide a quantitative assessment of the efficiency of cataract surgery across 
several UK hospitals, a TMS investigation was conducted at several different 
institutions and settings. These included: weekend waiting list initiative sessions, 
the provision of NHS cataract surgery in the private sector, as well as routine 
cataract surgery lists in NHS hospitals. Focus was placed on surgical time, 
surgeon tasks within and outside theatre, patient throughput, staffing levels of 
allied health care professional (AHPs) and their key tasks and timings. By 
analysing these variables and investigating correlations between them, it was 
hoped to provide greater awareness of different models of practice, to identify 
important factors leading to differences in the individual number of cataract 
operations per theatre session and provide information to improve surgical 
productivity while maintaining high levels of patient safety. To my knowledge, 
there are no previous examples of such TMS investigations of cataract surgery 
with a public health setting in the literature.  
 37 
2.2.  Methods 
 
Continuous observation TMS of 18 routine four-hour cataract theatre sessions, 
was undertaken in 5 different hospitals and settings. These settings included two 
district general hospitals, two teaching hospitals, a weekend waiting list initiative 
theatre session in an NHS hospital, a dedicated high-volume theatre list in an 
NHS hospital and an NHS cataract surgery list in a private hospital (Table 2.2-A). 
The five institutions studied were the BMI Southend Private Hospital, Norfolk and 
Norwich NHS Foundation Trust, Guy’s & St Thomas’ NHS Foundation Trust, 
Southend University Hospital NHS Foundation Trust and West Suffolk NHS 
Foundation Trust. A consultant ophthalmic surgeon or associate specialist 
performed all lists, no lists were designated teaching lists. All patients were listed 
for only routine cataract surgery and all surgeries were conducted by 
phacoemulsification with intraocular lens insertion under local anaesthesia. All 
cases were unilateral. The number and type of AHPs supporting each individual 
theatre list was recorded (Table 2.2-A). 
 
Each list had been observed prior to undergoing TMS investigation to identify 
preliminary staffing models and tasks (Table 2.2-A and Table 2.3-A). Agreement 
analysis was used to define the list of tasks and then a basic model for each 
setting was set up and used as a template to observe and time the steps of every 
defined task (table 2). Each list was observed by one or two ophthalmologists. 
Each observer used a template Excel spreadsheet (Microsoft Corp, Redmond, 
WA) with specifically designed macros to facilitate the prompt and accurate 




Institution 1. 2. 3. 4. 5 







 Routine theatre 
list 
 Weekend initiative 
list 






















scheduled / list 






Total number of 
cases studied 









the day (%) 









3 nurses 3 nurses, 1 
HCA 
3.5 nurses, 1 ODP  
 3 nurses, 1 HCA 
 4 nurses, 1 HCA, 




2 nurses, 1 
HCA, 1 ODP 
Table 1.4.3-1. Details of cataract theatre lists studied. (HCA = Health care assistant. ODP = Operating Department 
Practitioner) 
 
Noting the start and finish times of some of the key tasks was self-explanatory, 
while other tasks required specific moments agreed upon in advance to maintain 
reproducibility. Surgical start and end times were regarded at the point of insertion 
or removal of lid speculum. Patient entry time was defined as the time from patient 
entry into theatre until final positioning for surgery had been achieved. Patient 
exit time was defined as the time from removal of lid speculum to patient exiting 
the theatre. Start and end of scrubbing were regarded as the opening of the tap 
and finishing the gowning process. The start and end of the safety checklist were 
recorded once the first member of staff began speaking until the last member of 
staff had finished speaking. The start of the scrub nurse clearing up from the case 
was the time when the first instrument was passed out or dismantled once the lid 
speculum had been removed. The end of clearing time was recorded once the 
scrub nurse re-entered the theatre from the sluice, having disposed of all 
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equipment and waste. The cause and duration of any unexpected delays greater 
than 5 minutes were recorded. 
 
In addition to defining each key task and its reproducible start and finish, a series 
of quotients were defined as follows and produced for each setting. The efficiency 
quotient was defined as the proportion of time that the surgeon was engaged in 
a task (total surgeon time spent productive/total time(Gavin C Harewood MD et 
al., 2008). The surgery quotient was defined as the proportion of time that surgery 
was occurring (total surgical time/total time). The theatre utilisation quotient was 
defined as the utilisation of the maximum available theatre time (time between 
start of first and end of last case/4 hours) (Weinbroum et al., 2003). 
 
2.2.1. Statistics 
Data is presented as non-parametric and parametric as appropriate. Differences 
between the groups were analysed with analysis of variance (ANOVA) one-way 
test where appropriate. Linear regression models were calculated to estimate the 
key factors effecting the time to perform the surgery, and the time an individual 
patient spent in theatre. Descriptive statistics was used to calculate averages and 
standard deviation of the performances in each list. IBM SPSS Statistics for 
Windows (Version 22.0. Armonk, NY: IBM Corp) was used to perform the 
analysis.   
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2.3.  Results 
 
TMS of 140 individual cataract operations were prospectively recorded during 18 
NHS cataract theatre sessions. All cataract operations were performed with 
phacoemulsification. All operations were under local anaesthesia. All operations 
were unilateral. No operations were combined procedures or required additional 
procedures outside small-incision phacoemulsification cataract extraction and 
intraocular lens insertion. The details of each theatre session can be seen in 
Table 2.2-A.  
 
 
Figure 2.2.1-A Diagram of model summarizing the results of the time motion studies 
 
Timings from each theatre list can be seen in Table 2.3-A and Figure 2.2.1-A. 
The reason and duration of any unscheduled delays can be seen in Table 2.3-B. 
Mapping of the workflow of the 2 highest volume theatre lists can be seen in 
Figure 2.2.1-B and Figure 2.2.1-C. 
 
The median number of operations per 4-hour theatre session was 7 (range 5 - 
14). The mean time to perform a cataract operation was 10.3 minutes (min) 
(standard deviation (SD) 4.11 min). The mean time to complete one case 
including patient turnaround was 19.97 min (SD 8.77 min). The mean surgical 
scrub time was 1.86 min (SD 0.77 min). The mean time to complete pre-
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procedure WHO checklist was 0.55 min (SD 0.52 min). The mean time to 
complete post procedure paper/computer work was 1.77 min (SD 1.35 min). The 
mean time for patients to enter theatre to being positioned for surgery was 2.28 
min (SD 1.88 min). The mean time from patient entry to start of operating was 
4.56 min (SD 1.49 min). The mean time for patient to exit theatre from removal of 
lid speculum was 1.90 min (SD 1.00 min). The mean duration of patients’ time in 
theatre was 17.07 min (SD 7.30 min). The mean time in between cases was 4.12 
min (SD 2.78 min). The correlations of the surgical time to patient time in theatre 
was R2=0.95. The correlation between surgical time and number of cases 
scheduled was R2 = 0.696. 
 
 
Figure 2.2.1-B Model of workflow of staff duties at Institution 3C 
 
The minimum number of AHPs (nurses/health care assistants/operating 
department practitioners) allocated to a theatre list in this study was 3. The 
majority of AHPs in this study were registered nurses. The two theatre lists with 
the greatest number of cases scheduled had either 4 or 7 AHPs (Table 2.3-C). 
There was a moderate correlation between number of AHP and number of cases 
scheduled (R2=0.489). If only the public healthcare settings were included 
(institutions 1, 2, 3A, 3B and 3C and 4) and one private institution was excluded 
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(institution 5), where practices may differ from the NHS, the correlation between 
number of AHP and number of cases scheduled was much higher (R2=0.823).  
 
 
Figure 2.2.1-C Model of workflow of staff duties at Institution 5 
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Institution 1 2 3A 3B 3C 4 5 
Average time of surgery 

























71.7% 67.1% 70.4% 67.9% 82.7% 50.8% 87.9% 
Theatre utilization 
quotient (assuming no 
cancellations) 
74.8% 73.2% 75.4% 76.4% 82.7% 59.3% 87.9% 
Efficiency Quotient 66.0% 65.2% 66.4% 71.9% 76.1% 65.6% 75.8% 
Surgery Quotient 53.2% 42.4% 44.0% 42.9% 52.9% 56.1% 56.7% 




















7.1 (3.67) 6.17 
(2.43) 
4.9 (56) 1.53 (0.7) 1.4 (1.12) 3.4 (1.4) 
Average time from patient 














Average time for patient 
to exit theatre after 
operation (S.D.) 
2.1 (1.1) 3.2 (1.03) 2.05 
(0.65) 








12.4 (2.8) 10.63 
(2.53) 






Average time surgeon 




3.7 (1.45) 1.85 
(0.93) 
1.88 (0.62 0 0 0.95 
(0.42) 








1.43 (0.4) 1.43 
(0.37) 
1.6 (0.53) 
Average nurse scrub time 
(S.D) 






2.4 (1.07) 1.47 (0.8) 
Average nurse time to 








7.17 (1.5) 5.6 (1.9) 5.27 
(1.53) 










2.6 (0.65) 3.9 (1.37) 2.07 (0.8) 
Average nurse time to 











7.5 (2.08) 3.48 
(2.07) 
Average time spent on 





0.7 (0.27) 0.45 
(0.15) 




Total number of key tasks 
performed by AHP per 
case 
11 11 12 12 15 12 18 
Average time taken to 
complete key tasks by 
































Table 2.2.1-1 Task durations in minutes from common tasks across the institutions studied 
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Institution 1 Institution 2 Institution 3B Institution 5 
Reason for delay Time Reason for 
delay 
Time Reason for 
delay 
Time Reason for 
delay 
Time 
Waiting for next 






















Waiting for next 
instrument trolley 
to be ready 
7.43 Surgeon 
required to see 
patient in clinic 
13.23 
Surgeon out of 
theatre 
8.75 Surgeon late 











  Waiting for next 
patient from 
day case unit 
10.5 
Waiting for next 
patient from 
day case unit 
8.95 
Total 39.88  79.88  10.3  11.75 
Table 2.2.1-2 The reason and duration, in minutes, of any unscheduled delays 
 
 
Setting Number of 
allied health 
professionals 
Median number of 
cataracts 
scheduled/session 
1 3 6 
4 3 7 
2 4 6 
3A 4.5 7.5 
3B 4 9 
5 4 13 
3C 7 13.5 
Table 2.2.1-3 Staffing levels associated with number of cases scheduled 
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2.3.1. Multiple linear regression models 
 
A multiple linear regression model was calculated to predict the time to perform 
one operation based on three factors: i) the number of AHPs, ii) the number of 
key tasks performed by AHPs and iii) time taken to perform these key tasks by 
AHPs. A significant regression was found (F (3,111) = 32.86 p<0.001) with an R2 
of 0.47. All the three factors were significant predictors of the time to perform a 
surgery. The surgical time decreases by 0.95 min for each additional AHP 
involved, by 0.39 min for every additional task performed by AHP, and by 0.19 
min for each additional minute spent by AHP performing tasks. 
 
An ANOVA-one way was performed to control for the effect on surgical time by:  
i) the number of AHPs, ii) the number of key tasks performed by AHPs and iii) 
time taken to perform these key tasks by AHPs. There was a significant effect 
(p<0.001) of all the factors as follows: i) F(1,113) = 35.12, p=0.001), ii) 
F(1,113)=53.43, p=0.001); iii) F(1,113)=42.23, p=0.001) (Figure 2.3.1-A).  
 
A similar multiple linear regression model was calculated to predict the effect of 
the same three factors i) the number of AHPs, ii) the number of key tasks 
performed by AHPs and iii) time taken to perform these key tasks by AHPs on 
the total patient time in theatre. Factors ii and iii were significant predictors of the 
time an individual patient spent in theatre i.e. the total time to complete one 
surgical case. The model was significant (F(2,116) = 43.18 p<0.001) with an R2 
of 0.43. The length of patient time in theatre decreased by 0.76 min for each task 
performed by AHPs and by 0.19 min for each minute spent by AHPs to perform 
their tasks. 
 
An ANOVA-one way was performed to control the effect on the total patient time 
in theatre by i) the number of AHPs, ii) the number of key tasks performed by 
AHPs and iii) time taken to perform these key tasks by AHPs. There were 





Figure 2.3.1-A Represents the significant relationships identified by ANOVA. The average time to perform the 
surgery was equal to 10.25. The average time to perform the case was equal to 14.08. Section A: shows the 
relationship between the time to perform the surgery and number of AHPs. Section B: shows the relationship 
between the time to perform the surgery and number of tasks performed by AHPs. Section C: shows the 
relationship between the time to perform the surgery and the time spent by AHPs to perform their tasks. Section 
D: shows the relationship between the time to perform the case and number of AHPs. Section E: shows the 




2.4.  Discussion 
 
This study adopted a TMS approach to evaluate the efficiency of public sector 
cataract surgery in the UK. A significant variance in the running of cataract theatre 
lists at five different UK institutions was observed, the most striking of which is 
the number of patients scheduled per list, which ranged from medians of 6 to 
13.5. From the perspective of the public healthcare sector, it is imperative to 
maximize the efficiency of elective surgery while maintaining quality and 
safety(Monitor, 2015a). The average duration of a cataract operation was 10.3 
min and the total time including pre- and post- procedure preparation and patient 
turnaround was 19.97 min. It could be expected therefore that at least 12 
operations could be completed in a 4-hour session and yet the median number 
of cases booked to a theatre list of 7 is much less. Based on the results of this 
TMS, one could expect that an increase in 70% efficiency might be possible. 
Whether this is an achievable target and why it is not currently being realized is 
a matter of conjecture, but certainly it highlights the great need to identify possible 
factors necessary to improve the efficiency of NHS cataract surgery.  
 
It was interesting to document that the sessions (institutions 3C and 5) providing 
the highest median number of cases per list (13, 13.5) and highest theatre 
utilization and efficiency quotients, had the longest duration of staff breaks, 
suggesting that these units have discovered how to ‘work smarter, not harder’ 
(Table 2.3-A, Figure 2.2.1-A, Figure 2.2.1-B, Figure 2.2.1-C). This strongly 
suggests that by changing working practices efficiency can be improved without 
increasing individual staff workload. 
 
This assumption is supported by the observation that institutions 4 and 5 share 
the same population, yet there are noticeable differences between the TMS of 
their theatre sessions, especially in terms of median number of cases per list (7 
versus 13), theatre utilization quotient (50.8% versus 87.9%) and efficiency 
quotient (65.6% versus 75.8%) (Table 2.3-A). As patient demographics should 
be similar at these two settings, differences in practice and efficiency presumably 




In considering the TMS of the surgeons, it is important to recognize that the 
theatre session is not an independent entity. Rather, differences in theatre 
practices often stemmed from factors outside the theatre itself, such as in the day 
case ward/clinic. For example, at institutions 1 and 4, the surgeons performed 
slit-lamp examination and marked all patients on the day of surgery, at institution 
2 the surgeon met the patients and marked them, at 3A/B/C the surgeon met the 
patient, marked and consented them, while at 5 (which had the highest theatre 
utilization quotient and second highest median number of cases at 13) all such 
tasks were performed by staff on the day-case unit. This suggests that utilizing 
AHPs to undertake some of the duties of the surgeon outside theatre, might be 
an important factor in improving efficiency by ensuring that the surgeon spends 
as much in theatre as possible during each allocated 4-hour cataract surgery 
session. This is supported by the observation that institution 1 (with a joint lowest 
median number of cases of 6 and an efficiency quotient of only 66%) was the 
only unit in which there was both staggered patient arrival and surgeon 
performing pre-operative examination, leading to the surgeon leaving the theatre 
for 26.57 min out of theatre during the 4 hour sessions (Table 2.3-A and Table 
2.3-B). Similarly, at institution 2 (joint lowest median number of cases of 6 and 
efficient quotient of 65.2%), the surgeons spent 48.75 min outside the operating 
theatre due to out-patient clinic overrun and the need to see additional patients 
on the day case ward (Figure 2.2.1-A, Table 2.3-A and Table 2.3-B). Clearly to 
achieve optimum efficiency it is imperative for the surgeon to be available within 
theatre to undertake the surgery rather than performing duties outside. Whether 
this is best achieved by AHPs performing such outside duties instead of the 
surgeon as at institution 5, or ring-fenced time before the theatre session itself is 
a matter of conjecture. 
 
Some units allowed patients to arrive on a staggered basis for their convenience 
and reduced overall patient waiting time (institutions 1, 3A/B/C, 5), while the 
remainder requested that all patients were present for the pre-theatre ward round. 
As such practices did not affect the overall median number of cases or efficiency 
quotients (Table 2.3-A), it seems a reasonable approach to stagger arrival times 
for patient convenience, provided protocols are introduced to avoid surgeons 
spending time out of theatre, as at institution 1. 
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Based on the observations of this current study, a minimum of 4 AHPs appear to 
be required to provide a high-volume service. This criterion was met at all settings 
other than institutions 1 and 4 (Table 2.3-C). Increasing the number of cases 
towards the goal of high volume lists may require either/both an increase in the 
number of AHPs supporting the surgeon with additional tasks (as in setting 3C) 
or changes in working practice (as in setting 5), with 4 AHPs performing more 
supporting tasks. It appears that in addition to the scrub nurse and circulating 
AHP, at least two AHPs are required to be able to clear up from the previous case 
and, more importantly, prepare for the subsequent case so there is only a minimal 
wait between cases. This is achieved at institutions 3C and 5 (this lists with the 
highest volumes of patients treated per session) with 18.92min and 22.63min of 
total AHP preparation time respectively before the patient even enters theatre 
(Figure 2.2.1-B and Figure 2.2.1-C). Ideally, the gap between cases needs to be 
minimized to the time it takes to escort the patient out and in, perform the WHO 
checklist, and for the surgeon to rescrub. In this series, the length of time from 
the end of one case to the start of the next ranged from 5.92 to 16.8 min. 
 
Between the institutions the average surgical time varied from 7.43 to 15.98 
minutes. This variation may reflect different case mix or differences between 
surgeons with some being faster than others or using more efficient equipment, 
such as the phacoemulsification machine. The surgeons in lists 3C and 5 have a 
national reputation of excellence and are known for their expertise and surgical 
skills and this may have created outlying results. However, despite this the 
correlation between AHP numbers and tasks was strong and means that 
efficiency can be improved for those that do not have exceptional surgical skills. 
The correlation between surgical time and number of cases scheduled was R2 = 
0.696, suggesting that factors such as surgical experience and case mix are likely 
to have a part to play in cataract surgery efficiency. However, a significant 
correlation was found in this study between the time undertaken to perform 
cataract surgery and the number of AHPs, the number of key tasks performed by 
AHPs and the time taken to perform these key tasks by AHPs (p<0.001). This 
was confirmed by ANOVA one-way testing, suggesting that alteration of the 
number of AHPs supporting a cataract surgery list and surgeon, their duties and 
their total time performing tasks, is strongly associated with and can indeed 
influence the time to perform individual cataract surgery (Figure 2.3.1-A). 
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Similarly, a strong correlation, confirmed by ANOVA one-way testing, was found 
between the number of key tasks performed by AHPs and the time taken to 
perform these key tasks by AHPs on the total patient time in theatre (p<0.001). 
Such correlations appear to high-light the importance of AHPs and their 
designated tasks in the development of high volume NHS cataract surgery. 
 
Concerning institution 5, which appeared to be an outlier in terms of correlation 
of number of AHPs with efficiency, these results might be explained by the fact 
that this was a private institution with different working practices from public 
health sector settings and there were direct financial incentives for the numbers 
of patients treated which it could be assumed positively influence productivity. 
Most importantly, whilst the number of AHPs supporting the cataract theatre list 
at institution 5 was 4, the number of key tasks performed by AHPs per case was 
much higher at 18 than any other organization (Table 2.3-A). At institution 5, it 
clearly appeared that AHPs were undertaking many of the tasks performed by 
the surgeons at other institutions, which ensured that the surgeon was spending 
far more time in theatre undertaking surgery than at any other institution. As such 
this unit could optimize surgical productivity and theatre utilization. Indeed, the 
results at institution 5 strongly support the correlations concerning the importance 
of AHPs, their roles and tasks they undertake, in optimizing cataract surgical list 
efficiency. It appears that expansion of the role of AHPs in the public-sector health 
setting to incorporate some the non-surgical roles currently undertaken by the 
surgeon, as well as the maintenance of adequate AHP staffing levels is vital to 
optimize cataract surgery efficiency. 
 
There was generally an under-utilization of the full 4-hour (240 min) theatre 
session. Average theatre utilization was 70.11% (range 50.8% to 87.9%) and was 
73.9% (range 59.3% to 87.9%) when extrapolated to consider the cancelled 
operations. The reasons for delayed start of theatre sessions included the 
surgeon being delayed by an overbooked clinic or administrative duties on the 
day case ward (table 3). Pre-operative examination of surgical patients and 
associated duties (patient marking, confirmation of consent, etc.) is an integral 
part of the surgical process, but duration should be minimized to maximize 
potential surgical time. However, in the interests of patient safety, it is not 
suggested that the target for theatre utilization should be 100% due to the 
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possibility of a case taking longer than expected or the event of a surgical 
complication, albeit the risks of surgical complications in cataract surgery is 
generally low (<5%) (Day, Donachie, et al., 2015). 
 
The current study does have several limitations. Firstly, it focused on single 
independent consultant or associate specialist surgeon theatre sessions and not 
on training lists with junior doctors. Ophthalmic specialist trainees are known to 
take longer to perform cataract surgery than experienced consultants (Park et al., 
2016). Clearly there is a need to balance the desire for high volume services and 
the promotion of high quality provision of training for the next generation of 
surgeons. However, if sufficient high volume can be achieved in single surgeon 
lists, this can reduce the pressure of service-provision demands in training lists. 
Indeed, given the increased future demand for cataract surgery within the NHS 
(Chapter 1), there is a great need for senior trainees as future consultant 
surgeons to have exposure to high volume models of cataract surgery.  
 
Secondly, observations were made based on a relatively small number of 
observed sessions (eighteen). To our knowledge this is the first TMS of its kind 
in cataract surgery. TMS are, by their nature, very labour intensive. Historically, 
TMS would often require one observer for each person studied which would, of 
course, introduce great difficulty (logistical and financial) in studying a cataract 
theatre session. It was found that through the use of Macros on Microsoft Excel, 
timings for all staff involved with a theatre session could be recorded with only 
two observers. This study represents the first example of TMS of cataract theatre 
sessions published, which is of importance, especially in understanding 
differences in productivity within state-funded healthcare systems. Clearly, 
however, there is scope for future research incorporating greater numbers of 
operations at more institutions which may facilitate analysis of a greater number 
of factors and less risk of chance findings. 
 
It is also of note, that results from the five hospitals participating in this study, 
incorporated a mixture of academic centres and district general hospitals, with 
both rural and urban populations. They were chosen carefully to reflect a broad 
spectrum of environments. However, this study does not claim to represent 
universal provision of cataract services across the UK. We did not evaluate any 
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different case mixes, including theatre lists with a variety of different cases or 
where an anaesthetist is present. However, the vast majority of cataract surgery 
performed with the UK is undertaken under topical/local anaesthesia 
(Department of Health, 2015a; Day, Donachie, et al., 2015)  and the aim of this 
study was to focus on the delivery of high volume services, wherein general 
anaesthetic (GA) cases are unlikely to feature. Furthermore, it was assumed that 
all theatre teams were experienced with cataract theatre lists and familiar with 
working with each other. Indeed, during the TMS nothing was observed to the 
contrary. 
 
Finally, although the focus of this study was the efficiency of cataract surgery, the 
metrics of the quality of the surgery, such as post-operative visual acuity, post-
operative complications, post-operative refraction and patient satisfaction were 
not evaluated. Suggestions to changes in practice laid out in this chapter relate 
to improving efficiency only. It is important to remember that the quality of any 
aspect of cataract surgery and overall patient satisfaction should never be 
compromised to enhance efficiency, for example satisfaction may be adversely 
affected if surgeons lack sufficient time with the patient pre-operatively to 




This current TMS study, highlights the huge variation in the efficiency of cataract 
surgery, within the NHS. It suggests that by providing sufficient levels of AHP 
staffing and expanding the roles of AHPs to minimize patient turnover time and 
most importantly undertake some of the non-surgical tasks currently performed 
by surgeons during cataract theatre sessions when ideally they should be mainly 
concentrating on operating, productivity in cataract surgery and theatre utilisation 
could be significantly improved in the public sector. 
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Chapter 3. Financial modelling of Femto-second 
Laser Assisted Cataract Surgery within the 
National Health Service using a “Hub and Spoke” 
model for the delivery of high volume Cataract 
Surgery 
Supplementary Material #2. Roberts, H., Ni, M. Z., & O'Brart, D. P. S. (2017). Financial modelling of 
femtosecond laser-assisted cataract surgery within the National Health Service using a “hub and spoke” 






Until better evidence exists of improved surgical outcomes it is difficult at present 
to support the wide-spread implementation of FLACS. This is particularly 
pertinent as the introduction of FLACS has significant associated financial costs. 
These include initial purchase costs of the FL system itself, servicing, 
depreciation and the individual patient interfaces (PI), which call into question its 
financial viability, especially in a state funded healthcare system. The majority of 
existing literature on the economics of FLACS originates from healthcare systems 
within such countries as the US or Australia, where additional costs from 
procedures perceived as having a premium status may be passed onto the 
patient in the form of a co-payment system (Abell and Vote, 2014; Hansen and 
Hardten, 2015; Bartlett and Miller, 2016). In these healthcare systems, the 
existing literature suggests that FLACS is not currently a cost-effective solution. 
It is not surprising therefore, that adoption of this technology within the NHS so 
far has been minimal and largely directed at research rather than service 
provision.  
 
Despite associated costs, by its very nature the FL offers the potential to remove 
several steps of cataract extraction from needing to be performed by a fully 
trained surgeon in a fully-equipped ophthalmic operating theatre. FL technology 
can automate several surgical steps of the cataract procedure, such as corneal 
incisions, arcuate keratotomies, capsulotomy and nuclear lens division, all of 
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which can be potentially undertaken with this technology by a doctor in training 
or suitably trained nurse or technician in a clean room. By reducing the actual 
amount of time each patient spends within the operating theatre under the care 
of a trained surgeon, the volume of surgical cases undertaken in a given period 
might potentially be increased. This may be especially true if a “hub and spoke” 
model is utilized, with the FL performing these initial automated steps and then 
allowing the completion of the surgical procedure to be undertaken in more than 
one operating theatre at a time. If the number of cases per theatre session can 
be increased sufficiently then the initial expenditure and additional costs 
associated with FL technology might be offset.  
 
For FLACS to see increased adoption by a state funded healthcare system such 
as the NHS, it would need to be shown to be cost-effective based on an 
acceptable incremental cost effectiveness ratio (ICER). The ICER is defined by 
the difference in the cost between two possible interventions divided by the 
difference in their clinical effectiveness. This study aims to investigate, in the 
anticipation of outcomes from the subsequent RCT (Chapter 5), the cost of 
incorporating FLACS into the NHS system to determine whether the increased 







3.2.1. Financial Model 
 
A financial model was designed to compare FLACS against CPS for the provision 
of cataract surgery within the NHS. The inputs for this model can be seen in Table 
3.2-A. The model was based on data from four separate NHS Foundation Trust 
Ophthalmology Departments (Guy’s and St Thomas’ NHS Foundation Trust, 
Norfolk and Norwich NHS Foundation Trust, Peterborough and Stamford NHS 
Foundation Trust and West Suffolk NHS Foundation Trust) and four 
manufacturers of commercially available FL devices (Abbott Medical Optics, 
Santa Ana, CA; Ziemer Ophthalmic Systems AG, Switzerland; Alcon 
Laboratories, Inc., Fort Worth, TX and Bausch & Lomb, Rochester, NY). The data 
was collated and averaged to ensure the results were more representative than 
had just one ophthalmology department or one FL been used.  
 
Values for each input were derived from the following sources. 
i. Income for each procedure is reimbursed at the NHS national tariffs for 
2014-15 plus an additional market forces factor(Department of Health, 2016b; 
2016a). 
ii. Costs were divided into direct labour costs, equipment costs and 
overheads. Direct labour costs per theatre session were derived from NHS pay 
scales and midpoint values were chosen. This was then proportioned to the 
estimated duration of each theatre session.  
iii. Costs relating to the FL were averaged from those provided by four 
manufacturers of commercially available FL devices.  
iv. Costs such as estate, equipment, and supplies were averaged from four 
NHS Foundation Trusts’ departmental budgets (2014-15). 
v.  Pharmacy and administrative costs were obtained by reviewing the 
departmental budget at our institution. 
vi. Baseline values for the number of cases achievable per 4-hour theatre 
session were given nominal values of 7 cases for CPS and 10 cases for FLACS. 
These initial values were then tested using sensitivity and threshold analyses. 
 
The model was tested based on two scenarios: FLACS versus CPS based on an 
average number of 7 cases currently performed on a CPS cataract lists and a 
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FLACS delivery model based on a “hub-and-spoke” method with one FL in a 
clean room and operated by a doctor in training preparing patients for two 
operating theatres running in parallel with their associated surgeons, nursing and 
technical support staff.  
 
3.2.2. “Hub and Spoke” FLACS model 
  
The theoretical ‘hub-and-spoke’ model for FLACS is based on a single FL 
platform in a clean room and operated by an ophthalmology registrar or suitably 
trained allied health professional and supported by a theatre nurse (Figure 
3.2.2-A). The laser would be programmed to perform capsulotomy, nuclear lens 
division and arcuate keratotomies (when indicated) for each individual patient. 
Patients would be prepared for two operating theatres running in parallel with 
their associated surgeons, nursing and technical support staff. The assumed FL 
treatment time is a maximum of 10 minutes per patient allowing for the 
preparation of up to 20 cataract surgery cases, 10 per theatre per 4-hour 
operating theatre session. The assumed theatre time is a maximum of 24 minutes 








Source Input Value (£) Range (£) 
Income NHS tariff for 
cataract surgery 
789 729-917 
Expenses Staffing (per 
session) 
Consultant surgeon 246  




Band 6 nurse /laser 
technician 
102  









585,676 353,245 – 
962,287 
Laser Initial cost 262,500 175k – 350k 
Maintenance/year 28,333 20k-35k 
Cost of patient 
interface 
134.75 99-170 
Other costs Disposables and 
IOL (per case) 
103  












27 - 96 
Number of cases on 
CPS list 
7 operations  
Number of cases on 




Lifetime of FL 10 years  
Table 3.2.2-1 Inputs for the model and nominal values * Based on the hub and spoke FLACS delivery model 
 
3.2.3. Sensitivity Analysis 
The model was constructed using Microsoft Excel (Microsoft Corp, Redmond, 
WA) based on the range of the above inputs (Table 3.2-A). Uni- and bi-variate 
sensitivity analyses were conducted by varying the inputs into the model to 
simulate the impact on the final service costs. The inputs chosen for the sensitivity 
analysis were as follows: 
i. Capital cost of the FL 
ii. Cost of the PI 
iii. Number of cases possible on a FLACS theatre list 
iv. Number of cases performed on a CPS list 
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v. Number of cataract operations required per week 
 
Threshold analyses were performed on the same variables as the sensitivity 
analyses to determine threshold values at which FLACS may break even with 





The first model tested FLACS versus CPS based on an average number of 7 
cases currently performed on CPS cataract lists. Our model estimated that the 
current CPS service at its existing productivity was costing £433 per case. Using 
a model that incorporates one FL into one theatre list, and therefore assuming no 
increase in productivity, the laser increases the cost per case by £167 to £600. 
Based on these values, the CPS service would be 72% of the cost of a FLACS 
service. 
 
Using the averaged and nominal values for our theoretical “hub-and-spoke” 
model for FLACS, use of the FL reduced the weekly theatre requirements from 8 
CPS theatre sessions to 2.7 FLACS sessions with both theatres in the FL model 
running in parallel (total theatre sessions 5.4). This reduced the anticipated 
running costs of theatres, the ophthalmic day-case unit and staffing costs. 
However, the laser introduced additional costs into the model (FL equipment, 
supplies, maintenance and additional staff). Based on the nominal values, even 
with our hub and spoke model running optimally, the CPS service (average of 
£433/case) was found to be 86.3% of the cost of the FLACS service (average of 
£502/case).  
 
The capital cost of the FL when amortized over its lifetime of 10 years was £505 
per week (pw). Maintenance of the laser was £545pw. The cost of one week’s 




Figure 3.2.3-A Comparison of the costs per week of CPS compared with FLACS 
 
The model was not affected when the salary of the laser operator was changed 
from a mid-point registrar to a band 6 nurse as the hourly rates were of negligible 
difference (Table 3.2-A). 
 
Univariate sensitivity analyses were conducted by varying one variable at a time. 
Minimum and maximum values were obtained from the original data (Table 
3.3-A). Only when the number of operations on a CPS list were reduced or the 
number of operations on a FLACS list were increased, could the model give an 
output in favour of FLACS. Best and worst-case scenarios were constructed for 
both CPS and FLACS, by aligning the most important variables all in favour of 
one or other modality, with costs of £371 and £515 for CPS and £381 and £545 











Input Range of values Values inputted 
into hub-and-
spoke model 





Minimum 27 82.7 
Average 55 86.3 
Maximum 96 87.8 
Number of 
cataracts on CPS 
list* 
Minimum 5 108.5 
Nominal 7 86.3 
Maximum 9 73.8 
Number of 
cataracts on FL 
list** 
Minimum 8 78.6 
Nominal 10 86.3 
Maximum 16 100.8 
Initial cost of FL Minimum £175,000 86.7 
Average £262,500 86.3 
Maximum £350,000 85.7 
Cost of PI Minimum £99 92.8 
Average £135 86.3 






































96 5 10 50 £545 £381 143.2 
Table 3.2.3-1 A. Univariate sensitivity analysis of the hub-and-spoke model based on range of values from data 
collected 
*Assuming 10 cases on FLACS list 
** Assuming 7 cases on CPS list. 
B. Best case scenarios for CPS and FLACS 
 
Univariate threshold analyses were performed to demonstrate the ‘break-even’ 
values of each input. Keeping all other inputs at their original values, the model 
could not find solutions by which the FL broke even when the capital cost of the 
FL or the number of operations performed per week were chosen. The costs of 
the services were equivalent if the true number of cases on a CPS list was 6, or 
if the FL could increase productivity to 16cases/each theatre, or if the cost of the 
laser consumables were reduced to £66. It was thereby ascertained that these 
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three parameters are the most important in this model for determining a cost-
neutral scenario for FLACS. 
 
Bivariate sensitivity analyses were performed using combinations of the above 
inputs. For example, Table 3.3-B shows the outcomes of the model when the 
capacity for number of cases on both CPS and FLACS are simultaneously tested. 
It shows that the FLACS service would be required to approximately double the 
number of operations possible during a theatre list for FLACS to break even. 
Table 3.3-C tests the outcome of the model based on an assumption that the 
NHS or a hospital trust could negotiate lower PI costs based on the provision of 
a large number of operations per year. It shows that FLACS cannot break even 
unless the cost of the PI is significantly reduced (to approximately £50 per case). 




 Number of operations on CPS list 
Number of operations 
on FLACS list 5 6 7 8 9 
8 99.0% 87.1% 78.6% 72.3% 67.3% 
10 108.5% 95.5% 86.2% 79.2% 73.8% 
12 115.9% 102.0% 92.1% 84.7% 78.9% 
14 121.9% 107.3% 96.9% 89.0% 82.9% 
16 126.8% 111.6% 100.8% 92.6% 86.3% 
Table 3.2.3-2 Cost of FLACS vs CPS. Bivariate sensitivity analysis: demonstrating relative costs of CPS service 
compared to FLACS when total number of cases on each theatre list are tested 
 
 Number of cataract operations per year  
Cost of 
PI (£) 2000 3000 4000 5000 6000 
50 101.5% 104.0% 105.2% 106.0% 106.5% 
75 95.9% 98.1% 99.2% 99.9% 100.4% 
100 90.9% 92.8% 93.8% 94.4% 94.9% 
125 86.4% 88.1% 89.0% 89.6% 89.9% 
150 82.3% 83.8% 84.7% 85.2% 85.5% 
Table 3.2.3-3 Cost of FLACS vs CPS. Bivariate sensitivity analysis: demonstrating relative costs of CPS service 














Number of operations on FLACS list 
Cost of PI 8 9 10 12 14 16 
50 92.9% 98.6% 103.7% 112.4% 119.5% 125.5% 
65 90.0% 95.4% 100.1% 108.2% 114.8% 120.3% 
80 87.3% 92.3% 96.7% 104.3% 110.4% 115.5% 
100 83.9% 88.5% 92.6% 99.5% 105.0% 109.6% 
120 80.8% 85.1% 88.8% 95.1% 100.2% 104.3% 
135 78.6% 82.6% 86.2% 92.1% 96.8% 100.7% 
Table 3.2.3-4 Cost of FLACS vs CPS. Bivariate sensitivity analysis: demonstrating relative costs of CPS service 





A hypothetical treatment delivery model based on a “hub and spoke” service and 
utilizing FLACS was designed to improve the efficiency of cataract surgery in 
terms of number of cases undertaken per operating list. The model was then 
tested with sensitivity and threshold analyses to allow for variations or 
uncertainties. 
 
Even with an optimized delivery model FLACS is still more expensive than CPS 
based on current estimates of costs. To break even, the incorporation of FLACS 
would have to approximately double the number of cataract operations performed 
per theatre list and indeed could not offer a cost-neutral solution if the number of 
cases on a CPS theatre list was 8 or more. The model indicates that the greatest 
cost impediment to a FLACS service is the price of the PI (average cost 
£135/case) (Figure 3.2.3-A), which represents almost 27% of the total cost per 
case. Unlike other service costs, the cost of the PI is not mitigated by potential 
increased productivity. It is therefore a major financial impediment to FLACS ever 
becoming cost effective within the NHS, where the total tariff for each operation 
is fixed between £718-932 (Department of Health, 2016b; 2016a). Potentially this 
problem may be overcome by the manufacturer considerably discounting this 
cost to the NHS. In contrast to the PI our financial model indicates that the costs 
of the laser itself, staffing and maintenance were much less important (4.8% of 
total costs). 
 
There are three important unknowns with regards to our model. Firstly, we are 
awaiting clinical results from large RCTs comparing FLACS to CPS (Schweitzer 
et al., 2014; Day, Burr, et al., 2015). Meta-analyses shows no significant 
advantages in terms of safety of FLACS over CPS (Xiaoyun Chen et al., 2015; 
Popovic et al., 2016). However, there are advantages in terms of endothelial cell 
loss, effective phacoemulsification time and unaided visual acuity, albeit no 
difference in long-term best corrected visual acuity and an increased risk of 
anterior capsular tear (Kohnen et al., n.d.). It was assumed in the financial 
modelling that there are no differences in outcomes and complication rates 
between the two procedures. If, however, FLACS were to show significant 
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advantages in terms of patient safety and outcomes then such improvements 
then this may have additional positive financial implications.  
 
Secondly, potential gains in productivity from the FL are yet unpublished and 
unrealized. Several studies investigating FLACS report decreased patient 
turnover with FLACS (Abell and Vote, 2014; Bali et al., 2012; Lubahn et al., 2014). 
This is because at present typically the operating surgeon is performing both the 
FL treatment as well as the subsequent lens extraction. There are yet no 
publications on the most effective way to design a FL-centric cataract service. I 
this study a “hub-and-spoke” model based on one FL in a clean room, operated 
by an ophthalmic surgeon in training or ophthalmic technician/nurse was chosen. 
The FL then fed patients into two independent operating rooms, each with its own 
surgeon and support staff. This model is theoretical. It needs to be tested in the 
NHS setting to see if it is viable and further work may need to be done to 
determine a ‘best-practice’ and optimized efficiency model for FLACS. 
 
Thirdly, it is likely that the costs of the PIs would be reduced below the values 
quoted to us by the manufacturers, as a large public-sector ophthalmology 
department performing several thousand operations per year could negotiate on 
costs and capitalise on market competition. As discussed above this would 
considerably improve the financial burdens associated with implementing 
FLACS. 
 
Abell and Vote have previously designed a hypothetical model to derive cost-
effectiveness of FLACS (Abell and Vote, 2014). In the absence of better 
evidence, conservative estimates were used for complication rates with FLACS. 
Their use of the FL resulted in reducing their theatre efficiency by 2 cases per list, 
and subsequently they estimated the additional cost of FL to be AUS$1065 per 
case, AUS$750 of which were the direct costs from the FL and AUS$315 from 
lost productivity. Our model was based upon using the laser to improve, rather 
than impede productivity. We estimated the additional cost per case to be £158, 
of which £135 is the PI. I chose to amortise the costs of the laser over 10 years 
rather than only 3 but reducing the lifetime of the laser to 3 years increased the 
cost of each operation by only £22. This demonstrates yet again the greatest cost 
of FLACS is the cost of the PI rather than the laser itself.  
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In addition to the above, there are important limitations to mention regarding this 
hypothetical model. The model assumes that all patients are suitable for a high 
volume FLACS theatre list. However some patients may not be suited to FLACS 
or to a high volume service, although the number of contraindications for FLACS 
are decreasing as experience with the technology improves (Conrad-Hengerer, 
Hengerer, Joachim, et al., 2014; Dick and Schultz, 2014a; Hatch et al., 2015). 
  
Departmental costs used in this model were obtained from a retrospective review 
of the financial records at 4 NHS foundation trusts. To ensure that the results 
were applicable to more than just one hospital with its associated population, 2 
teaching hospitals and 2 district general hospitals of varying sizes, with annual 
numbers of between approximately 1,400 and 5,000 cataract operations were 
selected for this study. These hospitals serve both urban and rural populations 
(range approximately 275,000 to 823,000 served by each hospital) with a mixture 
of demographics (and include hospitals with one of the highest and one of the 
lowest cataract tariffs) (Department of Health, 2016a). 
 
The costs of consumables were assumed to be equal for FLACS and CPS. In 
reality, as the FL performs many stages of the procedure, the cost of some 
consumables may be reduced (vision blue, disposable capsulorrhexis forceps, 
less likelihood of additional viscoelastic etc.) and some cataracts may no longer 
require any phacoemulsification (Abell, Kerr, and Vote, 2013b). Our model 
incorporates the salary of a registrar to operate the laser (Cohen et al., 2015; Hou 
et al., 2015), yet if FLACS becomes widely adopted within the UK, then 
technicians may be trained to perform this duty, perhaps at a reduced cost. 
However, but no money was saved when the salary of a band 6 nurse to operate 
the laser instead of a doctor was introduced into the financial modelling. 
 
Overall, this model demonstrates that FLACS could only be financially viable if its 
implementation into the NHS allowed significant improvements in efficiency in the 
number of cases treated per theatre list and or if the cost of the PI was 
considerably reduced. Further research is required on the clinical outcomes of 
FLACS compared with CPS as well as real-world evidence of the effect to surgical 
efficiency afforded by this technology. 
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Chapter 4. Risk-adjusted CUSUM analysis of the 






The adoption of any new surgical technique or equipment may lead to a 
temporary increase in complications during the learning curve phase. Increased 
rates of complications within any learning curve raise ethical questions and 
highlight the need for mechanisms to reduce complications. Studies on FLACS 
have specifically investigated the rates of complications within the learning curve 
(Lubahn et al., 2014; Bali et al., 2012; Abell, Kerr, and Vote, 2013a; Chee et al., 
2015; Day, Dhallu, et al., 2016; T. V. Roberts et al., 2013). Bali et al. compared 
rates of complications within the first 200 cases between 7 surgeons and found 
that the first 100 cases had significantly greater rates of number of docking 
attempts, per-operative miosis and a lower rate of free floating capsulotomy (Bali 
et al., 2012). The same group later published the complication rates of their 
subsequent 1,300 cases and found statistically significant reductions in 
complication rates between the original cohort of 200 and subsequent 1,300 
surgeries for anterior capsular tears (4% vs 0.31%, p<0.001), posterior capsular 
tears (3.5% vs 0.31%, p<0.001), and dropped lens fragments (2% vs 0%, 
p<0.001) (T. V. Roberts et al., 2013). This provides a good demonstration that 
there are increased risks of intraoperative complications during the learning curve 
for FLACS but does not provide an indication of the length of learning curve for 
an individual surgeon. 
 
Day et al. described the rates of intraoperative complications as well as any 
issues relating to laser docking and delivery for 158 cataract operations over a 
during the initial 2 months after the arrival of a femtosecond laser in their 
department (Day, Dhallu, et al., 2016). A total of 32 surgeons, both consultants 
and non-consultants took part in the learning curve with a median number of only 
3 cases per surgeon. However, two surgeons were already experienced at 
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FLACS, having performed over 200 cases each. The authors report that 2.7% of 
operations were complicated by vitreous loss all of which were performed by non-
consultants. The authors conclude that their transition to FLACS was safe, based 
on comparing their complication rates and average post-operative visual acuity 
to national averages (Day, Donachie, et al., 2015).  
 
Chang et al. described the complication rates of the first 177 FLACS cases 
between 3 surgeons at their institution (J. S. M. Chang et al., 2014). However, 
76% of operations were conducted by one surgeon. 5.3% of surgeries were 
complicated by anterior capsular tear, which the authors state is not statistically 
significant compared to their conventional phacoemulsification surgery (CPS) 
cohort. However, this was was higher than the other studies previously 
discussed. Posterior capsular tear rate was 0.6% and intra-operative miosis 
occurred in 10%. 
 
The length of the learning curve has as yet not been investigated and suggestions 
vary within the literature (T. V. Roberts et al., 2013; Day, Burr, et al., 2015). 
Christy et al. have suggested that 30 cases are needed before consistency in 
docking time, number of docking attempts, problems encountered during 
docking, and complications attributable to docking are stabilised (Christy et al., 
2017). However, the protocol for the FACT study require a surgeon to have only 
completed 10 cases before being allowed to perform FLACS in the study (Day, 
Burr, et al., 2015). Despite the literature previously published on the learning 
curve of FLACS there is still a need to demonstrate complication rates and 
difficulties encountered on an individual surgeon basis of those beginning 
FLACS.  
 
The aim of this study was to evaluate the learning curve of 3 surgeons (one fully 
accredited with twenty years’ experience, one newly accredited consultant and 
one specialist registrar) at our institution (Guy’s & St Thomas’ NHS Foundation 
Trust) after the arrival of a femtosecond laser (LenSx, Alcon Inc, Fort Worth, TX, 
USA). Results would be analysed using a risk-adjusted cumulative sum method 




This was a retrospective review of FLACS performed by 3 surgeons (HWR, VKW, 
DOB) following installation of the LenSx femtosecond laser (Alcon Inc), for 
cataract surgery at St Thomas’ Hospital, London, United Kingdom. Prior to this, 
all 3 surgeons were naïve to FLACS. All surgeons had received training from the 
manufacturer. All FL treatments were performed by VKW or HWR and all patients 
gave informed consent for all treatments received. Cases were identified from the 
LenSx electronic log and were performed over a 12-month period between June 
2016 and June 2017. The project was approved by the Research & Development 
department at St Thomas’ Hospital. Retrospective studies of this type do not 
require research ethics committee permission. 
 
Details of the first 288 consecutive cases performed by the surgeons were 
evaluated. These patients included 200 cases that were performed as part of a 
prospective randomized interventional case-controlled comparing FLACS with 
CPS (Clinicaltrials.gov registration number NCT02825693, Alcon Inc, Fort Worth, 
TX, USA. Grant number: IIT#17440075). These cases were reviewed for baseline 
information (age, gender, etc.), pre-operative biometry, for patient comorbidities 
and for details on intra-operative complications. Exclusion criteria included dense 
corneal opacities, requirement for general anaesthetic, dilated pupil size <4mm, 
inability to lie flat or unable to dock with the FL. All cataract operations were 
performed under local anaesthetic. All were unilateral, and no other additional 
procedures planned, other than arcuate keratotomies for reduction of corneal 
astigmatism. Phacoemulsification was completed using an Infiniti 
Phacoemulsification machine with Ozil torsional handpiece (Alcon Inc). Intra-
operative complications were defined as any event that involved unintentional 
trauma to an ocular structure.  
 
Learning curve defined as cumulative difference between observed occurrence 
of PCR (0 or 1) and expected (risk adjusted) risks of PCR. Change point would 
occur where the CUSUM curve peaked. The assumption is that the surgeon 
would start off worse than expected with a positive cumulative difference (since 
complication =1 indicates an occurrence and 0 indicates safe performance). 
Learning curves were analysed by using risk-adjusted CUSUM curves with 
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individual analyses for PCR and for the event of any complication. Binary 
outcomes (uncomplicated/1 complication, PCR/no PCR) were risk adjusted. 
Each patient was risk assessed for probability of PCR using a composite risk 
calculation system (Narendran et al., 2008). Each operation was risk adjusted for 
any complication occurring by experience of the surgeon (Day, Donachie, et al., 
2015).  
 
The learning curves were analysed separately for each surgeon and pooled. As 
multiple surgeons provided data, the mean values of the expected and observed 
outcomes for each case order were computed. CUSUM curves were plotted by 
comparing observed and expected outcome values, with the use of the equation 
𝑆𝑆𝑖𝑖  =  S(i−1)  +  �𝑋𝑋𝑖𝑖(𝑜𝑜𝑜𝑜𝑜𝑜) −  𝑋𝑋𝑖𝑖(exp)� 
Equation 1.  S = cumulative means, i = case order, X = outcome value, obs = observed, exp = expected 
 
4.2.1. Statistics 
Raw data analysis was performed by using Microsoft Excel (Microsoft Excel, 
Microsoft Corp, Redmond, Washington). 
  
To determine the confidence level of an observed change, a change-point 
analysis was performed. For this purpose, CUSUM curves were bootstrapped by 
randomly reordering the cases 5,000 times. By comparing the difference between 
the maximum and minimum S (Smax− Smin (ΔS)) of the original CUSUM with 
those obtained from the bootstrapping samples, a confidence level could be 
determined for the point of change. A confidence level of >95% was deemed as 
providing strong evidence that a real change had occurred (i.e. 95% of the 





288 cases were reviewed. Patient demographics can be seen in Table 4.3-A. 
Gross rates of complications were calculated (Table 4.3-B). 
 
% Male 51.8% 
% 1st Eye 77.8% 
% Right Eye 53.2% 
Age (years) ± S.D. 69.62 ± 10.94 
Axial length (mm) 24.04 ± 1.41 
Anterior chamber 
depth (mm) 
3.33 ± 0.37 










NUMBER OF CASES 98 114 76 288 
AVERAGE PCR RISK 
(NARENDRAN, 2008) 
1.44% 1.65% 2.39% 1.73% 
PCR 0 1 1 2 (0.7%) 
VITREOUS LOSS 0 1 0 1 (0.3%) 
ANTERIOR CAPSULAR 
TEARS 
3 4 3 10 (3.4%) 
IRIS TRAUMA 0 1 1 2 (0.7%) 
DESCEMET’S 
MEMBRANE TEAR 
1 0 0 1 (0.3%) 
Table 4.2.1-2 Rates of complication per surgeon 
 
4.3.1. Overall rate of complications 
CUSUM curves for the occurrence of any complication for each surgeon and as 
an overall average can be seen in Figure 4.3.1-A, Figure 4.3.1-B, Figure 4.3.1-C 
and Figure 4.3.1-D. The pooled data demonstrated stable performance after 16 
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cases however this was not statistically significant (confidence level =1%). The 
individual data did not show learning curve effects by CUSUM analysis. Surgeon 
1’s performance was better than average initially but had late complications 
(Figure 4.3.1-B). Surgeon 2 demonstrated a learning curve effect with stable 
performance after the 14th case, but this was not statistically significant 
(confidence level = 1%) (Figure 4.3.1-C). Surgeon 3 did not exhibit a learning 
effect (Figure 4.3.1-D) 
 
 
Figure 4.3.1-A CUSUM curve for pooled data on any complication 
 






Figure 4.3.1-C CUSUM curve for Surgeon 2 on (A) posterior capsule rupture (B) any complication 
 
 
Figure 4.3.1-D CUSUM curve for Surgeon 3 on (A) posterior capsule rupture (B) any complication 
 
4.3.2. Posterior capsular rupture 
CUSUM curves for PCR for each surgeon and as an overall average can be seen 
in Figure 4.3.1-B, Figure 4.3.1-C, Figure 4.3.1-D and Figure 4.3.2-A. There was 
a strong confidence level (96%) that there was stable performance in terms of 
PCR after case 16 for the pooled data (Figure 4.3.2-A). Surgeon 1 did not have 
any cases of PCR (Figure 4.3.1-B), surgeons 2 and 3 exhibited change points at 





Figure 4.3.2-A CUSUM curve for pooled data on posterior capsule rupture 
 
4.3.3. Laser attributable complications 
The overall rate of patients affected by laser attributable complications was 9.6% 
(n=27) (Table 4.3-A). There was no demonstrable reduction in the incidences of 
these events over time (Figure 4.3.3-A). 2/27 of these patients sustained 
intraoperative complications, one of which was felt to be related (anterior capsular 
tear in a patient who had had an anterior capsular tag) and the other unrelated 
(iris trauma in a patient who sustained a corneal abrasion).  
 




post-laser miosis 4 1.4% 
AC tag 7 2.4% 
laser not completed 2 0.7% 
corneal abrasion 2 0.7% 
full thickness FS-AK 1 0.3% 











A risk-adjusted cumulative sum method approach was used to estimate the 
length of the learning curves of 3 cataract surgeons in relation to all intraoperative 
complications, and specifically posterior capsular ruptures. Determining the 
length and gradient of the learning curve is important in both consenting patients 
for FLACS, estimation of surgical risk, determining length of supervised practice, 
as well as in the planning of future prospective studies of FLACS. The present 
study found that the length of the learning curve with regards to PCR was 16 
cases on average with 96% confidence, but did not find evidence of a learning 
curve when considering all complications as a whole. Our overall rate of PCR 
was safe (0.7%) when compared with our expected PCR rate (1.73%) and our 
rate of anterior capsular tears (3.4%) was consistent with other reports in the 
literature (J. S. M. Chang et al., 2014). Only one of the anterior capsular tears 
extended posteriorly, no vitreous was lost and the IOL was placed in the sulcus; 
in all other cases of anterior capsular tears an IOL was successfully placed in the 
capsular bag. Figure 4.3.1-A showed that all surgeons continued to have 
complications which accounted for there being no overall learning curve effect by 
CUSUM analysis. This could possibly be accounted for that the learning curve 
was longer than the period of our analysis, but I suggest that it is most likely due 
to the fact that there does seem to be a slightly increased risk of anterior capsular 
tears during FLACS compared with CPS and this may be a complication 
independent of any learning effect (Abell, Davies, et al., 2014). 
 
Over the course of introducing FLACS, several changes to our pre-operative 
preparation were made, based on evidence from the literature and anecdotal 
advice from other surgeons experienced at FLACS. These included: 
• One drop of topical phenylephrine 10% after FL delivery (T. V. Roberts et al., 
2013). N.B. Phenylephrine 10% has been shown to be associated with a 
significant change in cardiovascular parameters compared to phenylephrine 
2.5%, namely an increase in pulse by 4.5beats/min and blood pressure by 
15mmHg within the first 10 minutes after administration(Stavert et al., 2015). It 
should therefore be used with caution in those at risk of cardiovascular events, 
however no adverse events occurred within our study. 
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• Two drops of topical pre-operative diclofenac sodium 0.1% w/v (L. Wang et al., 
2016; Yeoh, 2014; Diakonis et al., 2017; Hwa Jun et al., 2017) 
• Pre-operative mydriasis using Mydriasert (0.28 mg/5.4 mg ophthalmic insert, 
Thea Laboratories, Clermont-Ferrand, France) 
• All surgeons encountered cases with increased difficulty during removal of soft 
lens matter with irrigation/aspiration (I/A)(Day et al., 2018). One surgeon found 
that these cases were facilitated by using bimanual rather than coaxial (I/A) 
(Conrad-Hengerer, Schultz, et al., 2014). 
 
Incorporating these changes resulted in more consistent mydriasis with no further 
episodes of iris trauma secondary to intraoperative floppy iris syndrome (Diakonis 
et al., 2017). Other complications included one Descemet’s membrane tear which 
resulted in localized wound-associated post-operative corneal oedema which 
resolved by 3 months. There were no episodes of dropped lens matter. Of the 
two cases of PCR, one was felt to be unrelated to the laser treatment. The other 
was because of early posterior extension of an anterior capsular tear and 
therefore attributable to the FL treatment. 
 
Following refinement during the learning curve, the three surgeons adopted the 
same preferred laser settings (Table 4.3.3-B). In summary, this consisted of a 
sextants chop pattern with a central 2mm cylinder core (Figure 4.3.3-B and Figure 
4.3.3-C). This pattern facilitated easy nuclear disassembly and removal via initial 
phacoaspiration of the central core, allowing the instruments to be inserted 
towards the posterior pole of the lens with subsequent completion of the 6 cracks. 
Six was chosen as the preferred number of segments, as removal of quadrants 
in large lenses may stress the anterior capsulotomy and octants could be too 
small with a reduced surface profile to present to the tip of the 
phacoemulsification probe. 
 
LENS METHOD CHOP CYLINDER 
DIAMETER (mm) 6 2 
LENS ANTERIOR OFFSET (um) 500 500 
LENS POSTERIOR OFFSET 
(um) 
800 800 
ZONE 1 ENERGY 10 10 
ZONE 2 ENERGY 10 10 
ZONE 3 ENERGY 10 10 
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ZONE 4 ENERGY 10 10 




SPOT SEPARATION (um) 14 10 
LAYER SEPARATION (um) 14 14 
   
   
CAPSULOTOMY PARAMETERS  
   
DIAMETER 5  
CAPSULE DELTA UP (um) 250  
CAPSULE DELTA DOWN (um) 250  
ENERGY 6  
SPOT SEPARATION (um) 4  
LAYER SEPARATION (um) 3  
   
   
ARCUATE INCISION PARAMETERS  
   
DIAMETER (mm) 9  
PERCENT POST DEPTH (%) 80  
ENERGY 3  
SIDE CUT ANGLE 90  
SPOT SEPARATION (um) 4  
LAYER SEPARATION (um) 4  
ANTERIOR OVERLAP (um) 50  
NUMBER OF ARCS 2  
Table 4.3.3-2. Our LenSx preferred settings after completion of the learning curve 
 
 





Figure 4.3.3-C Operating microscope photograph of our preferred segmentation pattern 
 
One asset of this study is that the three surgeons had different levels of 
experience with cataract surgery (one fully accredited with twenty years’ 
experience, one newly accredited consultant and one specialist registrar). 
Despite these differences the complication rates and learning curves were safe 
for each surgeon when evaluated individually. Previous studies have evaluated 
the safety of FLACS for surgeons in training and demonstrated reduced rates of 
PCR when compared to a cohort of CPS (Pittner and Sullivan, 2017; Brunin et 
al., 2017).  
 
All surgeons performed their first cases of FLACS within these series. The 
surgeons had received full training from the manufacturer and were experienced 
at CPS, but complication rates may have been even lower if structured 
supervised training by an experienced FLACS surgeon had been implemented. 
FLACS introduces significant differences to a surgeon’s technique for CPS. As 
there is a demonstrated learning curve effect of FLACS, I suggest this underlines 
the need for structured supervised training with an experienced FLACS surgeon 
in addition to full training and accreditation by the manufacturer as well as 
objective assessment of competency in FLACS. Once surgeons start to perform 
independently, careful case selection is a key to avoid unnecessary 




The important limitations of this study are felt to be two-fold. Using CUSUM for 
analysis of learning curves is an important and valid method (Grigg et al., 2003). 
However, CUSUM analysis provides no indication of the time interval between 
cases or the case mix of the surgeon which may influence results. Furthermore, 
it does not account for the severity of the complications incurred, with an equal 
inflection of the learning curve for the most inconsequential and most sight 
threatening complications. 
 
This study used an established composite risk calculation system based on 
55,567 cataract operations to determine estimated risks of PCR in this cohort 
(Narendran et al., 2008). Our observed rates of PCR were superior to our 
predicted rate. This may be due a number of factors including the improved 
awareness of risk factors for PCR and how to mitigate these risks since the 
original paper was published (e.g. alpha adrenergic antagonists). Alternatively, 
the relative risks for PCR in CPS may not be as valid for FLACS, for example 
FLACS has been found to be safe in case series on white cataracts or subluxed 
lenses(Conrad-Hengerer, Hengerer, Joachim, et al., 2014; Schultz and Dick, 
2014; Titiyal et al., 2016; Chee et al., 2017). 
 
In summary this study found that the learning curve for FLACS is relatively short 
when considering posterior capsular rupture and that overall complication rates 





Chapter 5. A randomised controlled trial comparing 
femtosecond laser assisted cataract surgery vs. 
conventional phacoemulsification surgery 
Supplementary Material #3. Roberts, H.W., Wagh, V.K., Sullivan, D.L., Hidzheva, P., Detesan, D.I., 
Heemraz, B.S., Sparrow, J.M. and O'Brart, D.P., 2019. A randomized controlled trial comparing 
femtosecond laser–assisted cataract surgery versus conventional phacoemulsification surgery. Journal of 





The introduction of FL technology to allow the automation of a number of surgical 
steps within cataract extraction has been claimed to offer potential advantages of 
reduced complications and better visual outcomes through greater surgical 
precision and reproducibility (L. Mastropasqua, Toto, Mattei, et al., 2014; Kránitz 
et al., 2012). However, systems to undertake FL assisted cataract surgery 
(FLACS) are expensive both to purchase and use. In chapter 3, it was estimated 
that FLACS adds £167 (approx. 220USD) to each operation within the context of 
a state-funded healthcare system (H. W. Roberts MSc FRCOphth, Ni, et al., 
2017). From a public health perspective, costs may be mitigated by improved 
safety leading to increased reliability and reduced post-operative need for 
additional clinical or surgical interventions, and better patient outcomes 
(Qatarneh et al., 2012).  
 
The aim of the present study was to complete the largest RCT published to date 
comparing FLACS with CPS with the intention to inform clinical practice and 
health policy worldwide. As there have been a lack of patient reported outcome 
measures (PROMs) in previous RCTs, this study aimed to correct this by 
measuring quality of life with EuroQOL’s EQ-5D and patient reported quality of 






The study design was a prospective randomised interventional case-controlled 
study at a single University Hospital (Guy’s & St Thomas’ Hospital NHS 
Foundation Trust, London, UK) to compare FLACS with CPS (Clinicaltrials.gov 
registration number NCT02825693). The study was approved by local Research 
& Development and Cambridge South Research Ethics Committee (reference 
16/EE/0180). This study was conducted adhering to the tenets of the Declaration 
of Helsinki.  
 
Patients were screened, recruited and informed consent obtained from routine 
cataract clinics by members of the trial team (HWR, VKW) as per the trial protocol 
(Version 2.0, 18/05/2016). Inclusion and exclusion criteria are listed in Table 
5.2-A. Within the enrolment visit, patients had a complete ophthalmological 
examination. Only one eye per patient was enrolled to the study. Patients were 
randomised to receive CPS or FLACS in equal proportions using computer 
generated random number tables (Microsoft Excel, Microsoft Corp, Redmond, 
Washington) just prior to being offered a date for surgery. Excel Macros were 
used to perform the randomisation (this was concealed from the allocator) and 
then lock the allocation with the patient’s research information to address 
allocation bias. All patients’ treatments in this study were delivered by the NHS 
and were free at the point of care. At the follow up visit, if the patient failed to 
attend, the patient was contacted and offered another appointment within one 





Inclusion Criteria:  
 Patients must have reduced visual acuity or visual symptoms attributed to the 
presence of cataract in one or both eyes by the examining ophthalmologist or 
else must require cataract surgery on clinical grounds other than visual 
symptoms.   
 Patients must be willing to attend for follow-up at 3-4 weeks after cataract 
surgery.   
 Patients must have sufficient English language for informed consent and 
completion of the patient reported outcome questionnaires.  
Exclusion Criteria:   
 Children below the age of 18  
 Already enrolled in another study   
 Clinical contraindications for FLACS, such as:   
 Significant corneal opacities   
 Small pupils (<4mm) following pharmacological dilatation   
 Patients unable to lie sufficiently flat to be positioned underneath the laser 
machine.   
Table 4.3.3-3. Inclusion and exclusion criteria for enrolment into the study 
 
Data collection for this study occurred at the pre-operative assessment, the day 
of surgery, and the post-operative visit scheduled at 4 weeks after surgery (Table 
5.2-B). Visual acuity and any investigations performed (corneal topography, 
specular microscopy etc.) were conducted by an optometrist or technician (DS, 
PH, DD) masked to the participant’s treatment arm. Due to the nature of the 
intervention, neither the surgeon, surgical team nor the participant could be 
masked to their treatment arm. All clinical technicians and nurses were masked 
to the intervention received. Visual acuity (unaided, best corrected, and pinhole) 
was measured with a Snellen chart at 6 meters. This was not ideal for a study of 
this nature with visual acuity as the primary outcome measure but occurred due 
to logistical reasons as the department at the time was using Snellen visual 
acuity, however has since switched to COMPLog (Complog Clinical Vision 
Measurement Systems Ltd, London, UK) Participants’ refractive errors were 
collected using an RK-501A Autorefractor (Nidek Co. Ltd, Aichi, Japan). Biometry 
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was performed using an IOL master 500 (Carl Zeiss Meditec AG, Switzerland). 
Corneal topography was performed with Pentacam (Oculus, Germany). Macular 
Optical Coherence Tomography (OCT) was performed with Spectralis SD-OCT 
(Heidelberg Engineering, Germany). Endothelial cell count (ECC) was performed 
with Topcon SP-3000 Specular Microscope (Topcon Medical Systems, Oakland, 
NJ, USA). Visual comorbidities and risk factors for complications of cataract 
surgery were recorded prospectively. Risk of posterior capsular rupture (PCR) 
were calculated for patients using a composite risk calculation system 
(Narendran et al., 2008). PROMs were collected with the Cat-PROM5 tool and 
QoL were assessed using the EuroQOL EQ-5D questionnaire. The EuroQuol 5D 
consists of 2 components: 5 questions about 5 dimensions of health-related 
quality of life (mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression) which are scored as 1, 2, or 3 (1 meaning no problems and 
3 meaning extreme problems). The 5 responses are then weighted and combined 
to create a summary index with values 0-1, where 1 indicates no problems. The 
visual analogue scale is a continuous scale anchored by best imaginable and 
worst imaginable health, with values ranging from 0 to 100 (where 100 indicates 
best possible health). EQ-5D was chosen as it is well recognized by public bodies 
(such as NICE) for comparative health economic analyses(Tosh et al., 2012). 
The Cat-PROM5 is a recently developed NIHR funded questionnaire consisting 
of 5 questions which provide a Rasch calibrated psychometrically robust measure 
which is highly responsive to cataract surgery (Sparrow et al., n.d.; 2018).  
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Baseline demographics X   
Unaided distance visual 
acuity (UDVA) 
X  X 
Corrected distance visual 
acuity (CDVA) 
X   
Pinhole visual acuity 
(PHVA) 
X  X 
Intraocular pressure (IOP) X  X 
Risk factors for cataract 
surgery(Narendran et al., 
2008) 
X   
Inclusion/Exclusion criteria X X  
Refractive error X  X 
Keratometry X   
Biometry X   
Corneal topography X  X 
Endothelial cell counts X  X 
Optical coherence 
tomography of the macula 
X  X 
EQ-5D-3L X  X 
CAT-PROM5 X  X 
Adverse event collection  X X 
Table 4.3.3-4 Schedule for data collection 
 
FLACS treatment was performed using the LenSx Femtosecond laser (Alcon Inc. 
Fort Worth, Tx, USA). Two surgeons (HWR, VKW) received training and full 
accreditation on the device in anticipation of this trial and performed at least 30 
laser applications each before the trial began. The femtosecond laser was used 
to perform capsulotomy, lens fragmentation ± astigmatic keratotomies. Where the 
laser treatment could not be performed for whatever reason (e.g. repeated 
inability to dock, laser machine fault, etc.) patients underwent surgery in 
accordance with conventional CPS. FS-AKs (within the FLACS group) or limbal 
relaxing incisions LRIs (within the CPS group) were offered to any patient with 
corneal astigmatism greater than 0.9D based on corneal topography. The 
astigmatic results are presented in chapter 7. All cataract operations were 
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performed under local anaesthetic. All operations were unilateral, and no other 
additional procedures were planned, other than arcuate keratotomies for the 
reduction of corneal astigmatism. 
 
The decision was made not to use the CCI function of the FL for several reasons. 
Two of the three trial surgeons do not place their incisions in clear cornea. The 
surgeon who did use CCIs did evaluate this function during the learning curve but 
found that opening the wounds with a blunt instrument took longer than making 
a manual CCI with a keratome, with no significant clinical advantage gained. 
 
Following FL treatment, the patient was transferred to the operating theatre for 
the remainder of the cataract extraction. Phacoemulsification was performed 
using the Infiniti phacoemulsification machine (Alcon Inc.) Patients undergoing 
CPS were prepared for surgery in the same way as those in the laser arm. Instead 
of receiving laser pre-treatment, they were brought straight to theatre. All 
operations were performed by surgeons who had completed at least 30 FLACS 
procedures (HWR, VKW, DOB). 
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 FLACS CPS 
Male/female 100/100 82/118 
1st Eye/2nd Eye 162/38 168/32 
Right Eye/Left Eye 107/93 109/91 





0.62 ± 0.49 0.54 ± 0.46 
Spherical equivalent 
refractive error (D) 
-0.17±2.99 -0.77 ± 4.88 
Axial length (mm) 23.88 ± 1.55 23.63 ± 1.26 
Anterior chamber 
depth (mm) 
3.25 ± 0.42 3.21 ± 0.44 
Target refraction 
(D) 
-0.21 ± 0.34 -0.22 ± 0.4 
Intraocular 
pressure (mmHg) 
13.7 ± 4.1 13.9 ± 3.6 
Central corneal 
thickness (µm) 
541 ± 49 546 ± 35 
Endothelial Cell 
Density (cells/mm2) 
2505 ± 313 2534 ± 327 
Central foveal 
thickness (µm) 





1.63% ± 0.91% 1.59% ± 1.29 % 
CAT-PROM5 
Calibrated Score 
0.45 ± 2.6 0.28 ± 2.31 
EQ-5D-3L Index 
Score 
0.82 ± 0.19 0.80 ± 0.23 
EQ-5D Visual 
Analogue Scale 
77.84 ± 16.53 75.17 ± 18.63 
Table 4.3.3-5 Baseline characteristics for the two treatment arms. (D= Dioptre, LogMAR = logarithm of minimum 
angle resolution, PCR = Posterior capsule rupture) 
5.2.1. Statistics 
Baseline characteristics were summarised for each treatment arm (Table 5.2-C). 
Results were analysed primarily as per intention to treat. Evaluators were masked 
to the participants’ treatment arm. For all evaluations of visual acuity as an 
outcome, patients with visually significant ocular co-morbidities were excluded 
prospectively. Snellen visual acuities were converted to LogMAR for 
analysis(Lange et al., 2008). Continuous data was reported using means and 
standard deviations if data appear Gaussian. Binary data was reported as 
frequencies and percentages and evaluated with Fischer’s exact test. Student’s 
t-tests were used for parametric data. All statistical tests used a two-sided p value 
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of α=0.05 unless otherwise specified. Intra-operative or post-operative 
complication were defined as any event that involved unintentional trauma to an 
ocular structure, requiring additional treatment, or having a negative effect on 
participants' eyesight. EQ-5D index scores were calculated using the visual 
analogue score method calibrated for the United Kingdom. Rasch calibrated Cat-
PROM5 scores (logits) were calculated from the questionnaire responses in 
accordance with the developer’s instructions(Sparrow et al., n.d.). 
 
Uncorrected distance visual acuity at 4 weeks was designated as the primary 
outcome with intra- and post-operative complications, refraction, corneal 
thickness, endothelial cell loss and quality of life outcomes and patient reported 
quality of vision pre-operatively and at 4 weeks after surgery selected as 
secondary outcomes. A priori calculations for sample size indicated a total 
sample size of 370 to have an 85% chance of detecting a 0.1 difference in 
LogMAR visual acuity and assumption of  σ=0.32 with α=0.05 and a two-tailed 
analysis. This sample size was rounded up to 400 to account for the possibility of 




427 patients were recruited to the study between August 2016 and June 2017. 
27 patients withdrew from the trial before surgery. 400 eyes of 400 patients 
received surgery between November 2016 and June 2017 (200 CPS, 200 
FLACS). 9 patients failed to attend their follow up appointments (2.3%). 7 
participants lost to follow up were in the CPS group compared with 2 in the 
FLACS group (p=0.17). Only one of the participants lost to follow up had had an 
untoward clinical event (CPS arm), requiring referral to vitreoretinal colleagues, 
and withdrew from providing further information to the study team, the remainder 
had had uneventful clinical courses (Table 5.3-A).  
 
182 (45.5%) of participants were male, 330 (82.5%) of operations were on first 
eyes, 216/400 (54%) were right eye operations. The average age of patients was 
70.2 ± 10.4 years. Average pre-operative best corrected distance LogMAR visual 
acuity was 0.58 ± 0.47. Patient demographics and full baseline data can be seen 
in Table 5.3-B. Clinical and self-reported questionnaire measures were similar 
between the 2 groups. 155/400 operations (39.0%) were on-axis and 314/400 
(78.5%) operations were performed with the main incision sited at the corneal 
limbus and 86/400 (21.5%) with clear corneal incisions. 49/400 (12.3%) of 
patients were excluded from post-operative visual acuity analysis due to pre-
existing visually significant ocular comorbidities (FLACS n=28, CPS n=21). 
Cases were distributed evenly between the three surgeons and between the two 
treatment arms (p=0.99) (Table 5.3-C).  
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 FLACS CPS 
Number of patients 2/200 7/200 
Proportion female 1/2 2/7 













-2.56±0.80 (-1.13, -4.00) -0.47 ± 0.58 
Axial length 
(mm)** 
25.19 ± 3.44 (22.8, 27.6) 23.6 ± 0.89 
Anterior chamber 
depth (mm)** 
3.67 ± 0.27 (3.48, 3.86) 3.49 ± 0.27 
Target refraction 
(D)** 
-0.17 ± 0.11 (-0.09, -0.25) -0.23 ± 0.08 
Intraocular 
pressure (mmHg)** 
15.5 ± 3.5 (13, 18) 14.1 ± 5.3 
Central corneal 
thickness (µm)** 













(PCR, vitreous loss) 
Table 5.2.1-1 Patient demographics for patients lost to follow up in the two treatment arms. (D= Dioptre, logMAR 
= logarithm of minimum angle resolution, PCR = Posterior capsule rupture). ** Since there are only 2 items in the 
FLACS group, the actual values have been provided because of the limited value of a standard deviation. 
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0.15 ± 0.19 0.15 ± 0.21 1 
Pinhole visual acuity 
(logMAR)) 
0.04 ± 0.12 0.04 ± 0.12 1 
Change in intraocular 
pressure (mmHg) 
-1.3 ± 4.5 -1.7 ± 3.8 0.45 
Cumulative dissipated 
energy 
9.6 ± 7.0 11.1 ± 9.8 0.08 
Change in central 
corneal thickness 
(µm) 
15 ± 25 13 ± 19 0.50 
Endothelial Cell loss 
(%) 
10.2 ± 13.7 9.7 ± 13.7 0.76 
Change in central 
foveal thickness (µm) 
6 ± 35 9 ± 35 0.55 
Mean arithmetic 
spherical equivalent 
refractive error from 
target refraction 
diopters (D) 
-0.01 ± 0.56 0.04 ± 0.58 0.39 
Mean absolute 
spherical equivalent 
refractive error from 
target refraction (D) 
0.42 ± 0.40 0.40 ± 0.46 0.65 
% spherical 
equivalent refraction 
within ± 0.5D of 
intended 
67.3 72.3 0.32 
% spherical 
equivalent refraction 
within ± 1D of 
intended 




-2.44 ± 3.13 -2.22 ± 2.89 0.49 
Change in EQ-5D-3L 
Index Score 
0.03 ± 0.17 0.03 ± 0.16 1 
Change in EQ-5D 
Visual Analogue 
Scale 
0.71 ± 13.61 4.18 ± 13.91 0.02 
Table 5.2.1-2 Post-operative results for the two treatment arms. (D= Dioptre, LogMAR = logarithm of minimum 
angle resolution, PCR = Posterior capsule rupture) 
 
FL treatment was delivered successfully to 96.5% of cases. Patients receiving 
FLACS spent, a mean time of 5.9±2.0 min in the laser room. 7 cases (3.5%) were 
unable to receive FL treatment and received CPS. The reasons were as follows: 
repeated bubbles in interface/flat cornea (n=1), administrative error (n=1), patient 
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compliance (n=2), and patient’s palpebral aperture too narrow (n=3). One of 
these patients suffered an intra-operative supra-choroidal haemorrhage; the 
others experienced uncomplicated operations. The average number of docking 
attempts was 1.3 ± 0.7 per patient. Reasons for failed attempts at docking and 
details of laser treatments delivered can be seen in Table 5.3-D. Average 
duration of surgical time was 11.7min ± 3.5 for FLACS and 14.7 ± 6.8 for CPS. 
 
Totals Surgeon 1 Surgeon 2 Surgeon 3 Total 
CPS 68 87 45 200 
FLACS 69 86 45 200 
 Total 137 173 90 400 
      Chi-squared p=0.99 
Table 5.2.1-3 Spread of operations between the three surgeons on the trial 
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 Reason for failed 
docking attempt 
n= % 
Facial anatomy 17 26.6 
Bubbles within the 
interface 
19 29.7 
Poor docking 2 3.1 
Patient compliance/fixation 11 17.2 
Software crashing 1 1.6 
Narrow palpebral aperture 7 10.9 






Unrecorded  5 7.8 
Total 64  
 
 Complication relating to 
laser delivery 
n= % 
Anterior capsular tags 3 1.5 
Failure to dock 7 3.5 
Corneal abrasion 2 1 
Incomplete capsulotomy 9 4.5 
Total 21 10.5 
 
 Laser procedures 
performed 
n= % 
Corneal incisions 0 0 
Capsulotomy 193 96.5 
Lens fragmentation 193 96.5 
Arcuate keratotomies 53 26.5 
Table 5.2.1-4 (A). Reasons for failed individual attempts at docking with the patient interface of the femtosecond 
laser. (B). Complications relating to femtosecond laser delivery. (C). Details of laser procedures performed. N.B. 
25.5% (n=51) of the conventional phacoemulsification surgery arm received manual limbal relaxing incisions. 
 
UDVA (LogMAR) after CPS was 0.15±0.21 and 0.15±0.19 after FLACS (p=1), 
and PHVA was 0.04±0.12 and 0.04±0.12 respectively (p=1) (Figure 5.2.1-A, 
Figure 5.2.1-B, Figure 5.2.1-C, Figure 5.2.1-D). Increase in CCT was 13µm±19 
after CPS and 15µm±25 after FLACS(p=0.5). ECL was 9.7%±13.7 after CPS and 
10.2%±13.7 after FLACS (p=0.76). Refractive mean spherical equivalent error 
was -0.14±0.60D after CPS and -0.12±0.60D for FLACS (p=0.74) (Figure 5.2.1-E, 
Figure 5.2.1-F, Figure 5.2.1-G, Figure 5.2.1-H). Change in central foveal 
thickness (CFT) was 9µm±35 after CPS and 6µm±35 after FLACS (p=0.55) 
(Table 5.3-B). Cat-PROM5 demonstrated a substantial shift between pre- to 
postoperative completions, signalling a significant self-reported reduction in 
visual difficulty following surgery which was similar in the 2 intervention groups. 
 95 
The EQ5D summary index similarly reflected an improved score which was 
similar in the 2 groups. The EQ5D visual analogue score was however 
unchanged in the FLACS group but increased in the CPS group (Table 5.3-B). 
There were no differences in total rates of intra-operative or post-operative 
complications (Table 5.3-E, Table 5.3-F). There was a significant difference in 
the rate of PCR with a higher rate occurring in the CPS group (p=0.03). 
 
 
Figure 5.2.1-A Unaided and corrected distance visual acuity at one month after FLACS 
 




Figure 5.2.1-C Difference between unaided and corrected distance visual acuity at one month after FLACS 
 
 
Figure 5.2.1-D Unaided and corrected distance visual acuity at one month after CPS 
 




Figure 5.2.1-F Spherical equivalent refractive accuracy one month after CPS 
 
 
Figure 5.2.1-G Postoperative refractive cylinder one month after FLACS 
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Figure 5.2.1-H Postoperative refractive cylinder one month after CPS 
 
 
FLACS % CPS % p 
Anterior Capsular tear 6 3 3 1.5 0.50 
Descemet’s Membrane 
tear 




3 1.5 8 4 0.22 
Residual Soft Lens 
Matter  
1 0.5 0 0 1.0 
Intraocular Lens 
exchange 
1 0.5 0 0 1.0 
Suprachoroidal 
haemorrhage* 
1 0.5 0 0 1.0 
Posterior Capsular tear 0 0 6 3 0.03 
Vitreous loss 0 0 5 2.5 0.06 
Dropped lens 
fragments 
0 0 3 1.5 0.25 
Zonulodialysis 0 0 1 0.5 1.0 
Total number of cases 
with intra operative 
complications 
14 7 17 8.5 0.71 





% CPS % P= 
Corneal oedema 4 2 2 1 0.69 
Return to theatre day 1 for suspected vitreous 
in Anterior Chamber 
0 0 1 0.5 1.0 
Clinically significant macular oedema 4 2 3 1.5 1.0 
Prolonged anterior uveitis* 2 1 0 0 0.50 
Steroid response/Post-operative raised 
intraocular pressure 
2 1 0 0 0.5 
Return to theatre for residual soft lens matter 
in bag 
1 0.5 0 0 1.0 
Suture abscess 0 0 1 0.5 1.0 
Hypotony 0 0 1 0.5 1.0 
Suprachoroidal haemorrhage 0 0 1 0.5 1.0 
Total number of cases with post-operative 
complications 
11 6.5 5 2.5 0.20 








This RCT is larger than any yet published comparing the safety and effectiveness 
of FLACS vs CPS including 400 eyes of 400 patients. All surgeries were 
performed by 3 surgeons at a single centre who had previously completed their 
FLACS learning curve having completed at least 30 cases. Patients were 
reviewed at 4 weeks post-operatively to perform clinical examination, assess for 
complications and gather post-operative data. 
 
Overall, these results point overwhelmingly to an absence of clinical differences 
between FLACS and CPS (except for PCR and EQ-5D VAS), despite this study 
including a greater number of patients than any RCT preceding it. In many 
aspects, our findings are congruous with the available evidence and on occasion 
are in contrast with conventional understanding.  
 
Previously reported gains in visual acuity for FLACS tended to be early (one week 
after surgery) or late (at 6 months) but equivalence between 1 – 3 months 
(Xiaoyun Chen et al., 2015; Day, Gore, et al., 2015). This current study found no 
difference in the post-operative visual acuity between the two groups at one 
month (Figure 5.2.1-A, Figure 5.2.1-B, Table 5.3-B). It is conceivable that FLACS 
has superiority in the early phase due to reduced ultrasound energy and reduced 
corneal oedema resulting in faster visual rehabilitation, followed by equivalence 
in the interim, with any late differences perhaps due to differences in late lens 
decentration or posterior capsular opacification (Okada et al., 2014; Kovacs et 
al., 2014; Yu et al., 2015; Tran et al., 2016). This study showed found no 
differences in CCT, ECL or rates of corneal oedema at one month after surgery. 
 
Measurement of post-operative intraocular pressure occurred after the window 
one usually expects to identify post-operative pressure spikes. In the two patients 
seen with raised IOP post op, both were due to a steroid response. Indeed, no 
differences were found in the IOP change between the two groups. Furthermore, 
no adverse events were recorded of patients presenting in the early post-
operative phase with the sequelae of raised IOP. 
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This is the first large scale randomised controlled trial to evaluate rates of 
clinically significant macular oedema (CSMO) between FLACS and CPS. Our 
rates of CSMO were equivalent between the two groups (FLACS 2%, CPS 1.5%) 
and there was no overall difference in the mean change in CFT. This is in keeping 
with previous reports (Conrad-Hengerer, Hengerer, Juburi, et al., 2014; Levitz et 
al., 2015). Of the 7 cases of CSMO in this study, risk factors were prospectively 
identified for 5 cases (previous macula off retinal detachment = 1, previous 
epiretinal membrane peel = 1, previous central retinal vein occlusion = 1, 
epiretinal membrane = 2). A recently published large RCT (PREMED) 
demonstrated the efficacy of combined bromfenac and dexamethasone in the 
prophylaxis of CSMO in comparison with either agent in isolation(Wielders et al., 
2018). This was not published in time to influence our management and hence 
patients routinely received only dexamethasone post-operatively. However our 
rates of CSMO (1.75%) were lower than expected based on the incidence in the 
PREMED study of 5.1% in patients with no comorbidities. A retrospective case-
control series of cataract surgery in patients with neovascular age related 
macular degeneration (nAMD) showed no difference in post-operative visual 
acuity, macular thickness or number of intravitreal injections between 17 eyes 
treated with FLACS compared with 123 eyes treated with CPS (Enz et al., 2018). 
 
This study found a statistically significant increase in the rate of PCR in the CPS 
group. This is an important finding due to the associated risks of further 
complications in the post-operative phase associated with increased morbidity 
and cost (Qatarneh et al., 2012; Day, Donachie, et al., 2015). The Cochrane 
review of published RCTs reported an overall rate of PCR in 0/529 cumulative 
FLACS cases compared with (1/547, 0.1%) for CPS (Day, Gore, et al., 2015). It 
might be considered that the rates of PCR in both these groups to be lower than 
expected; perhaps reflecting patient selection for the studies or the expertise of 
the surgeons or both. The EUREQUO case control study compared 2814 FLACS 
cases with 4987 CPS and found no significant difference in the PCR rates of 0.4% 
and 0.7% (p=0.79) respectively(Manning et al., 2016). The two other largest 
studies of note included a case series of over 7000 operations in the public sector 
in the US (which found a greater rate of vitreous loss in the CPS group) (Scott et 
al., 2016) and a case-control study of over 4000 patients which found no 
significant difference in PCR rates (Abell et al., 2015). Our study was performed 
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in the public sector in a hospital based within an inner-city area of London with 
the accompanying demographics and high rates of co-morbidities. Of the patients 
sustaining PCR in our cohort the mean composite risk calculation score was 
2.04% (Range 0.84% - 3.13%) (Narendran et al., 2008), suggesting that although 
on the high side, the 3% rate in the CPS arm of our study was at least in part a 
reflection of the surgical case complexity in our patient cohort. The lower rate in 
the FLACS group could imply that segment removal is made easier by automated 
nuclear fragmentation. 
 
It is worth noting that the difference in PCR rates was only just statistically 
significant. One more PCR in the FLACS group or one less in the CPS group 
would have rendered this result not statistically significant (and the risk of type 2 
error is increased when analysing outcomes with smaller numbers). All but one 
of the PCRs in the CPS group occurred during the phacoemulsification /fragment 
removal stage. The nuclear fragmentation patterns of the FL may produce more 
regular nuclear segments after cracking which may assist the surgeon by 
ensuring a more reproducible stage 2. It was possible to compare observed rates 
of PCR with expected rates as this study prospectively risk stratified patients 
according to a composite risk calculation system (Narendran et al., 2008; Day, 
Donachie, et al., 2015).  
 
Self-reported visual difficulty and PROMs results were interesting. The Cat-
PROM5 scores overall shifted significantly towards less visual difficulty with 
similar reductions in each group. The EQ5D scores likewise shifted towards 
better quality of life postoperatively, with similar improvements in each group. 
There was a significant increase in the EQ-5D visual analogue score after CPS 
compared to FLACS (p=0.02), however in the absence of a plausible clinical 
explanation or safety issue, and as there were no differences in the EQ-5D-3L 
Index Score (p=1.0) or Cat-PROM5 Calibrated Score (p=0.49). In view of such a 
finding this may be the result of a type 1 statistical error. Furthermore the EQ5D 
visual analogue score is known to correlate poorly with the impact of cataract 
surgery (Ang et al., 2013). One limitation was that both first and second eye 
operations were pooled for the self-reported outcomes. Both CPS and FLACS 
groups had the same proportion of first/second eye surgeries, however binocular 
function will be affected by the visual status of the fellow eye, whether cataractous 
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or with a clear lens. One advantage of Cat-PROM5 as a PROM is that it aims to 
ascertain the effect of vision of the eye in question on overall binocular 
function(Sparrow et al., n.d.). 
 
Our anterior capsular tear rate was greater in the FLACS group (3% vs 1.5%) but 
this was not statistically significant. Anterior capsular tear rates in other RCTs 
were, again, low. However Abell et al. found increased risk of anterior capsular 
tears in FLACS compared with CPS, as discussed in chapter 1 reflecting the 
‘postage-stamp edge’ microanatomy of the capsulotomy rim (Abell et al., 2015; 
Yu et al., 2015; Conrad-Hengerer et al., 2013; Reddy et al., 2013; Takagi et al., 
2017). In our experience the FL anterior capsulotomy is more likely to tear than 
a manual CCC, which resulted in each surgeon adapting their surgical technique 
during each of our learning curves i.e. not to overly stretch the capsulotomy by 
removing large and dense fragments. This is in turn facilitated by predictable 
capsulotomy and lens fragmentation sizes created by the FL. 
 
In contrast with other studies, this study did not show that FLACS resulted in more 
predictable refractive outcomes than CPS (Filkorn et al., 2012; L. Mastropasqua, 
Toto, Mattei, et al., 2014; Yu et al., 2015). Our overall median absolute error 
(0.32D for FLACS and 0.29D for CPS) and proportions within ±0.5D, ±1.0D were 
similar between both groups and in keeping with other studies in the literature 
(Figure 5.2.1-E, Figure 5.2.1-F). However, in a subgroup analysis of this same 
study,  better outcomes with FS-AKs compared with manual LRIs were 
demonstrated (Chapter 7). 
 
One more surprising result is that this study did not realize the reduction in 
phacoemulsification energy (CDE) previously reported with FLACS (9.6 ± 7.0) 
compared with CPS (11.1 ± 9.8, p=0.08). There was a non-significant result. 
However our surgeon preference for segmentation of the cataract rather than 
fragmentation into cubes may have been a factor. Two studies have 
demonstrated reduced ultrasound energy in FLACS, but either using a grid 
pattern, or segmentation with multiple concentric cylinders (Abell, Kerr, and Vote, 
2013b; Yesilirmak et al., 2017). Less CDE was used in a group of 34 patients 
treated with a ‘complete’ fragmentation pattern compared with 37 patients treated 
with a ‘quadrant’ pattern (Huseynova et al., 2015). Shajari et al. recently 
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published their findings that CDE was reduced in grid pattern compared with the 
segmentation pattern which was our favoured technique (Shajari et al., 2017). It 
follows therefore, that grid pattern softens the nucleus and permits more 
phacoaspiration, reducing CDE, in comparison with segmentation pattern which 
requires a nuclear disassembly technique resembling divide-and-conquer.  
 
The limitations of this study include that many clinical outcomes were evaluated 
leading to an increased risk of type 1 statistical errors. Furthermore, RCTs are 
often underpowered for safety and complications in cataract surgery are 
fortunately rare (making it harder to meaningfully evaluate). However, as this is 
the largest RCT completed to date evaluating complication rates it clearly adds 




This large RCT compares the clinical outcomes of FLACS and CPS and confirms, 
in the majority, the non-significant differences between these two treatment 
modalities in terms of visual, refractive and a range of other clinical and patient 
reported outcomes, while suggesting a possibly higher rate of posterior capsular 
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Until more evidence is available it is not possible to currently support the 
widespread introduction of FLACS within public healthcare organisations such as 
the NHS. This is especially pertinent as by the very nature of its complex 
technology, FLACS has significant associated financial costs, including initial 
purchase costs of the laser itself, servicing, depreciation and the individual PI 
(Chapter 3). These costs seriously question its financial viability, especially in 
healthcare systems funded by the state.  
 
Studies investigating productivity with FLACS report increased total surgical time 
and therefore reduced patient turnover and productivity (Abell and Vote, 2014; 
Bali et al., 2012; Lubahn et al., 2014). One common factor in these studies is that 
the operating surgeon is typically performing both the FL treatment as well as the 
subsequent lens extraction within the operating room (OR). There is therefore a 
transfer time between the FL and the theatre table. This reduction in productivity, 
is highly important within the public health sector, where high volume surgical 
models are necessary to meet the both the increasing numbers of patients 
requiring cataract surgery and economic limitations. It is of note that, the current 
published literature on the economics of FLACS mainly originates from 
healthcare systems within the private sector, where supplementary costs of 
advanced technologies may to a certain extend be passed onto the patient in the 
form of a co-payment system(Abell and Vote, 2014). However, even in such 
healthcare models, the literature described FLACS as a longer procedure than 
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CPS and advocates that FLACS at this time is not cost-effective (Abell and Vote, 
2014).  
 
Despite these considerations, FLACS does offer the promise to automate several 
the component parts of cataract surgery so that they do not need to be 
undertaken by an appropriately trained ophthalmic surgeon within the OR. 
Surgical steps such as corneal incisions, arcuate keratotomies, capsulotomies 
and nuclear lens division can be undertaken with FL by a doctor in training or 
suitably accredited and trained nurse/technician in a clean room. This has the 
potential to reduce the amount of time each individual patient spends in the OR 
with the ophthalmic surgeon. As a result, the efficiency of cataract surgery might 
be improved by increasing the number of surgical cases undertaken in a given 
time. This potential efficiency is increased if a hub and spoke model is utilised, 
with a single FL treating and then feeding patients into several ORs for completion 
of surgery. Potentially, if the number of cases per theatre session can be 
increased sufficiently then the additional costs associated with FL technology 
might be offset. In chapter 3, this possibility was explored using a hypothetical 
model based on real world financial data (H. W. Roberts MSc FRCOphth, Ni, et 
al., 2017). It was reported that, in order to break even, there would need to be, 
for example, a 43% increase in the number of operations performed per theatre 
list accompanied by a need to discount the cost of the PIs by at least 52% by the 
manufacturers. 
  
As yet, there are no publications looking at the efficacy, safety and additionally 
the economics of FLACS compared to CPS, within a ‘hub-and-spoke’ model, as 
described above, in a real world public health sector setting, where both trainee 
and fully accredited surgeons undertake surgery, with all the constraints that can 
be associated with the Public Health Sector, such as limited financial resources, 
OR space and resistance to change in formalized working practices In order to 
investigate some of these issues, as part of the RCT comparing FLACS with CPS, 
we delivered our FLACS service using a hub-and-spoke model. Surgeries were 
performed by 3 cataract surgeons of differing levels of experience (one fully 
accredited with twenty years’ experience, one newly accredited and one 
specialist registrar). Two hundred and ninety-nine of the 400 cases were 
performed on designated high-volume theatre lists, whereby a hub-and-spoke 
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FLACS model (with one femtosecond laser and two ORs) was compared to 
independent CPS theatre lists. Details of operative timings and OR utilisation 
within these lists were recorded. The aims were to provide the best quality 
evidence to date on whether FLACS can improve productivity in cataract surgery 
in the public health sector while maintaining safety and efficacy and what models 




6.2.1. Randomised Controlled Trial 
This analysis of relative productivity of FLACS delivered by hub-and-spoke model 
vs CPS was performed as a secondary outcome of a prospective randomised 
interventional case-controlled study at a single University Hospital (Guy’s & St 
Thomas’ Hospital NHS Foundation Trust, London, UK) to compare the clinical 
outcomes of FLACS with CPS (Clinicaltrials.gov registration number 
NCT02825693). The study was approved by local Research & Development and 
Cambridge South Research Ethics Committee (reference 16/EE/0180). This 
study adhered to the tenets of the declaration of Helsinki. 
 
Methods of the study are described in more detail in Chapter 5.2.  
 
6.2.2. Cataract Surgery Delivery Models 
 
6.2.3. General Model, Staff-duties and Patient Flow 
Cataract operations were performed during 4-hour theatre sessions, either in the 
morning or afternoon. Patients for cataract surgery were admitted on a staggered 
arrival basis to an ophthalmic day care unit (ODCU) which staffed by a 
receptionist and a mixture of ophthalmic technicians (OTs) and ophthalmic 
nurses (ONs) (Table 6.3-C). 
 
After electronic registration by the receptionist, the patients were prepared for the 
OR by the ON/OTs. This included a series of medical observations, such as blood 
pressure and blood sugar (if diabetic), and administration of mydriatic therapy. 
Mydriatic therapy used in this study included a Mydriasert implant (Thea 
Laboratories, Clermont-Ferrand, France) and two drops of topical diclofenac 
sodium 0.1% to reduce the risk of intraoperative miosis (L. Wang et al., 2016; 
Schultz et al., 2013). The ward ON/OTs brought and collected the patients to and 
from the OR, which were adjacent to the ODCU, after being telephoned by one 
of the OR nurses (TNs). After surgery was completed the ON/OTs performed 
further medical observations, gave advice about aftercare, dispensed 
medication, discharged the patients and arranged follow-up. 
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Patients were treated on either all-FLACS or all-CPS theatre lists. All cataract 
operations were performed under local anaesthetic. All were unilateral, and no 
other additional procedures planned, other than arcuate keratotomies for 
reduction of corneal astigmatism. 
 
The duties of the ophthalmologist inside the OR included: helping positioning the 
patient on the operating table, the scribing of patient details onto the whiteboard, 
the removing of the Mydriasert implant, the marking of the forehead above the 
eye for cataract surgery prior to the WHO checklist(The World Health 
Organization, 2009), scrubbing and gowning, leading the WHO checklist, 
preparation and draping of the eye for surgery, operating, writing the operation 
notes, and scanning the paper WHO checklist into the hospital’s electronic patient 
record software. 
 
6.2.4. FLACS Hub and Spoke Delivery Model 
FLACS theatre lists were run as a hub-and-spoke model (Figure 3.2.2-A). A 
LenSx femtosecond laser (Alcon Inc, Fort Worth, Tx, USA) was installed in the 
anaesthetic room of one of the ORs, hereafter referred to as the laser suite (LS), 
and was used to feed patients into two adjacent ophthalmic ORs which were 
running in parallel. The FL was operated by an ophthalmologist (HR, VW). The 
model required an additional OT who supervised patients waiting in the corridor 
outside the LS (Table 6.3-C). There was a maximum of 4 patients seated in the 
theatre corridor at any one time (2 patients waiting for laser treatment, 2 patients 
waiting to enter OR). In the FLACS model, the ophthalmologist performing the FL 
laser treatment was responsible for marking the patients’ eyes before laser, 
delivering laser treatment, removing the Mydriasert implant, and instilling 
additional topical phenylephrine 10%. Performing laser treatment included 
preparing the patient interface, entering patient details into the FL, selecting the 
planned treatment profile, positioning the patient on the laser bed, instilling topical 
anaesthetic in to the operative eye, inserting the lid speculum, docking the patient 
interface to the eye, performing OCT of the anterior segment, choosing the 
treatment parameters, and delivering the laser treatment. If completion of FL 
treatment was not possible for any reason, this and the reason why was recorded, 
and the patient proceeded to the OR for CPS. 
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The number of patients booked to each 4-hour theatre list were decided in 
advance of each theatre list. The intention was to attempt to always maximize the 
number of patients treated during the allotted theatre time with reference to the 
levels of nursing and para-medical staffing. Initial targets were chosen based on 
existing experience of CPS and FLACS at our institution and titrated as the trial 
progressed, according to whether theatre lists were finishing early or over-
running. 
 
6.2.5. Operating Room Timings 
Two hundred and ninety-nine of the 400 cases were performed on designated 
high-volume theatre lists, whereby patients were randomized to either hub-and-
spoke FLACS model (with one FL and two ORs) or CPS only theatre lists. Various 
timings of OR utilisation was undertaken by a TN and included the time taken for 
the patient to enter the OR, duration of cataract surgery, time taken for the patient 
to exit the OR after completion of surgery, the total individual patient time in the 
OR, the time the OR was empty between patients, over and under-runs of allotted 
OR time, etc 
 
Timings of patient entry to the OR, start of operation, end of operation and patient 
exit from the OR were recorded contemporaneously by TNs using the existing 
theatre management software (Galaxy Theatre Management System, iSOFT, 
DXC Technology, Virginia, US). Accuracy of timings was ensured by a trained 
observer (IJMM). Timings of patient entry and exit from the LS were recorded by 
the ophthalmologist performing the laser treatment. Start of operation and end of 
operation were defined as application of antiseptic solution to the eye and skin, 
and removal of eyelid speculum. Due to the nature of the surgery, it was not 
possible to mask any of the surgical team to the treatment arm. 
 
6.2.6. Economic Model 
The results from this were used as inputs for a hypothetical economic model, 
reported in a previous publication, to determine an estimation of the costs of 
cataract surgery (Chapter 3) (H. W. Roberts MSc FRCOphth, Ni, et al., 2017). 
This financial model has been described in greater detail in the previous chapter 
but was based on averaged costs/values from 4 different NHS foundation trusts 
and 4 femtosecond laser manufacturers. This model was used to provide an 
estimation of the difference in cost per case of running a FLACS service as 
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compared with a traditional cataract service. Furthermore, if the results supported 
that a hub and spoke model could be run with more than two ORs, these iterations 
were also tested using the model. 
 
6.2.7. Statistics 
For the purposes of this study, the first two CPS and FLACS theatre lists each 
were excluded from analysis as they were scheduled with reduced patient 
numbers to allow theatre staff to familiarize with the models. The final four theatre 
sessions of the study were run as mixed lists to facilitate the scheduling of the 
remaining research participants and to avoid underutilised theatre sessions. 
These final mixed lists were also excluded from analysis.  
 
The primary outcome as per the study protocol were the relative costs of FLACS 
and CPS. However, considering inherent difficulties in accurate recordings of 
costs within a large tertiary ophthalmology service, it was determined that this 
would be replaced with the number of cases on FLACS and CPS lists and the 
duration of the operations. This current study of 299 patients had a power of 99% 
to detect an effect size (d) of 0.5 for the numbers of participants included in this 
analysis with regards to duration of surgery with α=0.05 and a two tailed analysis. 
 
Baseline characteristics were summarised for each treatment arm. Results were 
analysed primarily as per intention to treat. Continuous data was reported using 
means and standard deviations if data appear Gaussian, or medians and inter-
quartile ranges if not. Binary data was reported as frequencies and percentages 
and evaluated with Fischer’s exact test. Student’s t-tests were used for 
parametric data and the Mann Whitney U test for non-parametric. All statistical 
tests used a two-sided p value of α=0.05 unless otherwise specified. Intra-
operative complications were defined as any event that involved unintentional 
trauma to an ocular structure, requiring additional treatment, or having a negative 







A total of 427 patients (427 eyes) were recruited for the study and randomized to 
receive FLACS or CPS. Twenty-seven were excluded or withdrew in advance of 
surgery. For this study comparing FLACS in a hub and spoke model with dual 
CPS theatre lists 299 of 400 operations were included for analysis. Excluded 
patients included 57 patients who had had surgery on the first 2 of each theatre 
sessions for FLACS/CPS and 44 patients treated on mixed (CPS and FLACS) 
theatre lists. There were no significant differences between patients included and 
excluded for this analysis other than those excluded were on average 3 years 
older (p=0.01) and had shallower anterior chambers by 0.17mm (p<0.01) (Table 
6.3-A). Of the 299 eyes included in this analysis, 134 patients had received 
FLACS, and 165 patients underwent CPS. Baseline demographics for the FLACS 
and CPS groups are seen in Table 6.3-B. The only significant difference at 
baseline was the FLACS group had a longer axial length by 0.39mm (p=0.02). 5 
patients due to receive FLACS were treated with CPS due to the following 
reasons: palpebral aperture too narrow for patient interface (n=3, 2.2%), patient 
lack of compliance (n=1, 0.7%), administrative error (n=1, 0.7%). 
 









Male/female 140/159 41/60 0.30 
1st Eye/2nd Eye 243/56 87/14 0.29 
Right Eye/Left Eye 164/135 55/46 1 










-0.50 ± 4.32 -0.38 ± 3.52 0.80 
Axial length (mm) 23.78 ± 1.39 23.67 ± 1.56 0.51 
Anterior chamber 
depth (mm) 





1.63 % ± 1.24 1.63 % ± 0.71 % 1 
 113 
Table 6.2.7-1. Demographics of patients included and excluded from the hub-and-spoke model analysis 
demonstrating equivalence between the two groups 
 
The 139 patients undergoing FLACS were treated during 8 hub-and-spoke 
sessions, involving 16 four-hour theatre sessions. The 160 patients randomized 
to CPS were treated on 20 cataract theatre lists. The average OR utilisation of a 
hub-and-spoke session was 221mins ± 21 (92.05%±8.71) with a median of 9 
patients treated in each OR, while the average duration of a CPS list was 230± 
22 min (95.81%±9.17) (p<0.001) with a median of 8 patients treated per list. 
Patients receiving FLACS spent, a mean time of 5.85±1.99 min in the LS. 25% of 
FLACS theatre sessions over-ran the allotted 4 hours compared with 30% of CPS 
lists. Average theatre over-run was 5±2.16 min for FLACS and 13.67±8.76 mins 
for CPS (p=0.09). 
 
 FLACS CPS p 
Male/female 62/72 78/87 0.90 
1st Eye/2nd Eye 111/23 132/33 0.55 
Right Eye/Left Eye 70/64 94/71 0.42 










-0.58±5.34 -0.42 ± 3.15 0.75 
Axial length (mm) 23.99 ± 1.44 23.60 ± 1.33 0.02 
Anterior chamber 
depth (mm) 





1.64% ± 0.99% 1.62% ± 1.43 % 0.89 
Table 6.2.7-2. Patient demographics for the two treatment arms 
 
Staffing levels for both models can be seen in Table 6.3-C. The hub-and-spoke 
model required one additional OT to be present compared with the CPS. A 
comparison of the average times associated with each operation can be seen in 




 FLACS (BOTH ORS) CPS (BOTH ORS) 
OPERATING ROOMS (ORS) 
OPHTHALMOLOGISTS 3 3 
OR NURSES 6.5 6.5 
OPHTHALMIC DAY CARE UNIT 
OPHTHALMIC TECHNICIANS 3 2 
OPHTHALMIC NURSES 2 2 
RECEPTIONIST 1 1 
Table 6.2.7-3. Staffing levels associated with delivery of hub-and-spoke FLACS and CPS services. ORs = Ophthalmic 
Operating Rooms 
 
 FLACS (N=139) CPS (N=160) T TEST 
(P 
VALUE) 
TIME FROM ENTERING OR 
TO START OF OPERATION 
5.83 ± 2.58 6.25 ± 2.91 0.19 
DURATION OF OPERATION 12.04 ± 4.89 14.54 ± 6.19 <0.001 
TIME FROM END OF 
OPERATION TO EXITING 
OR 
2.47 ± 0.66 2.6 ± 1.02 0.20 
TOTAL TIME IN OR 20.34 ± 5.82 23.39 ± 6.89 <0.001 
OR EMPTY 5.27 ± 3.25 5.23 ± 3.28 0.92 
Table 6.2.7-4. Comparison of OR timings (in minutes) between hub-and-spoke FLACS and CPS based on intention 













TO START OF 
OPERATION 
5.82 ± 2.62 6.24 ± 
2.87 
0.19 6 ± 1.58 
DURATION OF 
OPERATION 
11.73±3.53 14.71 ± 
6.76 






2.47 ±0.66 2.59 ± 
1.02 
0.24 2.4 ± 0.89 
TOTAL TIME 
IN OR 
20.2 ±4.59 23.55 ± 
7.47 
<0.001 28.8 ± 19.33 
OR EMPTY 5.79±3.9 5.27 ± 
3.25 
0.21 6.4 ± 1.95 











The overall rate of intraoperative complications was similar between the two 
groups 3.54% vs 3.76%. However, there was a noticeable difference in the rates 
of vitreous loss (0% with FLACS compared to 1.88% in CPS) (Table 6.3-A). 
 
COMPLICATIONS FLACS CPS RR P 
ANTERIOR CAPSULAR 
TEAR 




TEAR WITH VITREOUS 
LOSS 
0 (0%) 3 (1.88%) 0.16 (95% CI 
0.01 -3.15) 
0.23 
DM TEAR 1 (0.72%) 0 (0%) 3.45 (95% CI 




1 (0.72%)* 0 (0%) 3.45 (95% CI 










3.54% 3.76% 0.95 (95% CI 
0.30-3.07) 
0.94 
Table 6.3.1-1. Incidence of complications between the two treatment arms based on intention to treat analysis. 
*This patient was allocated to FLACS but was unable to undergo this procedure and the patient underwent CPS 
(RR = Relative Risk).  
 
 
6.3.2. Economic Modelling 
Based on the OR timings, using a hub-and-spoke model, we achieved a mean 
reduction of total time in the OR per patient of 3.05min. This allowed us to 
undertake one extra FLACS case per 4-hour theatre list compared to our CPS 
only lists. The average number of cases on using our operative models were 8 
for CPS and 9 for FLACS, which represents an average 12.5% increase in 
productivity. We applied these results to our economic model. Based on these 
results, the average cost for each cataract operation was £355.42 for CPS and 




Figure 6.3.2-A Comparison of weekly costs of FLACS vs CPS services 
 
A bivariate sensitivity analysis examining the number of cases/week and the cost 
of the patient interface (PI) was performed, reporting the additional cost per case 
of a FLACS service (Table 6.3-A).  
 
 
  NUMBER OF CATARACT OPERATIONS PERFORMED/WEEK 




20 40 60 80 
40 £72.75 £46.51 £37.76 £33.39 
70 £102.75 £76.51 £67.76 £63.39 
100 £132.75 £106.51 £97.76 £93.39 
130 £162.75 £136.51 £127.76 £123.39 
Table 6.3.2-1. Bivariate sensitivity analysis comparing effects of cost of patient interface and number of 




6.3.3. 3:1 and 4:1 Hub and spoke model 
Although the duration of FL application to the eye is usually between 25 and 45 
seconds, patient time inside the laser room was 5.85mins ±1.99. In the model, 
the laser operator is an ophthalmologist working unassisted, and therefore most 
of time spent is on preparing the patient and setting up the laser. Based on these 
results, I suggest that the maximum number of ORs which could be run (to 
maximize the utility of a femtosecond laser) in a hub-and-spoke model would be 
four (average total patient time in OR + turnaround time 25.12mins±5.25). Adding 
a third OR to the economic modelling of the costs of cataract surgery reduced the 
cost per case from £500.02 to £477.28 and adding a fourth reduced it to £465.91. 
Performing the same bivariate analyses on a 3:1 and 4:1 hub-and-spoke models 
as above shows that the difference in cost could be reduced further if the hospital 
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was performing greater numbers of cataract surgery and received a significant 
discount in the cost of the patient interface from the manufacturer (Table 6.3-A). 
However, to break even, financial modelling shows the manufacturers would 
need to offer between 78-99% discount on the cost of the PIs (Table 6.3-B). 
 
   Number of operations performed per week 




3:1 Model 40 £33.40 £24.65 £20.28 £17.65 
70 £63.40 £54.65 £50.28 £47.65 
100 £93.40 £84.65 £80.28 £77.65 
130 £123.40 £114.65 £110.28 £107.65 
  Number of operations performed per week 
  40 60 80 100 
4:1 model 40 £26.84 £18.10 £13.72 £11.10 
70 £56.84 £48.10 £43.72 £41.10 
100 £86.84 £78.10 £73.72 £71.10 
130 £116.84 £108.10 £103.72 £101.10 
Table 6.3.3-1. Bivariate sensitivity analyses demonstrating the additional cost of FLACS compared with CPS 
within a theoretical 3:1 and 4:1 hub-and-spoke FLACS model when the cost of the patient interface and the 
number of operations per week are varied. 
 
 
  NUMBER OF CATARACT OPERATIONS/YEAR 
 
% DISCOUNT 
ON COST OF PI 
 2000 3000 4000 5000 6000 
4:1 model 91 84 81 79 78 
3:1 model 96 89 86 84 82 
2:1 model n/a 99 95 93 92 
Table 6.3.3-2. Break even points for hub-and-spoke FLACS with CPS services calculated for the % discount of the 
patient interface based on the number of ORs concurrently run and the number of operations performed per year 
 
6.3.4. Cases unable to undergo FLACS 
Five (3.6%) patients randomised to FLACS did not receive femtosecond laser 
treatment. This is consistent with reported rates of unsuccessful attempts at 
FLACS between 2.3-6.3%(Day, Dhallu, et al., 2016; Brunin et al., 2017; J. S. M. 
Chang et al., 2014). In our experience, the most common reason was that the 
palpebral aperture was too narrow to permit the 16mm patient interface to 
applanate with the cornea. Four of these patients underwent uneventful CPS, 
with one suffering a supra-choroidal haemorrhage. This patient was considered 







When FLACS is performed within traditional models featuring one surgeon, or 
installing the FL in the OR, productivity may be adversely affected, leading to 
incurring additional indirect costs (Abell and Vote, 2014; Lubahn et al., 2014; Bali 
et al., 2012; Vasquez-Perez et al., 2018). This is because the duration of the 
patient’s experience is increased with FLACS compared with CPS (time in OR + 
LS = 26.05 for FLACS vs 23.55 for CPS). Evaluating new models of delivering 
cataract surgery (such as a hub-and-spoke model) within a RCT, where patients 
are prospectively randomised to CPS or FLACS, allows testing of the model 
within a rigorous framework, rather than performing a case-control study where 
bias may be inherent. 
 
By deploying a FL in the anaesthetic room adjacent to the OR and using a hub-
and-spoke model, this study showed that surgical time and patient time in OR are 
shorter for FLACS than CPS. Transferring some of the surgical steps outside the 
OR using the FL reduces patient time in OR by 3.05minutes for FLACS (p<0.001). 
This led to an average of one extra operation per OR operating list of FLACS 
(median 9 cases per list) compared to CPS (median 8 cases per list), resulting in 
a 12.5% improvement in productivity (overall 2 more operations per session). 
Furthermore, despite the additional cases, the FLACS lists were shorter than the 
CPS lists, and more CPS sessions overran. The method of titrating the numbers 
of patients scheduled for surgery to maximise the number of operations within 
the four-hour session resulted in extremely high levels of OR utilisation. Our 
ambition to maximize theatre utilization and test the limits of the hub and spoke 
model, resulted in a number of theatre sessions overrunning (25% FLACS vs 
30% CPS), especially when unforeseen complications had occurred. Theatre list 
overruns may incur financial penalty at some NHS/public hospitals..  
 
These results are in contradiction to a comparative case series of 38 operations 
(19 FLACS, 19 CPS), which used instrument tracking software to calculate the 
amount of time and instrument movement in each stage of the cataract operation 
(Day et al., 2018). This study found that FLACS was on average 88 seconds 
longer, largely due to increased difficulty with lens cortex removal by aspiration. 
Limitations of this study include the relatively low number of operations and that 
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it is a single surgeon series. Our experience found that removal of lens cortical 
material during FLACS is facilitated with bimanual irrigation-aspiration (I/A), 
which is borne out in the literature (Conrad-Hengerer, Schultz, et al., 2014), yet 
during the adoption of FLACS, none of the surgeons changed their preferred I/A 
handpiece (2 silicone co-axial, 1 bimanual) (Blomquist and Pluenneke, 2005). 
 
A study evaluating a model of attempting to improve OR efficiency with a FL, 
utilised a Ziemer LDV Z8 FL, which is the only currently mobile platform and has 
a sufficiently small footprint to be installed adjacent to the operating table, in a 
single surgeon/single theatre model. This was a retrospective series of 90 
patients and showed that FLACS took on average 5.2minutes±4.5 longer 
(Vasquez-Perez et al., 2018). Limitations include its retrospective nature, 
relatively smaller cohort size, and that each surgeon may have been less 
experienced with FLACS (only learning curve of 10 operations required). Despite 
this, even a FL platform sufficiently small to be positioned alongside the surgical 
bed, is unable to escape the general truth that a FL installed in the same 
operating theatre hinders efficiency (Abell and Vote, 2014; Lubahn et al., 2014). 
 
There were some differences between the 299 patients included for this analysis 
and the 101 excluded, namely that the excluded group were 3 years older on 
average, with a corresponding shallower anterior chamber depth (ACD) by 
0.17mm. It is unlikely that these differences are clinically significant and would 
have had a material effect on the timings of the theatre list (Narendran et al., 
2008). Importantly, the prospectively calculated risk of PCR was equivalent 
between the two groups. 
 
The mean time of each patient undergoing patient preparation for FL and FL 
application was 5.85 ±1.99 mins. Based such results it is easily possible to have 
a hub-and-spoke model of one FL feeding into 3 or 4 ORs (4:1 or 3:1) rather than 
2 (2:1). This study suggests that the ideal number of ORs to maximize the utility 
of a femtosecond laser in a hub-and-spoke model would be four (average total 
time per patient in OR + turnaround 25.12mins ± 5.25). This would result in 3 or 




Potential issues of having a 3:1 or 4:1 model to attempt to use a femtosecond 
laser as a tool for high volume surgery is that this requires a suitable and 
dedicated room within theatres and multiple ORs. This limits the use of such a 
model to an institution with such facilities already in place or a purpose-built unit 
(thus incurring additional costs). For instance, with a maximum of 2 ophthalmic 
ORs at our institution we were unable to evaluate adding additional ORs to our 
existing hub-and-spoke model and it would be important to incorporate any 
development costs in the planning process if deciding whether to adopt this 
technology.  
 
To minimize costs of running the hub and spoke model it is important to minimise 
the additional number of staff needed. Our model required 2 additional members 
of staff, one ophthalmologist to operate the laser and one OT to chaperone the 
patients between the LS and ORs. For our CPS lists, the extra OT was not 
present, however there were 3 ophthalmologists between the two ORs. This may 
have improved the efficiency of the CPS lists in our study to a degree by allowing 
the surgeons to rotate. The cost of the 3rd surgeon was included in the financial 
modelling for the CPS model so as not to bias the model further in favour of CPS. 
In the FLACS model, it was also possible to permit surgeon rotation between the 
ophthalmologists performing laser and operating, thus possibly reducing the risk 
of surgeon fatigue during high volume cataract surgery. 
 
In Chapter 3, hypothetical financial modelling of hub-and-spoke delivered FLACS 
was undertaken. Using a 2:1 model, bivariate sensitivity analyses showed that 
(for example) a 43% improvement in productivity would need to be achieved and 
accompanied by a 52% discount on the PI for the service to break even. This 
improvement in productivity was not realised by our study with a time saving of 3 
minutes per patient (in the OR). The financial model demonstrates that the PI is 
the single most expensive item for the FLACS service. However, thus far FL 
platforms have tended to be used, and marketed as a premium product (based 
on reported improved refractive outcomes and stability) (Conrad-Hengerer et al., 
2015). However it is very likely that a public health care service may be able to 
negotiate discounts on the costs of FLACS, especially if used within a high-
volume service (which further improves affordability) (Table 6.3-A and Table 
6.3-A). Further cost savings may be made by improved safety which may make 
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cost savings in post-operative management (Qatarneh et al., 2012). The FL may 
bring other advantages to a department, such as adding corneal surgical 
capabilities. It is important to note therefore that whilst there was no difference in 
posterior capsular rupture (PCR) and vitreous loss rates in this arm of the present 
study to investigate comparative high-volume hub-and-spoke FLACS and CPS 
theatres lists (table 7), the results of the chapter 5 RCT showed a statistically 
significant reduction in PCR with FLACS. As such complications incur additional 
costs, if our findings with respect to PCR rates are replicated by others, then our 
economic modelling might be more favourably inclined toward a FLACS hub-and-
spoke model. 
 
Investigation of the effects of number of AHPs assisting in cataract theatre lists 
on the overall productivity showed a marked difference in the number of cataract 
surgeries performed between different institutions, but furthermore that a 
minimum of 4 AHPs are required to deliver high volume cataract surgery with 
effective use of theatre time and minimum delays (Chapter 2) (H. W. Roberts 
MSc FRCOphth, Myerscough, et al., 2017). The cataract theatre lists at St 
Thomas’ are generally run with 3 AHPs, which precludes further increases in 
productivity, which is evident in our turnaround time compared with other surgical 
units. The average time between one operation finishing and the start of the next 
was 13.57min and 14.08min for FLACS and CPS respectively, meaning that only 
between 47.0 - 50.8% of OR time is spent engaged in surgery. Our previous time 
and motion studies showed that patient turnover with 4 AHPs present can be 
reduced to 9.70mins within NHS units. Including one additional AHP per OR to 
our unit (at a cost of £70 per session) to facilitate patient turnover could possibly 
provide a greater overall time saving than this FLACS hub and spoke model. 
 
6.4.1. Limitations 
This study  considered the productivity difference in terms of number of 
operations per OR and found a 12.5% improvement in FLACS. However other 
methods of assessing productivity could have been chosen (for example number 
of cases per surgeon). However, there are usually an abundance of cataract 
surgeons in a department compared with theatre time and space, making the 
latter more of a limiting factor. The department did not incur any infrastructure 
costs in the installation of the laser into the anaesthetic room and so it was not 
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possible to provide a representation of infrastructure costs into the model. 
However, other surgical units have incurred significant costs during the 
installation of a FL, so this is an important consideration. The surgical team was 
not masked to the treatment arms and this may be associated with performance 
bias. Another potential source of bias is that we had to book patients to theatre 
lists pre-emptively; having a busier list may have improved productivity. 
Nevertheless, we aimed to combat this by a fair and transparent method of a run-
in period before the trial commenced to build experience with the model and 
titrating booking numbers in an objective way depending on previous early 
finishes and overrunning. These potential biases may have been even more 
evident within a cohort study methodology, hence why a RCT was preferred. 
 
6.5. Conclusion 
In summary, FLACS with a hub-and-spoke model was significantly faster than 
CPS, with patients spending less time in the OR. This enabled a slight 
improvement in productivity, but not sufficient to meaningfully offset the additional 
costs relating to FLACS. Further gains in productivity may have been achieved 
with a 3:1 or 4:1 hub-and-spoke model. 
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Chapter 7. Refractive outcomes after limbal 
relaxing incision or femtosecond laser assisted 
astigmatic keratotomy in the management of 
corneal astigmatism at the time of cataract surgery 
Supplementary Material #5. Roberts, H.W., Wagh, V.K., Sullivan, D.L., Archer, T.J. and O'Brart, D.P., 
2018. Refractive outcomes after limbal relaxing incisions or femtosecond laser arcuate keratotomy to 
manage corneal astigmatism at the time of cataract surgery. Journal of Cataract & Refractive 





LRIs or FS-AKs have been found to be efficacious in the management of low to 
moderate astigmatism (<2.5-3D) but are less suitable for moderate to high 
astigmatism which require toric IOLs or bioptics (Day, N. M. Lau, et al., 2016; 
Nanavaty et al., 2017). To my knowledge there are no trials comparing the 
effectiveness of LRIs with FS-AK in the management of low to moderate corneal 
astigmatism at the time of cataract surgery. The purpose of this study was to 
investigate any differences between laser and manually delivered keratotomies 
using vector analysis (Alpins, 2001; Alpins and Goggin, 2004; Alpins, 1993; 





This analysis of refractive outcomes of patients treated with LRIs or FS-AKs was 
performed as a secondary outcome of a prospective randomised interventional 
case-controlled study at a single University Hospital (Guy’s & St Thomas’ 
Hospital NHS Foundation Trust, London, UK) to assess the relative costs of 
delivering a FLACS service compared with CPS (Clinicaltrials.gov registration 
number NCT02825693). The study was approved by local Research & 
Development and Cambridge South Research Ethics Committee (reference 
16/EE/0180). This study was conducted adhering to the tenets of the Declaration 
of Helsinki.  
 
Methods of the study have been described in Chapter 5. Four hundred eyes of 
400 patients were randomised to receive FLACS or CPS. FLACS treatment was 
performed using the LenSx Femtosecond laser (Alcon Inc,). The femtosecond 
laser was used to perform capsulotomy, lens fragmentation in all patients and 
intrastromal FS-AK when appropriate. All cataract operations were performed 
under local anaesthetic. Following FL treatment, the patient was transferred to 
the operating theatre for the remainder of the cataract extraction. 
Phacoemulsification was performed using the Infiniti phacoemulsification 
machine (Alcon Inc) in both groups. Patients undergoing CPS were prepared for 
surgery in the same way as those in the laser arm. Instead of receiving laser pre-
treatment, they were brought straight to theatre and received LRIs at the start of 
the cataract operation. All operations were performed by experienced surgeons 
who had completed at least 30 FLACS procedures (HWR, VKW, DOB). 
 
Specific to this sub-group analysis, any patient with corneal astigmatism greater 
than 0.9D based on Pentacam Tomography (Oculus, Germany) were offered LRI 
or FS-AK as part of their cataract operation based on the initial randomisation. 
Eyes with previous refractive or corneal surgery, or corneal pathology were 
excluded. The IOL Master 500 (Carl Zeiss Meditec AG, Switzerland) provided 
keratometry measurements used for IOL formula calculation. Corneal 
astigmatism was measured using Pentacam topography and were used for pre-
operative astigmatism planning and post-operative analysis. Where biometry was 
not possible on IOL Master 500 owing to density of cataract, an A-scan ultrasound 
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biometry (Carl Zeiss Meditec) was performed. All post-operative results were 
recorded at 4 weeks follow up. 
 
7.2.1. LRI group 
LRI parameters were calculated based on Donnenfeld’s nomogram via an online 
software (Abbott Medical Optics, USA; available at 
https://www.lricalculator.com). This nomogram requires the age of the patient, 
steep and flat K values with axies, the location of the main CCI and the surgeons 
SIA. We based our nomogram inputs on the keratometric readings from 
Pentacam and individual surgeon’s surgically induced astigmatism (SIA) values. 
Target induced astigmatism (TIA) was always aimed at 100% correction. Paired 
arcuate LRIs were always performed; where the surgeon’s preference was to 
operate on axis, the 2.4mm main wound was positioned in the middle of the LRI. 
When anatomy or comfort dictated an off-axis approach, the surgeon’s SIA was 
used to modify the LRIs. 
 
Manual limbal markings at 0° and 180° were made for all eyes (LRI and FS-AK 
groups) preoperatively with patients in sitting position at the slit lamp with a 
needle to scratch the corneal epithelium at the limbus, followed by a sterile 
marker pen. 
 
A Mendez-style ring was used to mark the steep meridians at the start of the 
surgery. The LRI incision was made before the commencement of 
phacoemulsification using a 2.4mm keratome to incise through epithelium and 
Bowman’s layer, followed by a 600µm guarded diamond knife to incise through 
the stroma. No corneal sutures were used during the surgery.  
 
7.2.2. FS-AK group 
FS-AK parameters were determined by a nomogram previously reported by Day 
et al (Day, N. M. Lau, et al., 2016). The settings of the FL for the arcuate 
intrastromal incisions were also maintained. Although this nomogram was 
intended to achieve only up to 70% correction, for ease of interpretation of 
outcome data, the TIA was defined as an 100% correction with no residual 
postoperative corneal astigmatism. After docking with the FL, manual adjustment 
of the horizontal meridian was performed when cyclo-rotation had occurred 
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(Hummel et al., 2017). In cases where either of the AKs overlapped with the 
surgeons planned manual wound, the main section would be positioned more 
peripherally than the AK so that it would not be involved. 
 
7.2.3. Statistics 
Baseline characteristics were summarized for each treatment arm. Results were 
analysed primarily as per intention to treat. For all evaluations of visual acuity as 
an outcome, patients with visually significant ocular co-morbidities were excluded 
prospectively and those opting for a refractive target other than emmetropia were 
excluded from analysis of refractive outcome. Snellen visual acuities were 
converted to logMAR for analysis (Lange et al., 2008). Comparative and 
descriptive statistical analyses included the Fisher exact test, chi-square test, and 
Student t tests. All statistical tests used a two-sided p value of α=0.05 unless 
otherwise specified. Excel software (Microsoft Corp.) was used for data entry, 
analysis and graphical representation. Intra-operative or post-operative 
complications were defined as any event that involved unintentional trauma to an 
ocular structure, requiring additional treatment, or having a negative effect on 
participants' eyesight. 
 
Analysis of corneal astigmatic outcomes based on corneal topography 
measurements before and after surgery were performed using the Alpins method, 
with calculation of 3 vector parameters: target induced astigmatism (TIA), 
surgically induced astigmatism (SIA), and difference vector (DV) (Alpins, 2001; 
Alpins and Goggin, 2004; Alpins, 1993). TIA is defined as the intended correction 
in astigmatic magnitude and axis, SIA is the amount and axis of astigmatic 
change achieved by surgery and the DV is the magnitude and axis of the residual 
astigmatism. Results are presented based on the standardized graphs for 
reporting the outcomes of refractive surgery and IOL based refractive surgery 
(Reinstein et al., 2017; 2014). Additional parameters calculated include the 
correction index (CI), angle and magnitude of error and the index of success 
(IoS). The CI is a ratio of the SIA divided by the TIA, where values greater than 1 
indicate overcorrection, and less than 1, undercorrection. The angle of error is 
the difference in angle between the SIA and TIA. The IoS is the DV divided by 
the TIA with a value of 0 indicating perfect correction. The axis of the steep 




Four hundred and twenty-seven patients were recruited to the study between 
August 2016 and June 2017 as per the inclusion/exclusion criteria (Table 7.3-A). 
Twenty-seven patients withdrew from the trial before surgery. Four hundred eyes 
of 400 patients received surgery between November 2016 and June 2017 (200 
CPS, 200 FLACS). 
 
 LRI FS-AK p 





Sex (% female) 56.8% 41.5% 0.24 
Laterality (% right eyes) 55.0% 53.8% 1.0 
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A total of 51 eyes of 51 patients in the CPS group received LRIs of which 8 were 
excluded from analysis of UDVA for visual comorbidities (age related macular 
degeneration/AMD n=6, amblyopia n=1, chronic central serous chorioretinopathy 
n=1). A total of 53 eyes of 53 patients in the FLACS group received FS-AK of 
which 9 were excluded for visual comorbidities (AMD n=4, amblyopia n=2, 
previous retinal detachment n=1, vitreomacular traction n=1, central retinal vein 
occlusion n=1). 
 
Astigmatic Vectoral Analyses LRIs FS-Aks p 
Mean S.D. Mean S.D. 
Target Induced Astigmatism Vector 
(TIA) (D) 
     
 
Arithmetic mean 1.50 0.46 1.38 0.40 0.16 
 
Summated vector mean 0.31 Ax 160 
 
0.21 Ax 174 
  
Surgically Induced Astigmatism 
Vector (SIA) (D) 
     
 
Arithmetic mean 1.02 0.91 1.23 0.77 0.21 
 
Summated vector mean 0.07 Ax 161 
 
0.16 Ax 93 
  
Correction Index (CI) 
     
 
Geometric mean 0.48 0.57 0.73 0.49 0.02 
Difference Vector (DV) (D) 
     
 
Arithmetic mean 1.17 0.69 0.89 0.54 0.02 
 
Summated vector mean 0.25 Ax 160 
 
0.37 Ax 178 
  
Index of Success (IOS) 
     
 
Geometric mean 0.81 0.49 0.65 0.4 0.07 
Angle of Error (A of E) (deg) 
     
 
Arithmetic mean -3.35 29.90 2.35 25.95 0.30 
 
Absolute mean 22.10 20.19 17.99 18.69 0.28 
Table 7.2.3-2 Vector analysis of post-operative results 
 
Case demographics and pre-operative values can be seen in Table 7.3-A. There 
were some statistically significant differences at baseline between the two 
groups: namely worse visual acuity (7 letters), and longer axial length (by 0.7mm) 
in the femtosecond group. TIA & SIA single angle vector plots are displayed in 
Figure 7.2.3-A and Figure 7.2.3-B. SIA was less than TIA in both groups 
indicating under-correction. However, the FS-AK corrected more astigmatism 
than the LRI as the CIs were 0.73 and 0.48 respectively (p=0.02). The DV was 
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also lower in the FS-AK group (p=0.02) indicating better correction (Table 7.3-B, 
Figure 7.2.3-C and Figure 7.2.3-D). Despite a greater SIA, CI and lower DV, there 
was not quite a statistically significant difference in the Index of Success (ratio of 
DV to TIA) between the two groups (p=0.07). Angles of error and TIA versus SIA 
graphs are in Figure 7.2.3-E and Figure 7.2.3-F. The 4 standard graphs for 
representation of refractive outcomes of cataract surgery are seen in Figure 
7.2.3-G, Figure 7.2.3-H, Figure 7.2.3-I and Figure 7.2.3-J. In both groups, nearly 
60% of patients attained their visual potential without needing refractive 
correction (figure 8). 20% of LRI patients and 44% of FS-AK patients attained 
post-operative cylinder of <0.5D (p=0.01) and 44% vs 74% respectively had less 
than 1D cylinder (p=0.003) (Figure 7.2.3-J). Corneal astigmatism was reduced in 
the FS-AK group from 1.38D±0.40 to 0.89D±0.54 and from 1.50D±0.46 to 
1.17D±0.69 in the LRI group (p=0.02). Post-operative refractive cylinder was 
0.90D±0.50 and 1.18D±0.90 respectively (p=0.05). The arithmetic mean of the 
angle of error was very small in both groups indicating neither group had an 
overall misalignment of treatment. However, the absolute mean indicates a 
misalignment of 18 - 22 degrees (p=0.28). (Table 7.3-B). 
 
 
Figure 7.2.3-A Single angle polar plots regarding corneal astigmatism for target induced astigmatism (TIA) and 
surgically induced astigmatism (SIA) of the patients treated with limbal relaxing incisions (LRI). 
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Figure 7.2.3-B Single angle polar plots regarding corneal astigmatism for target induced astigmatism (TIA) and 




Figure 7.2.3-C Single angle polar plots regarding corneal astigmatism for difference vector (DV) and correction 
index (SIA) of the patients treated with limbal relaxing incisions (LRI). One outlier is not represented on the 
correction index graph – the correction index graph – the correction index of 3.38 is off the scale of the chart. 
 
Figure 7.2.3-D Single angle polar plots regarding corneal astigmatism for difference vector (DV) and correction 
index (SIA) of the patients treated with femtosecond laser astigmatic keratotomies (FS-AK). 
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Figure 7.2.3-E The astigmatism angles of error and the TIA vs SIA graphs of the patients treated with limbal 
relaxing incisions (LRI). 
 
Figure 7.2.3-F The astigmatism angles of error and the TIA vs SIA graphs of the patients treated with femtosecond 
laser astigmatic keratotomies (FS-AK). 
 
FL treatment was delivered successfully to 100% of cases. There was a 
complication relating to laser delivery in 5 cases (9.4%), which included: corneal 
abrasion (n=2, 3.7%), incomplete capsulotomy (n=3, 5.6%). The FL treatments 
delivered were corneal incisions (0%), capsulotomy (100%), lens fragmentation 
(100%) and arcuate keratotomies (100%). Limbal relaxing incisions were 
performed in the CPS group in all cases. None of the FS-AKs or LRIs resulted in 
any complication including posterior perforation or inadvertent placement. 
Intraoperatively, 2 patients in the FS-AK group sustained an anterior capsular 
tear and one patient had intraoperative floppy iris syndrome (IFIS), 2 patients in 
the LRI group had IFIS and one had iris prolapse/trauma. Post-operatively none 
of the LRI group suffered complications, 2 patients in the FS-AK group had CSMO 




Figure 7.2.3-G (A&B) Cumulative percentages of postoperative Snellen visual acuity (unaided distance and 
corrected distance) of A) limbal relaxing incisions and B) femtosecond laser astigmatic keratotomies. 
 
Figure 7.2.3-H (A&B): Number of lines difference between unaided and corrected distance visual acuity of A) 
limbal relaxing incisions and B) femtosecond laser astigmatic keratotomies. 
 
Figure 7.2.3-I (A&B): Spherical Equivalent Refractive Accuracy of A) limbal relaxing incisions and B) femtosecond 
laser astigmatic keratotomies. 
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Figure 7.2.3-J (A&B): Pre-operative and post-operative refractive astigmatism of A) limbal relaxing incisions and 
B) femtosecond laser astigmatic keratotomies. 
 
Sub-group analysis 
A subgroup analysis was performed on those with 0.9-1.5D cylinder 
preoperatively (Table 7.2.3-3). The FS-AK group continued to have the superior 
SIA (1.1 vs 0.92, p=0.28), CI (0.91 vs 0.74, p=0.19) and lower DV (0.78 vs 1.02, 









mean SD mean SD p 
TIA (ARITHMETIC 
MEAN) 
1.24 0.18 1.2 0.18 0.33 
SIA (ARITHMETIC 
MEAN) 
0.92 0.84 1.1 0.62 0.28 
CORRECTION INDEX 0.74 0.63 0.91 0.49 0.19 
DIFFERENCE VECTOR 1.02 0.67 0.78 0.5 0.08 
INDEX OF SUCCESS 0.83 0.54 0.66 0.44 0.2 
ANGLE OF ERROR 18.86 17.72 17.9 19.38 0.82 






The femtosecond laser can perform, with reliability and reproducibility, several 
important steps of cataract surgery. This includes arcuate keratotomies, which 
are performed to reduce corneal astigmatism at the time of surgery. While the 
effects of laser capsulotomy on IOL centration and refraction as well as the effects 
of lens fragmentation on total phacoemulsification energy have been previously 
investigated, this is the first study to investigate the efficacy of automated 
femtosecond AKs compared to manual LRIs during cataract surgery. Both 
techniques have been previously shown to be efficacious at reducing corneal 
astigmatism, but have not yet been directly compared (Day, N. M. Lau, et al., 
2016; Müller-Jensen et al., 1999). 
  
In this study, we used the FS-AKs nomogram as originally described by Day et 
al (Day, N. M. Lau, et al., 2016), notwithstanding two important differences. 
Firstly, we utilized a different femtosecond laser platform and secondly, unlike 
Day’s group where the main incisions were consistently temporal, we elected to 
perform our main incisions on axis whenever possible (accounting for surgical 
access etc). Using this methodology, we found that FS-AK had a greater 
correction index than LRI, indicating that SIA was 73% of TIA (compared with 
48% for LRI). For the purposes of analysis TIA of the FS-AK group was assumed 
to be a 100% correction but it is important to note that the nomogram for the FS-
AK aims for a 70% correction to avoid too many patients being overcorrected and 
therefore the FS-AK was remarkably accurate in what it aimed to deliver (Day, N. 
M. Lau, et al., 2016). It might be assumed therefore that aiming for a 100% 
correction with FS-AK with on axis incisions might deliver better astigmatic 
correction than these currently presented results and should be the subject of 
further clinical studies and nomogram refinement.  
 
A subgroup analysis was performed of those with 1.5DC of preoperative corneal 
cylinder or less (Table 7.2.3-3). With techniques such as LRIs or FS-AKs offering 
astigmatism correction in cases of low to moderate corneal cylinder, many 
surgeons will opt to use toric IOLs in those with above a certain threshold of 
corneal astigmatism(Lam et al., 2015), with individual surgeons commonly opting 
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for cut offs of 1DC, 1.25DC or 1.5DC. With our inclusion criteria requiring patients 
have >0.9DC, we were able to perform vector analysis excluding those with such 
significant astigmatism that these patients would commonly be offered a toric 
IOL. This did not show a statistically significant benefit of FS-AK over LRI. While 
both techniques had greater undercorrection with larger TIAs, they were more 
closely matched for lower magnitudes of astigmatism (Figure 7.2.3-E and Figure 
7.2.3-F).  
  
Further areas for refinement include the accuracy of the femtosecond laser 
incisions, the better understanding of corneal biomechanics in the context of FS-
AKs and the effects of the FS-AK on the posterior corneal curvature. A recent 
optical coherence tomography study of FS-AKs demonstrated that the midpoint 
depth of the intrastromal incisions were significantly more anterior than the 
planned parameters and that the locations of the paired intrastromal incisions in 
each eye were not correlated (L. Wang et al., 2017). Investigations of 
biomechanical properties and factors contributing to outcomes of FS-AK have 
shown that the type of astigmatism (against the rule, with the rule or oblique) are 
independent predictors of the efficacy of FS-AK and that corneal hysteresis has 
a negative correlation with the SIA at 1-6 months (Day and Stevens, 2016a; Byun 
et al., 2018). Löffler et al. demonstrated that FS-AKs have effects on the anterior 
corneal curvature and total corneal refractive power but not the posterior 
curvature (Löffler et al., 2017). A study of 50 eyes treated with FLACS and single 
8mm FS-AKs showed an increase in coma, trefoil and higher order aberrations 
post-operatively (T. C. Y. Chan et al., 2016). 
 
It is important to note that in this study, there were no significant differences in 
the absolute or arithmetic mean angle of error. This implies that femtosecond 
laser AKs are no better aligned than can be achieved manually. Interestingly, the 
FS-AK group had a significantly smaller mean difference vector (the residual 
correction required to achieve the TIA) and yet the index of success was not quite 
statistically significant between the two groups. The index of success is defined 
as the difference vector divided by the TIA, where a number closer to zero 
indicates greater success and the value for the LRI group was 0.81 compared 
with 0.65 for the laser group (p=0.07). This could therefore possibly be explained 
by TIA of the LRI group being 0.12D greater. 
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In addition to our findings that FS-AK had a greater correction index than LRI, 
there appear to be several advantages of FS-AKs over limbal relaxing incisions. 
Firstly, they only take a few seconds to program into the laser platform and for 
the laser platform to undertake them. In addition, although in this study we 
marked all eyes at the slit-lamp pre-operatively, with several FLACS platforms 
now allowing integration with corneal topography/tomography devices and 
featuring iris or conjunctival vessel recognition, pre-operative marking of the axis 
is becoming redundant (Hummel et al., 2017), further enhancing both patient and 
surgeon convenience as has been possible with the implantation of toric IOLs 
(Webers et al., 2017). Finally, as the incisions are intrastromal, there may be 
reduced postoperative discomfort compared with LRIs and less chance of 
posterior/full thickness perforation, infection or inflammation. However, it is 
important to note that there are significant additional costs associated with 
femtosecond laser technology, but only limited additional cost and materials are 
required to perform the AKs.  
 
One key limitation of this study is that follow-up was limited to the first post-
operative month and that longer-term efficacy was not evaluated. The published 
literature reports variable results in terms of the regression of the effects of LRIs 
with time, although generally such corrections appear to be relatively stable after 
the first post-operative month (Lim et al., 2014). In a series of 263 patients by 
Day et al., of which 87 had received intrastromal astigmatic keratotomies, 
regression in SIA was only 0.1D between 1 and 6 months and equivalent between 
groups which did or did not receive AKs (Day and Stevens, 2016b). Similarly, 
Chan et al. demonstrated stability of astigmatic correction by AK between 2 
months to 2 years post-operatively (T. C. Y. Chan et al., 2016) and a  series of 
89 eyes by Byun et al showed no significant changes between 2 and 6 months 
(Byun et al., 2018). This suggests that astigmatic corrections achieved at one 
month are a good indicator of efficacy, although we are following up these 
patients at 12 months to assess longer term efficacy. 
 
Interestingly, despite randomization there were some statistically significant 
differences at baseline between the two groups: namely worse visual acuity (7 
letters), and longer axial length (by 0.7mm) in the femtosecond group. However, 
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there were no differences of the pre-operative astigmatism or the keratometry. 
We believe that the differences in vision and axial length do not play a significant 
role in the analysed outcome parameters in this current study. 
 
In summary, we found that both manual limbal relaxing incisions and 
femtosecond laser intrastromal arcuate keratotomies were safe and easy to 
perform, with both achieving a meaningful reduction in corneal astigmatism. 
However, the laser group achieved a correction of greater magnitude than the 
limbal relaxing incision cohort at 4 weeks after surgery. The greatest differences 
occurred in cases with larger TIAs and a subgroup analysis of those with <1.5DC 
demonstrated no statistically significant differences.
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Chapter 8. Conclusions 
8.1. Summary 
 
The  aim in this thesis has been to appraise the possible role of FL technology 
with regards to cataract surgery in the NHS. To gain a better understanding of 
variables important to the efficiency of a cataract surgical session I began by 
performing a TMS (Chapter 2). Contrary to confirming the importance of the 
length of the operation (usually the metric most commonly reported in other 
studies evaluating productivity), this study demonstrated several inefficiencies of 
public sector based cataract surgery unrelated to the surgeon. Firstly, the 
variation in productivity and under-utilisation of theatre time, between routine 
NHS theatre lists and NHS surgeons with a special interest in high volume 
cataract surgery or the private sector. Secondly, the role of the AHP in 
productivity and that staffing levels of less than 3 AHPs creates a rate limiting 
step in the turnaround time between operations. Finally, the number of 
distractions to the surgeon and number of non-surgical tasks delaying the theatre 
list and preventing them from performing surgery during the allotted theatre list 
time, suggest that delegation of non-surgical tasks to trained AHPs is important 
band can greatly improve productivity as had occurred in the private hospital 
setting. The intention was to use the results of this TMS to better understand 
efficient or inefficient practices in the cataract service at Guy’s and St Thomas’ 
NHS Foundation Trust, before the introduction of a high-volume hub and spoke 
FLACS service. 
 
Discussions regarding cost effectiveness or profitability of FLACS typically focus 
on the capital outlay for the device itself (Abell and Vote, 2014; Trigueros et al., 
2016). One of the advantages of conducting some preliminary financial modelling 
in advance of a FL RCT was to understand better the relative importance of 
different financial factors in a FL centred service (Chapter 3). The most striking 
realisation of the financial modelling undertaken, was the relative inconsequence 
of the cost of the FL compared with the overwhelming cost of the single-use PIs, 
which became the single most expensive item in a hypothetical FL service. As 
this cost was applied to every case, a so-called pay-per-click fee, no 
improvements in efficiency could offset this financial burden. Therefore, the idea 
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of high volume FLACS offsetting its own costs would be a near impossibility, 
without some discount in the price of the PIs. 
 
A key concern in the planning of the RCT methodology was the effects of the 
learning curve of FLACS on any potential bias on the results of the study in favour 
of CPS. In particular I was aware of increased risk of anterior capsular tear within 
the learning curve (T. V. Roberts et al., 2013; Abell, Kerr, and Vote, 2013a). In 
planning the RCT, it was necessary to ensure that the other two surgeons and I 
had completed enough cases to avoid an increased rate of complications in the 
FLACS cohort. There was no consensus on the length of the learning curve in 
the published literature. Based on a review of the literature, I planned for each 
surgeon to have completed 30 cases before the start of the RCT, but the results 
of all FLACS were collected allowing for a retrospective evaluation of the learning 
curve using CUSUM. The profiles of the three surgeons was heterogeneous from 
an extremely senior surgeon to myself, with 3 years and 300 cases of previous 
cataract surgery experience before commencing this research fellowship. 
CUSUM analysis demonstrated pooled stability in rates of PCR after the 16th case 
(Chapter 4). This is relevant not only in the planning of future FLACS trials, but 
also in the supervision of surgeons new to FLACS. 
 
The FLACS RCT is larger than any previously published RCT(H. W. Roberts MSc 
FRCOphth et al., 2019). The 16 RCTs in the Cochrane Review analysed were 
generally underpowered (Day, Gore, et al., 2016). Furthermore, 11/16 studies 
were rated as having an unclear or high risk of bias. This study has been funded 
by the manufacturer, but by a non-commercial grant with the Funder having no 
input into the running or analysis of the study. The results of the RCT were 
noteworthy in their equivalence between the two techniques. The most significant 
result we found was a difference in the PCR rate. However, this is open to 
interpretation for various reasons including the marginal significance and the 
number of t-tests performed. Clinically, at least, the two other surgeons and I 
agree that FLACS is certainly an easier, more automated, technique for cataract 
surgery. We noticed a difference in our fatigue levels after a high volume FLACS 
list compared with CPS. We think this may translate into fewer surgical 
complications. Reduced complication rates, most notably PCR, are borne out in 
several published papers, however, are not reflected overall by the meta-
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analyses. One limitation of the literature is that outcomes may improve due to the 
continual refinement of the FL technology, mostly in software updates, for 
example as per the difference in anterior capsular tear rate with the Catalys FL 
as the software was upgraded to improve the speed of capsulotomy (Day et al., 
2014; Abell, Kerr, and Vote, 2013a). It is conceivable that grouping older studies 
with more recent publications in a meta-analysis may hide any clinical benefit 
from FL as the technology and clinical experience have improved. Equally, we 
did not derive any improvement in visual acuity or refractive outcome in the 
FLACS group, and we question whether a FLACS capsulotomy does result in a 
clinically meaningful improvement in lens decentration or tilt, although it is 
important to note that the follow up in our RCT was only 4 weeks. Neither was 
any benefit reflected by the 2 PROM questionnaires. In summary, it is an 
important result that there appears to be clinical equivalence between FLACS 
and CPS, it is unlikely to have worse outcomes as has been suggested in the 
EUREQUO study (Manning et al., 2016). Anecdotally, the FL at St Thomas’ since 
the end of the study has been involvement in further studies as well as some 
complicated cases but is not used, outside further research trials, for routine 
cataract surgery. In reflection, the FL may have a role in some academic/tertiary 
centres with a significant cohort of complicated cataracts and clinic research 
aspirations, but it unlikely to be of widespread relevance to the NHS in terms of 
clinical outcomes. 
 
Regardless of the clinical outcomes, the main hypothesis of this thesis was 
whether a FL-centred hub and spoke model for the provision of high volume 
cataract surgery would be significantly more productive than an equivalent 
attempt at a high-volume CPS service. This translated into a statistically 
significant improvement of one extra case per OR. However, this was insignificant 
in terms of reducing costs, and indeed the FL service was £145 more expensive 
per case. Based on the results in chapter 2, in terms of productivity it can be 
easily suggested that this money would be more efficiently used in recruiting 
additional AHPs to support the surgeon by undertaking non-surgical tasks during 
theatre lists. The findings of this study are important in that it was possible to 
extrapolate that, with our timings, one FL could support up to 4 ORs which would 




Finally, FS-AKs had not previously been compared to LRIs in their efficacy at 
reducing corneal astigmatism. Approximately 25% of the cases treated in the 
RCT had corneal astigmatism >0.9D and they were offered LRI or FS-AK 
appropriately. Analysis by the Alpins method was performed which showed a 
significantly lower DV and greater CI in the FS-AK group(H. W. Roberts MSc 
FRCOphth et al., 2018). The IOS was of near significance. This is an important 
finding, where it appears that the precision and automation of the FL can 
demonstrate superiority over a manual approach to corneal relaxing incisions. In 
addition to the refractive results, as the FS-AKs do not penetrate the epithelium 
they likely to be safer and more comfortable in the post-operative period, although 
we did not test for this in our study. As FL-dissected flaps have largely 
superseded the microkeratome in LASIK, the FS-AK similarly may become the 
preferred technique for the correction of low to moderate astigmatism, where 
available. 
 
8.2. Future direction of study 
 
Regardless of any further studies relating to the FL, the results of this thesis 
strongly support the need for further research on OR productivity to understand 
how the NHS can improve efficiency in this service. It is striking that the Monitor 
report called for a 20% improvement in efficiency in elective ophthalmic and 
orthopaedic surgery, yet a simplistic view of the results in chapter 2 suggest that 
a 100% improvement in theatre output is possible (Monitor, 2015a). It is of note 
that chapter 2 represents the first  published study to perform cataract surgery 
TMS, focussing on the role of every team member and not just the effects of 
surgical time on theatre productivity (H. W. Roberts MSc FRCOphth, 
Myerscough, et al., 2017). The intention of the TMS was not to highlight to NHS 
managers the under-utilisation of cataract theatres but to provoke a discussion, 
the heart of which is how best to incentivise the whole surgical team. By 
conducting an RCT, the number of patients treated on a CPS list increased from 
an average of 5.4 at St Thomas’ to 8 (with 3 AHPs), and after the study 
concluded, promptly fell to original levels. Improving efficiency within cataract 
services could save the NHS hundreds of millions of pounds. 
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One limitation of the FLACS RCT was the limited duration of the follow up to 4 
weeks. Two reasons for the choice of 4 weeks were that this is a common point 
to review patients after cataract surgery and is a common time point at which 
results are reported in the literature. Also, I would not have been able to include 
longer follow up within the time span of this MD. We are currently collecting the 
12-month outcomes from the FLACS study to look for longer term outcomes such 
as for lens decentration, PCO rates and the stability of the LRIs and FS-AKs.  
 
Planning of health policy of new technology or techniques requires calculation of 
the ICER. This would allow the financial quantification of any clinical benefit from 
FLACS. I suggest that a meta-analysis of UK based studies be conducted to allow 
for organisations such as NICE to determine healthcare policy for FL into the 
future. 
 
Whilst the studies within my thesis demonstrated that FLACS technology was 
both non-cost effective and did not offer any clear clinical benefits over CPS, it 
should be remembered that this technology has only been in clinical practice for 
cataract surgery for the past decade and is still in its infancy. It is important to 
remember that this technology represents the first step in the automation of this 
very commonly performed procedure and technology will continue to improve. 
The eye, by virtue of its accessibility and transparency of the cornea and internal 
structures, lends itself to the development of automation and robotics to 
undertake such delicate surgical procedures as cataract surgery and intraocular 
lens insertion. Indeed, robotics are already being employed in retinal surgery 
within a research context (Uneri et al., 2010). The development of faster FL lasers 
with lower energies and smaller but more numerous cavitation bubble creation, 
may allow for the emulsification of lens nuclear material rather than its 
fragmentation. This combined with faster, real time OCT scanning and precise 
robotic arm manipulations may, even within the next 10-20 years allow, for the 
complete automation of the cataract surgery process, with improved surgical 
precision and safety and perhaps even without the need for surgeon and 24-hour 
utilization of the OR. The introduction of FLACS perhaps represents the first step 
in this “brave new world” for Ophthalmology and whilst not cost-effective or 
clinically beneficial at present does merit further attempts at refinement. 
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ACD Anterior Chamber Depth 
AHP Allied Health Professional 
ANOVA Analysis of Variance 
A of E Angle of Error 
BCE Before Common Era 
CCC Continuous Curvilinear Capsulorrhexis 
CCI Clear Corneal Incision 
CCT Central Corneal Thickness 
CDE Cumulative Dissipated [phacoemulsification] Energy 
CDVA Corrected Distance Visual Acuity 
CE Conformité Européene 
CFT Central Foveal Thickness 
CI Correction Index 
CSMO Clinically Significant Macular Oedema 
CPS Conventional Phacoemulsification Surgery 
CUSUM Cumulative Sum Method 
D Dioptres 
DM Descemet’s Membrane 
DV Difference Vector 
ECL Endothelial Cell Loss 
ELP Effective Lens Position 
EPT Effective Phacoemulsification Time 
FL Femtosecond Laser 
FS-AK Femtosecond Laser Arcuate Keratotomy 
FLACS Femtosecond Laser Assisted Cataract Surgery 
GA General Anaesthetic 
I/A Irrigation Aspiration 
ICER Incremental Cost Effectiveness Ratio 
IFIS Intraoperative Floppy Iris Syndrome 
IOL Intraocular Lens 
IOP Intraocular Pressure 
IOS Index of Success 
logMAR Logarithm of Minimal Angle of Resolution 
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LRI Limbal Relaxing Incision 
LS Laser suite 
nAMD Neovascular Age Related Macular Degeneration 
NHS National Health Service 
NICE National Institute for Health and Care Excellence 
NIHR National Institute for Health Research 
nm nanometer 
NOD National Ophthalmic Database 
N.S. Non significant 
OCT Optical Coherence Tomography 
ODCU Ophthalmic Day Care Unit 
ON Ophthalmic Nurse 
OR Operating Room 
OT Ophthalmic Technician 
PBK Pseudophakic Bullous Keratopathy 
PCO Posterior Capsular Opacification 
PCR Posterior Capsular Rupture 
PHVA Pinhole Visual Acuity 
PI Patient Interfaces 
PMMA Polymethylmethacrylate 
PROM Patient Reported Outcome Measure 
QALY Quality Adjusted Life Year 
RCOphth Royal College of Ophthalmologists 
RCT Randomised Controlled Trial 
SD Standard Deviation 
SEM Scanning Electron Microscopy 
SIA Surgically Induced Astigmatism 
TIA Target Induced Astigmatism 
TMS Time Motion Study 
TN Theatre Nurse 
UDVA Unaided Distance Visual Acuity 
WHO Word Health Organisation 
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ABSTRACT
Aim To provide a quantitative assessment of cataract 
theatre lists focusing on productivity and staffing levels/
tasks using time and motion studies.
Methods National Health Service (NHS) cataract 
theatre lists were prospectively observed in five different 
institutions (four NHS hospitals and one private hospital). 
Individual tasks and their timings of every member of 
staff were recorded. Multiple linear regression analyses 
were performed to investigate possible associations 
between individual timings and tasks.
Results 140 operations were studied over 18 theatre 
sessions. The median number of scheduled cataract 
operations was 7 (range: 5–14). The average duration of 
an operation was 10.3 min±(SD 4.11 min). The average 
time to complete one case including patient turnaround 
was 19.97 min (SD 8.77 min). The proportion of the 
surgeons’ time occupied on total duties or operating 
ranged from 65.2% to 76.1% and from 42.4% to 
56.7%, respectively. The correlations of the surgical 
time to patient time in theatre was R2=0.95. A multiple 
linear regression model found a significant association 
(F(3,111)=32.86, P<0.001) with R2=0.47 between 
the duration of one operation and the number of allied 
healthcare professionals (AHPs), the number of AHP key 
tasks and the time taken to perform these key tasks by 
the AHPs.
Conclusions Significant variability in the number 
of cases performed and the efficiency of patient flow 
were found between different institutions. Time and 
motion studies identified requirements for high-
volume models and factors relating to performance. 
Supporting the surgeon with sufficient AHPs and tasks 
performed by AHPs could improve surgical efficiency up 
to approximately double productivity over conventional 
theatre models.
INTRODUCTION
In 2014–2015, over 370 000 cataract operations 
were performed by the National Health Service 
(NHS) in the UK.1 This was 3.7 times the number 
performed in 1989, with cataract surgery being the 
most common operation undertaken in the UK.2 
The demand for cataract surgery is expected to rise 
still further with increasing life expectancy, rising 
population size, growing patient expectations and 
an increase in age-related chronic diseases associ-
ated with cataracts, such as diabetes.3 Surgeons are 
also conducting, and patients are being referred and 
presenting for, cataract surgery at an earlier stage of 
the disease.4 In 1990, less than 9% of eyes which 
underwent cataract surgery had a Snellen acuity 
of 6/12 or better,4 while two decades later in the 
period between August 2006 and November 2010, 
the Royal College of Ophthalmologists’ (RCOphth) 
National Ophthalmology Database showed that 3%, 
5% and 36% of eyes undergoing cataract surgery 
had preoperative Snellen visual acuities of better 
than or equal to 6/6, 6/9 and 6/12, respectively.5 
With current financial constraints, the increased 
future demand for cataract surgery within the NHS 
is liable to be problematic. Meeting an ever-greater 
demand with a constrained budget requires an 
improvement in efficiency while, ensuring that stan-
dards of patient care are maintained or improved. 
A recent report from Monitor (Department of 
Health) estimated that 13%–20% productivity gains 
might be made in elective ophthalmology if prac-
tices were optimised.6 The recently published The 
Way Forwards report (RCOphth) found a median of 
seven cases scheduled per theatre list (range 4–12).7 
To the authors’ collective experience, NHS cataract 
lists exist with anything between 5 and 15 patients 
routinely booked. Why this difference of a three-
fold difference in productivity between minimum 
and maximum values exists in public sector cataract 
surgery has not received the due attention it should.
In 1911, F.W. Taylor introduced the time and 
motion study (TMS) as an application of the scien-
tific method to the management of workers in order 
to improve productivity. Historically, TMS was 
applied to the manufacturing industry. However, 
it has also been shown to have useful applications 
within healthcare.8 9 A century after the intro-
duction of scientific management method, there 
is genuine interest in aggregating knowledge in 
healthcare workflow, inefficiencies, patient safety 
and quality. Among several approaches commonly 
used to date, TMS, which involves continuous and 
independent observation of clinicians’ work, is 
generally regarded as a more reliable methodology 
compared with alternative approaches such as work 
sampling and time efficiency questionnaires.8 9
To provide a quantitative assessment of the effi-
ciency of cataract surgery across several UK hospi-
tals, we conducted TMS investigations at several 
different institutions and settings. These included 
weekend waiting list initiative sessions, the provi-
sion of NHS cataract surgery in the private sector, 
as well as routine cataract surgery lists in NHS 
hospitals. In particular, we focused on surgical time, 
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surgeon tasks within and outside theatre, patient throughput, 
staffing levels of allied healthcare professionals (AHPs) and their 
key tasks and timings. By analysing these variables and investi-
gating correlations between them, we hope to provide greater 
awareness of different models of practice, to identify important 
factors leading to differences in the individual number of cata-
ract operations per theatre session and provide information to 
improve surgical productivity while maintaining high levels of 
patient safety. To the authors’ knowledge, there are no previous 
examples of such TMS investigations of cataract surgery with a 
public health setting in the literature.
METHODS
Continuous observation TMS of 18 routine 4-hour cataract 
theatre sessions, was undertaken in five different hospitals and 
settings. These settings included two district general hospitals, 
two teaching hospitals, a weekend waiting list initiative theatre 
session in an NHS hospital, a dedicated high-volume theatre list 
in an NHS hospital and an NHS cataract surgery list in a private 
hospital (table 1). The five institutions studied were the BMI 
Southend Private Hospital, Norfolk and Norwich NHS Foun-
dation Trust, Guy’s and St Thomas’ NHS Foundation Trust, 
Southend University Hospital NHS Foundation Trust and West 
Suffolk NHS Foundation Trust. A consultant ophthalmic surgeon 
or associate specialist performed all lists, no lists were designated 
teaching lists. All patients were listed for only routine cataract 
surgery and all surgeries were conducted by phacoemulsification 
with intraocular lens insertion under local anaesthesia. All cases 
were unilateral. The number and type of AHPs supporting each 
individual theatre list was recorded (table 1).
Each list had been observed prior to undergoing TMS investi-
gation in order to identify preliminary staffing models and tasks 
(tables 1 and 2). Agreement analysis was used to define the list of 
tasks and then a basic model for each setting was set up and used 
as a template to observe and time the steps of every defined task 
(table 2). Each list was observed by one or two ophthalmologists 
(HWR and JM). Each observer used a template Excel spread-
sheet (Microsoft, Redmond, Washington, USA) with specifically 
designed macros to facilitate the prompt and accurate recording 
of tasks and their timings.
Noting the start and finish times of some of the key tasks was 
self-explanatory, while other tasks required specific moments 
agreed on in advance in order to maintain reproducibility. 
Surgical start and end times were regarded at the point of inser-
tion or removal of lid speculum. Patient entry time was defined 
as the time from patient entry into theatre until final positioning 
for surgery had been achieved. Patient exit time was defined as 
the time from removal of lid speculum to patient exiting the 
theatre. Start and end of scrubbing were regarded as the opening 
of the tap and finishing the gowning process. The start and end 
of the safety checklist were recorded once the first member of 
staff began speaking until the last member of staff had finished 
speaking. The start of the scrub nurse clearing up from the 
case was the time when the first instrument was passed out or 
dismantled once the lid speculum had been removed. The end of 
clearing time was recorded once the scrub nurse re-entered the 
theatre from the sluice, having disposed of all equipment and 
waste. The cause and duration of any unexpected delays more 
than 5 min were recorded.
In addition to defining each key task and its reproducible start 
and finish, a series of quotients were defined as follows and 
produced for each setting. The efficiency quotient was defined 
as the proportion of time that the surgeon was engaged in a task 
(total surgeon time spent productive/total time).10 The surgery 
quotient was defined as the proportion of time that surgery 
was occurring (total surgical time/total time). The theatre util-
isation quotient was defined as the utilisation of the maximum 
available theatre time (time between start of first and end of last 
case/4 hours).11
STATISTICS
Data are presented as non-parametric and parametric as appro-
priate. Differences between the groups were analysed with 
one-way analysis of variance (ANOVA) test where appropriate. 
Linear regression models were calculated to estimate the key 
factors affecting the time to perform the surgery, and the time 
Table 1 Details of cataract theatre lists studied
Institution 1 2 3 4 5
Type of theatre list studied Routine theatre list Routine theatre list A. Routine theatre list
B. Weekend initiative list
C. Dedicated high volume 
list
Routine theatre list NHS patients receiving 
surgery at adjacent private 
institution




Median no of operations 
scheduled/list








Percentage of operations 
cancelled on the day (%)






3 nurses 3 nurses, 1 HCA A. 3.5 nurses, 1 ODP
B. 3 nurses, 1 HCA
C. 4 nurses, 1 HCA, 1 ODP, 1 
medical secretary
3 nurses 2 nurses, 1 HCA, 1 ODP
 HCA, healthcare care assistant; NHS, National Health Service; ODP, operating department practitioner.
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an individual patient spent in theatre. Descriptive statistics was 
used to calculate averages and SD of the performances in each 
list. IBM SPSS Statistics for Windows (V.22.0, IBM) was used to 
perform the analysis.
RESULTS
TMS of 140 individual cataract operations were prospectively 
recorded during 18 NHS cataract theatre sessions. All cata-
ract operations were performed with phacoemulsification. 
All operations were under local anaesthesia. All operations 
were unilateral. No operations were combined procedures 
or required additional procedures outside small-incision 
phacoemulsification cataract extraction and intraocular lens 
insertion. The details of each theatre session can be seen in 
table 1.
Timings from each theatre list can be seen in table 2 and 
figure 1. The reason and duration of any unscheduled delays can 
be seen in table 3. Mapping of the workflow of the two high-
est-volume theatre lists can be seen in figures 2 and 3.
The median number of operations per 4-hour theatre session 
was 7 (range 5–14). The mean time to perform a cataract opera-
tion was 10.3 min (SD 4.11 min). The mean time to complete one 
case including patient turnaround was 19.97 min (SD 8.77 min). 
The mean surgical scrub time was 1.86 min (SD 0.77 min). 
Figure 1 Diagram of model summarising the results of the time motion studies.
Table 3 The reason and duration, in minutes, of any unscheduled delays
Institution 1 Institution 2 Institution 3B Institution 5
Reason for delay Time Reason for delay Time Reason for delay Time Reason for delay Time
Waiting for next patient from day 
case unit
5.88 Instrument error 6.52 Patient vasovagal episode 10.3 Waiting for next patient from 
day case unit
6.0
Surgeon examining staggered 
patients
9.5 Equipment error 5.17 Waiting for next patient from 
day case unit
5.75
Waiting for next instrument 
trolley to be ready
7.43 Surgeon required to see patient 
in clinic
13.23
Surgeon out of theatre 8.75 Surgeon late for theatre due to 
clinic overrun
28.17
Surgeon examining staggered 
patients
08.32 Surgeon reviewing latecomer 7.35
Waiting for next patient from 
day case unit
10.5
Waiting for next patient from 
day case unit
8.95
Total 39.88 79.88 10.3 11.75
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The mean time to complete preprocedure WHO checklist was 
0.55 min (SD 0.52 min). The mean time to complete postpro-
cedure paper/computer work was 1.77 min (SD 1.35 min). The 
mean time for patients to enter theatre to being positioned for 
surgery was 2.28 min (SD 1.88 min). The mean time from patient 
entry to start of operating was 4.56 min (SD 1.49 min). The mean 
time for patient to exit theatre from removal of lid speculum 
was 1.90 min (SD 1.00 min). The mean duration of patients’ 
time in theatre was 17.07 min (SD 7.30 min). The mean time in 
between cases was 4.12 min (SD 2.78 min). The correlations of 
the surgical time to patient time in theatre was R2=0.95. The 
correlation between surgical time and number of cases scheduled 
was R2=0.696.
The minimum number of AHPs (nurses/healthcare assistants/
operating department practitioners) allocated to a theatre list in 
this study was 3. The majority of AHPs in this study were regis-
tered nurses. The two theatre lists with the greatest number of 
cases scheduled had either 4 or 7 AHPs (table 4). There was 
a moderate correlation between number of AHP and number 
of cases scheduled (R2=0.489). If only the public healthcare 
settings were included (institutions 1, 2, 3A–C and 4) and we 
excluded the one private institution under taking NHS oper-
ations (institution 5), where practices may differ from the 
NHS, the correlation between number of AHP and number of 
cases scheduled was much higher (R2=0.823). However, if we 
excluded the institution with the highest number of AHP per 
case (3C) from the analysis, the correlation became insignificant 
(R2=0.13).
Multiple linear regression models
A multiple linear regression model was calculated to predict 
the time to perform one operation based on three factors: (1) 
the number of AHPs, (2) the number of key tasks performed by 
AHPs and (3) time taken to perform these key tasks by AHPs. 
A significant regression was found (F(3,111)=32.86, P<0.001) 
with an R2 of 0.47. All the three factors were significant predic-
tors of the time to perform a surgery. In particular, the surgical 
time decreases by 0.95 min for each additional AHP involved, 
by 0.39 min for every additional task performed by AHP and by 
0.19 min for each additional minute spent by AHP performing 
tasks.
A one-way ANOVA way was performed to control for the effect 
on surgical time by: (1) the number of AHPs, (2) the number of 
key tasks performed by AHPs and (3) time taken to perform 
these key tasks by AHPs. There was a significant effect (P<0.001) 
of all the factors as follows: (1) F(1,113)=35.12, P=0.001), 
(2) F(1,113)=53.43, P=0.001) and (3) F(1,113)=42.23, 
P=0.001) (figure 4).
Figure 2 Model of workflow of staff duties at institution 3C. HCA, healthcare assistant; ODP, operating department practitioner.
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A similar multiple linear regression model was calculated 
to predict the effect of the same three factors: (1) the number 
of AHPs, (2) the number of key tasks performed by AHPs and 
(3) time taken to perform these key tasks by AHPs on the total 
patient time in theatre. Factors (2) and (3) were significant 
predictors of the time an individual patient spent in theatre, that 
is, the total time to complete one surgical case. The model was 
significant (F(2,116)=43.18, P<0.001) with an R2 of 0.43. The 
length of patient time in theatre decreased by 0.76 min for each 
task performed by AHPs and by 0.19 min for each minute spent 
by AHPs to perform their tasks.
A one-way ANOVA was performed to control the effect on the 
total patient time in theatre by: (1) the number of AHPs, (2) the 
number of key tasks performed by AHPs and (3) time taken to 
perform these key tasks by AHPs. There were significant effects 
of factors 2 and 3 (F(1,117)=43.97, P<0.001) (figure 4).
DISCUSSION
This study adopted a TMS approach to evaluate the efficiency of 
public sector cataract surgery in the UK. We observed a significant 
variance in the running of cataract theatre lists at five different 
UK institutions, the most striking of which is the number of 
patients scheduled per list, which ranged from medians of 
6–13.5. From the perspective of the public healthcare sector, it 
is imperative to maximise the efficiency of elective surgery while 
maintaining quality and safety.6 The average duration of a cata-
ract operation was 10.3 min and the total time including prepro-
cedure and postprocedure preparation and patient turnaround 
was 19.97 min. It could be expected, therefore, that at least 12 
operations could be completed in a 4-hour session and yet the 
median number of cases booked to a theatre list of 7 is much less. 
On the basis of the results of this TMS, one could expect that 
an increase in 70% efficiency might be possible. Whether this is 
an achievable target and why it is not currently being realised is 
a matter of conjecture, but certainly it highlights the great need 
to identify possible factors necessary to improve the efficiency of 
NHS cataract surgery.
It was interesting to document that the sessions (institutions 
3C and 5) providing the highest median number of cases per 
list (13, 13.5) and highest theatre utilisation and efficiency 
quotients, had the longest duration of staff breaks, suggesting 
Figure 3 Model of workflow of staff duties at institution 5. HCA, healthcare assistant; ODP, operating department practitioner.
Table 4 Staffing levels associated with number of cases scheduled
Setting
No of allied health 
professionals
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that these units have discovered how to ‘work smarter, not 
harder’ (table 2, figures 1–3). This strongly suggests that by 
changing working practices efficiency can be improved without 
increasing individual staff workload.
This assumption is supported by the observation that institu-
tions 4 and 5 share the same population, yet there are noticeable 
differences between the TMS of their theatre sessions, especially 
in terms of median number of cases per list (7 vs 13), theatre 
utilisation quotient (50.8% vs 87.9%) and efficiency quotient 
(65.6% vs 75.8%) (table 2). As patient demographics should 
be similar at these two settings, differences in practice and effi-
ciency presumably arise from internal organisation of the cata-
ract theatre lists rather than external factors.
In considering the TMS of the surgeons, it is important to 
recognise that the theatre session is not an independent entity. 
Rather, differences in theatre practices often stemmed from 
factors outside the theatre itself, such as in the day case ward/
clinic. For example, at institutions 1 and 4, the surgeons 
performed slit-lamp examination and marked all patients on the 
day of surgery, at institution 2 the surgeon met the patients and 
marked them, at 3A/B/C the surgeon met the patient, marked 
and consented them, while at 5 (which had the highest theatre 
utilisation quotient and second highest median number of cases 
at 13) all such tasks were performed by staff on the day-case unit. 
This suggests that using AHPs to undertake some of the duties 
of the surgeon outside theatre, might be an important factor 
in improving efficiency by ensuring that the surgeon spends as 
much in theatre as possible during each allocated 4-hour cataract 
surgery session. This is supported by the observation that insti-
tution 1 (with a joint lowest median number of cases of 6 and an 
efficiency quotient of only 66%) was the only unit in which there 
was staggered patient arrival and surgeon performing preoper-
ative examination, leading to a time relating to these duties of 
26.57 min out of theatre during the 4-hour sessions (tables 2 
and 3). Similarly, at institution 2 (joint lowest median number 
of cases of 6 and efficient quotient of 65.2%), the surgeons 
spent 48.75 min outside the operating theatre due to outpatient 
clinic over-run and the need to see patients on the day case ward 
(figure 1, tables 2 and 3). Clearly to achieve optimum efficiency 
it is imperative for the surgeon to be available within theatre 
to undertake the surgery rather than performing duties outside. 
Whether this best achieved by AHPs performing such outside 
duties instead of the surgeon as at institution 5, or ring fenced 
time before the theatre session itself is a matter of conjecture.
Figure 4 The significant relationships identified by analysis of variance. The average time to perform the surgery was equal to 10.25. The average 
time to perform the case was equal to 14.08. (A) The relationship between the time to perform the surgery and number of allied healthcare 
professionals (AHPs). (B) The relationship between the time to perform the surgery and number of tasks performed by AHPs. (C) The relationship 
between the time to perform the surgery and the time spent by AHPs to perform their tasks. (D) The relationship between the time to perform the case 
and number of AHPs. (E) The relationship between the time to perform the case and the time spent by AHPs to perform their tasks.
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Some units allowed patients to arrive on a staggered basis 
for their convenience and reduced overall patient waiting time 
(institutions 1, 3A/B/C, 5), while the remainder requested that 
all patients were present for the pretheatre ward round. As such 
practices did not affect the overall median number of cases or 
efficiency quotients (table 2), it seems a reasonable approach to 
stagger arrival times for patient convenience, provided protocols 
are introduced to avoid surgeons spending time out of theatre, 
as at institution 5.
Based on our observation, a minimum of four AHPs appear 
to be required to provide a high-volume service. This criterion 
was met at all settings other than institutions 1 and 4 (table 4). 
Increasing the number of cases towards the goal of high-volume 
lists may require either/both an increase in the number of AHPs 
supporting the surgeon with additional tasks (as in setting 3C) 
or changes in working practice (as in setting 5), with four AHPs 
performing more supporting tasks. It is our experience that in 
addition to the scrub nurse and circulating AHP, at least two 
AHPs are required to be able to clear up from the previous case 
and, more importantly, prepare for the subsequent case so there 
is only a minimal wait between cases. This is achieved at insti-
tutions 3C and 5 (this lists with the highest volumes of patients 
treated per session) with 18.92 and 22.63 min of AHP prepa-
ration time, respectively, before the patient even enters theatre 
(figures 2 and 3). Ideally, the gap between cases needs to be 
minimised to the time it takes to escort the patient out and in, 
perform WHO checklist, and for the surgeon to rescrub. In this 
series, the length of time from the end of one case to the start of 
the next ranged from 5.92 to 16.8 min.
Between the institutions the average surgical time varied 
from 7.43 to 15.98 min. This variation may reflect different 
case mix or differences between surgeons with some being 
faster/more experienced than others. The surgeons in lists 
3C and 5 have a national reputation of excellence and are 
known for their expertise and surgical skills and this may have 
created outlying results. However, despite this the correlation 
between AHP numbers and tasks was strong and means that 
efficiency can be improved for those that do not have excep-
tional surgical skills. The correlation between surgical time 
and number of cases scheduled was R2=0.696, suggesting that 
factors such as surgical experience and case mix are likely to 
have a part to play in cataract surgery efficiency. However, 
we found significant correlation between the time undertaken 
to perform cataract surgery and the number of AHPs, the 
number of key tasks performed by AHPs and the time taken 
to perform these key tasks by AHPs (P<0.001). This was 
confirmed by one-way ANOVA  testing, suggesting that alter-
ation of the number of AHPs supporting a cataract surgery list 
and surgeon, their duties and their total time performing tasks, 
is strongly associated with and can indeed influence the time 
to perform individual cataract surgery (figure 4). Similarly, a 
strong correlation, confirmed by one-way ANOVA- testing, 
was found between the number of key tasks performed by 
AHPs and the time taken to perform these key tasks by AHPs 
on the total patient time in theatre (P<0.001). Such correla-
tions appear to highlight the importance of AHPs and their 
designated tasks in the development of high-volume NHS 
cataract surgery.
Concerning institution 5, which appeared to be an outlier in 
terms of correlation of number of AHPs with efficiency, these 
results might be explained by the fact that this was a private 
institution with different working practices from public health 
sector settings and there were direct financial incentives for the 
numbers of patients treated which it could be assumed positively 
influence productivity. Most importantly, while the number of 
AHPs supporting the cataract theatre list at institution 5 was 4, 
the number of key tasks performed by AHPs per case was much 
higher at 18 than any other organisation (table 2). At site 5, it 
clearly appeared that AHPs were undertaking many of the tasks 
performed by the surgeons at other institutions, which ensured 
that the surgeon was spending far more time in theatre under-
taking surgery than at any other institution. As such, this unit 
could optimise surgical productivity and theatre utilisation. 
Indeed the results at institution 5 strongly support our correla-
tions concerning the importance of AHPs, their roles and tasks 
they undertake, in optimising cataract surgical list efficiency. 
It appears that expansion of the role of AHPs in the public 
sector health setting to incorporate some the non-surgical roles 
currently undertaken by the surgeon, as well as the maintenance 
of adequate AHP staffing levels is vital to optimise cataract 
surgery efficiency.
There was generally an under utilisation of the full 4-hour 
(240 min) theatre session. Average theatre utilisation was 
70.11% (range 50.8%–87.9%) and was 73.9% (range 59.3%–
87.9%) when extrapolated to take into account the cancelled 
operations. The reasons for delayed start of theatre sessions 
included the surgeon being delayed by an overbooked clinic 
or administrative duties on the day case ward (table 3). Preop-
erative examination of surgical patients and associated duties 
(patient marking, confirmation of consent, etc) is an integral 
part of the surgical process, but duration should be minimised 
to maximise potential surgical time. However, in the inter-
ests of patient safety, it is not suggested that the target for 
theatre utilisation should be 100% due to the possibility of 
a case taking longer than expected or the event of a surgical 
complication, although the risks of surgical complications in 
cataract surgery is generally low (<5%).5
This study does have a number of limitations. First, it 
focused on single independent consultant or associate specialist 
surgeon theatre sessions and not on training lists with junior 
doctors. Clearly, there is a need to balance the desire for high-
volume services and the promotion of high-quality provision 
of training for the next generation of surgeons. However, if 
sufficient high volume can be achieved in single surgeon lists, 
then we believe this can reduce the pressure of service provi-
sion in lists with junior trainees. Indeed, given the increased 
future demand for cataract surgery within the NHS (as 
discussed above), there is a great need for senior trainees as 
future consultant surgeons to have exposure to high-volume 
models of cataract surgery.
Second observations were made based on a relatively small 
number of observed sessions (18). To our knowledge, this is the 
first TMS of its kind in cataract surgery. TMS are, by their nature, 
very labour intensive. Historically, TMS would often require 
one observer for each person studied which would, of course, 
introduce great difficulty (logistical and financial) in studying a 
cataract theatre session. However, we have found that through 
the use of Macros on Microsoft Excel, we were able to record 
timings for all staff involved with a theatre session with no more 
than two observers. This would be the first example of TMS 
of cataract theatre sessions published, which we feel is of great 
importance, especially in understanding differences in produc-
tivity within state-funded healthcare systems. Clearly, however, 
there is scope for future research incorporating greater numbers 
of operations at more institutions which may facilitate analysis 
of a greater number of factors and less risk of chance findings.
It is also of note that the five hospitals participating in this 
study incorporated a mixture of academic centres and district 
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general hospitals, with both rural and urban populations. They 
were chosen carefully to reflect a broad spectrum of environ-
ments. However, this study does not claim to represent universal 
provision of cataract services across the UK. We did not eval-
uate every model of surgical provision, including patients having 
surgery under sedation or general anaesthetic (GA). However, 
the vast majority of cataract surgery performed with the UK 
is undertaken under topical/local anaesthesia1 5 and the aim of 
this study was to focus on the delivery of high-volume services, 
wherein GA cases are unlikely to feature. Furthermore, it was 
assumed that all theatre teams were experienced with cataract 
theatre lists and familiar with working with each other. Indeed 
during the course of the TMS nothing was observed to the 
contrary.
Finally, although the focus of this study was the efficiency of 
cataract surgery, the metrics of the quality of the surgery, such 
postoperative visual acuity, postoperative complications, post-
operative refraction and patient satisfaction were not evaluated. 
It is important to remember that the quality of any aspect of 
cataract surgery and overall patient satisfaction should never be 
compromised to enhance efficiency. To further investigate this, 
we are currently investigating patient satisfaction and patient-re-
ported outcomes in high-volume cataract models.
CONCLUSION
This current TMS study highlights the huge variation in the effi-
ciency of cataract surgery within the NHS. It suggests that, with 
provision of sufficient levels of AHP staffing and expansion of 
the roles of AHPs , productivity in cataract surgery and theatre 
utilisation could be significantly improved in the public sector.
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ABSTRACT
Aims: To develop financial models which offset
additional costs associated with femtosecond laser
(FL)-assisted cataract surgery (FLACS) against
improvements in productivity and to determine
important factors relating to its implementation into the
National Health Service (NHS).
Methods: FL platforms are expensive, in initial
purchase and running costs. The additional costs
associated with FL technology might be offset by an
increase in surgical efficiency. Using a ‘hub and spoke’
model to provide high-volume cataract surgery, we
designed a financial model, comparing FLACS against
conventional phacoemulsification surgery (CPS). The
model was populated with averaged financial data from
4 NHS foundation trusts and 4 commercial
organisations manufacturing FL platforms. We tested
our model with sensitivity and threshold analyses to
allow for variations or uncertainties.
Results: The averaged weekly workload for cataract
surgery using our hub and spoke model required either
8 or 5.4 theatre sessions with CPS or FLACS,
respectively. Despite reduced theatre utilisation, CPS
(average £433/case) was still found to be 8.7%
cheaper than FLACS (average £502/case). The greatest
associated cost of FLACS was the patient interface (PI)
(average £135/case). Sensitivity analyses demonstrated
that FLACS could be less expensive than CPS, but only
if increased efficiency, in terms of cataract procedures
per theatre list, increased by over 100%, or if the cost
of the PI was reduced by almost 70%.
Conclusions: The financial viability of FLACS within
the NHS is currently precluded by the cost of the PI
and the lack of knowledge regarding any gains in
operational efficiency.
INTRODUCTION
In 2014–2015, over 370 000 cataract opera-
tions were performed on the National
Health Service (NHS).1 This was 3.7 times
the number performed in 1989.2 The need
for cataract surgery is expected to rise
further with increasing life expectancy, rising
population size, growing patient expectations
and an increase in age-related chronic dis-
eases associated with cataracts, such as dia-
betes.3 With current financial constraints,
this increased future demand for cataract
surgery within the NHS is liable to be
problematic.
Femtosecond laser (FL) technology has
been recently introduced into cataract
surgery in an attempt to automate and
improve the efficacy and safety of some of
the surgical steps within this procedure.4
Within the scientific literature, there are now
numerous prospective case series supporting
its usage and continued development and
more surgeons are adopting this new tech-
nology.4–9 However, while FL technology
undoubtedly offers great surgical precision, a
Strengths and limitations of this study
▪ Data were collected and collated from four NHS
foundation trusts of various sizes, locations and
demographics to ensure the conclusions could
be more representative.
▪ This is the only study investigating the financial
implications of femtosecond laser-assisted cata-
ract surgery (FLACS) which highlights the signifi-
cance of the cost of the disposable patient
interfaces over the capital cost of the laser
machine itself.
▪ This is the only study investigating the financial
implications of FLACS which has developed a
working model incorporating a laser to improve,
rather than impede productivity.
▪ This study falls short of providing an incremental
cost-effectiveness ratio for FLACS. For the pur-
poses of this model, clinical outcomes are
assumed to be equivalent. This is currently sup-
ported by the latest evidence.
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recent meta-analysis shows no significant advantages in
terms of safety and efficacy of FL-assisted cataract
surgery (FLACS) over conventional phacoemulsification
cataract surgery (CPS).10 Two large multicentre rando-
mised controlled trials (RCTs) are currently underway in
France and the UK and may provide further evidence as
to whether there is a difference in the clinical outcomes
from FLACS.11 12
Until evidence exists of improved surgical outcomes, it
is difficult at present to support the widespread imple-
mentation of FLACS. This is particularly pertinent as the
introduction of FLACS has significant associated finan-
cial costs. These include initial purchase costs of the FL
system itself, servicing, depreciation and the individual
patient interfaces (PI), which call into question its finan-
cial viability, especially in a state-funded healthcare
system. The majority of existing literature on the eco-
nomics of FLACS originates from healthcare systems
within countries such as the USA or Australia, where
additional costs from procedures perceived as having a
premium status may be passed onto the patient in the
form of a copayment system.13–15 In these healthcare
systems, the existing literature suggests that FLACS is
not, at this time, a cost-effective solution. It is not surpris-
ing, therefore, that adoption of this technology within
the NHS so far has been minimal and largely directed at
research rather than service provision.
Despite associated costs, by its very nature, the FL
offers the potential to remove several steps of cataract
extraction from needing to be performed by a fully
trained surgeon in a fully equipped ophthalmic operat-
ing theatre. FL technology can automate several surgical
steps of the cataract procedure, such as corneal inci-
sions, arcuate keratotomies, capsulotomy and nuclear
lens division, all of which can be potentially undertaken
with this technology by a doctor in training or suitably
trained nurse or technician in a clean room. By redu-
cing the actual amount of time each patient spends
within the operating theatre under the care of a trained
surgeon, the volume of surgical cases undertaken in a
given period of time might potentially be increased.
This may be especially true if a ‘hub and spoke’ model
is utilised, with the FL performing these initial auto-
mated steps and then allowing the completion of the
surgical procedure to be undertaken in more than one
operating theatre at a time. If the number of cases per
theatre session can be increased sufficiently then the
initial expenditure and additional costs associated with
FL technology might be offset.
For FLACS to see increased adoption by a state-funded
healthcare system such as the NHS, it would need to be
shown to be cost-effective based on an acceptable incre-
mental cost-effectiveness ratio (ICER). The ICER is
defined by the difference in the cost between two pos-
sible interventions divided by the difference in their clin-
ical effectiveness. This study aims to investigate, in the
absence of clinical outcomes from large RCTs showing
any surgical benefit, the cost of incorporating FLACS
into the NHS system in order to determine whether the
increased costs of equipment may be offset by an
increase in the volume of surgery performed.
METHODS
Financial model
A financial model was designed to compare FLACS
against CPS for the provision of cataract surgery within
the NHS. The inputs for this model can be seen in
table 1. The model was based on data from four separate
NHS Foundation Trust Ophthalmology Departments
(Guy’s and St Thomas’ NHS Foundation Trust, Norfolk
and Norwich NHS Foundation Trust, Peterborough and
Stamford NHS Foundation Trust and West Suffolk NHS
Foundation Trust) and four manufacturers of commer-
cially available FL devices (Abbott Medical Optics, Santa
Ana, California, USA; Ziemer Ophthalmic Systems AG,
Switzerland; Alcon Laboratories, Fort Worth, Texas, USA
and Bausch & Lomb, Rochester, New York, USA). The
data were collated and averaged to ensure the results
were more representative than had just one ophthalmol-
ogy department or one FL been used.
Values for each input were derived from the following
sources.
1. Income for each procedure is reimbursed at the NHS
national tariffs for 2014–2015 plus an additional
market forces factor.16 17
2. Costs were divided into direct labour costs, equip-
ment costs and overheads. Direct labour costs per
theatre session were derived from NHS pay scales
and midpoint values were chosen. This was then pro-
portioned to the estimated duration of each theatre
session.
3. Costs relating to the FL were averaged from those
provided by four manufacturers of commercially
available FL devices.
4. Costs such as estate, equipment and supplies were
averaged from four NHS Foundation Trusts’ depart-
mental budgets (2014–2015).
5. Pharmacy and administrative costs were obtained by
reviewing the departmental budget at our institution.
6. Baseline values for the number of cases achievable
per 4-hour theatre session were given nominal values
of 7 cases for CPS and 10 cases for FLACS. These
initial values were then tested using sensitivity and
threshold analyses.
The model was tested based on two scenarios: FLACS
versus CPS based on an average number of seven cases
currently performed on a CPS cataract lists and a FLACS
delivery model based on a ‘hub and spoke’ method with
one FL in a clean room and operated by a doctor in
training preparing patients for two operating theatres
running in parallel with their associated surgeons,
nursing and technical support staff.
‘Hub and spoke’ FLACS model
Our theoretical ‘hub and spoke’ model for FLACS is
based on a single FL platform in a clean room and
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operated by an ophthalmology registrar or suitably
trained allied health professional and supported by a
theatre nurse (figure 1). The laser would be pro-
grammed to perform capsulotomy, nuclear lens division
and arcuate keratotomies (when indicated) for each
individual patient. Patients would be prepared for two
operating theatres running in parallel with their asso-
ciated surgeons, nursing and technical support staff.
The assumed FL treatment time is a maximum of
10 min per patient allowing for the preparation of up to
20 cataract surgery cases, 10 per theatre per 4-hour oper-
ating theatre session. The assumed theatre time is a
Figure 1 A proposed ‘hub and
spoke’ model for femtosecond
laser-assisted cataract surgery.
Table 1 Inputs for the model and nominal values
Source Input Value (£) Range (£)
A




Band 5 nurse 79
Registrar/laser technician 101




Ophthalmic day-case unit 525 620 30 112–
1 061 481
2× operating theatres 585 676 353 245–
962 287
Laser Initial cost 262 500 175k–350k
Maintenance/year 28 333 20k–35k
Cost of patient interface 134.75 99–170
Other costs Disposables and IOL (per case) 103






Number of cataract operations required per week 55
operations
27–96
Number of cases on CPS list 7 operations
Number of cases on FLACS list* 10
operations
Lifetime of FL 10 years
*Based on the hub and spoke FLACS delivery model.
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maximum of 24 min per case. These values are based on
our own experience with the FL.
Sensitivity analysis
The model was constructed using Microsoft Excel
(Microsoft Corp, Redmond, Washington, USA) based on
the range of the above inputs (table 1). Univariate and
bivariate sensitivity analyses were conducted by varying
the inputs into the model to simulate the impact on the
final service costs. The inputs chosen for the sensitivity
analysis were as follows:
1. capital cost of the FL,
2. cost of the PI,
3. number of cases possible on a FLACS theatre list,
4. number of cases performed on a CPS list,
5. number of cataract operations required per week.
Threshold analyses were performed on the same vari-
ables as the sensitivity analyses to determine threshold
values at which FLACS may break even with CPS. The
results are reported as weekly costs.
RESULTS
The first model tested FLACS versus CPS based on an
average number of seven cases currently performed on
CPS cataract lists. Our model estimated that the current
CPS service at its existing productivity was costing £433
per case. Using a model that incorporates one FL into
one theatre list, and therefore assuming no increase in
productivity, the laser increases the cost per case by £167
to £600. Based on these values, the CPS service would
be 72% of the cost of a FLACS service.
Using the averaged and nominal values for our theor-
etical ‘hub and spoke’ model for FLACS, the use of the
FL reduced the weekly theatre requirements from 8 CPS
theatre sessions to 2.7 FLACS sessions with both theatres
in the FL model running in parallel (total theatre ses-
sions 5.4). This reduced the anticipated running costs of
theatres, the ophthalmic day-case unit and staffing costs.
However, the laser introduced additional costs into the
model (FL equipment, supplies, maintenance and add-
itional staff). Based on the nominal values, even with
our hub and spoke model running optimally, the CPS
service (average of £433/case) was found to be 86.3% of
the cost of the FLACS service (average of £502/case).
The capital cost of the FL when amortised over its life-
time of 10 years was £505/week. Maintenance of the
laser was £545/week. The cost of 1 week’s worth of PI
(n=55) at £135 each was £7356 (figure 2).
The model was not affected when we changed the
salary of the laser operator from a midpoint registrar to
a band 6 nurse as the hourly rates were of negligible dif-
ference (table 1).
Univariate sensitivity analyses were conducted by
varying one variable at a time. Minimum and maximum
values were obtained from the original data (table 2).
Figure 2 Comparison of the costs per week of conventional phacoemulsification surgery compared with femtosecond
laser-assisted cataract surgery.
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Only when the number of operations on a CPS list was
reduced or the number of operations on a FLACS list
was increased, could the model give an output in favour
of FLACS. Best and worst-case scenarios were con-
structed for CPS and FLACS, by aligning the most
important variables all in favour of one or other modal-
ity, with costs of £371 and £515 for CPS and £381 and
£545 for FLACS, respectively (table 2B).
Univariate threshold analyses were performed to dem-
onstrate the ‘break-even’ values of each input. Keeping
all other inputs at their original values, the model could
not find solutions by which the FL broke even when the
capital cost of the FL or the number of operations per-
formed per week was chosen. The costs of the services
were equivalent if the true number of cases on a CPS list
was 6, or if the FL could increase productivity to 16
cases/each theatre, or if the cost of the laser consumables
was reduced to £66. It was thereby ascertained that these
three parameters are the most important in this model
for determining a cost-neutral scenario for FLACS.
Bivariate sensitivity analyses were performed using
combinations of the above inputs. For example, table 3
shows the outcomes of the model when the capacity for
the number of cases on CPS and FLACS is simultan-
eously tested. It shows that the FLACS service would be
required to approximately double the number of opera-
tions possible during a theatre list for FLACS to break
even. Table 4 tests the outcome of the model based on
an assumption that the NHS can negotiate lower PI costs
based on the provision of a large number of operations
per year. It shows that FLACS cannot break even unless
the cost of the PI is significantly reduced (to approxi-
mately £50 per case). Table 5 compares the cost of the
PI against the number of cases on a FLACS list.
DISCUSSION
We have designed a hypothetical treatment delivery
model based on a ‘hub and spoke’ service and utilising
FLACS to improve the efficiency of cataract surgery in
terms of number of cases undertaken per operating list.
We then tested our model with sensitivity and threshold
analyses to allow for variations or uncertainties.
Even with our optimised delivery model, FLACS is still
more expensive than CPS based on current estimates of
costs. To break even, the incorporation of FLACS would
Table 2 (A) Univariate sensitivity analysis of the hub and spoke model based on range of values from data collected and (B)
best-case scenarios for conventional phacoemulsification surgery and femtosecond laser-assisted cataract surgery




Cost of CPS service





















Minimum £175 000 86.7
Average £262 500 86.3
Maximum £350 000 85.7






























96 5 10 50 £545 £381 143.2
Bold indicates where FLACS is less expensive than CPS option.
*Assuming 10 cases on FLACS list.
†Assuming seven cases on CPS list.
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have to approximately double the number of cataract
operations performed per theatre list and indeed could
not offer a cost-neutral solution if the number of cases
on a CPS theatre list was 8 or more. Our model indicates
that the greatest cost impediment to a FLACS service is
the price of the PI (average cost £135/case) (figure 2),
which represents almost 27% of the total cost per case.
Unlike other service costs, the cost of the PI is not miti-
gated by potential increased productivity. It is therefore
a major financial impediment to FLACS ever becoming
cost-effective within the NHS, where the total tariff for
each operation is fixed between £718 and £932.16 17
Potentially, this problem may be overcome by the manu-
facturer considerably discounting this cost to the NHS.
In contrast to the PI, our financial model indicates that
the costs of the laser itself, staffing and maintenance it
were much less important (4.8% of total costs).
There are three important unknowns with regard to
our model. First, we are awaiting clinical results from
large RCTs comparing FLACS with CPS.11 12 The latest
meta-analysis shows no significant advantages in terms of
safety of FLACS over CPS.10 However, there are advan-
tages in terms of endothelial cell loss, effective phacoe-
mulsification time and unaided visual acuity, albeit no
difference in long-term best-corrected visual acuity and
an increased risk of anterior capsular tear.18 We assumed
in our financial modelling that there are no differences
in outcomes and complication rates between the two
procedures. If, however, FLACS were to show significant
advantages in terms of patient safety and outcomes then
such improvements then this may have additional posi-
tive financial implications.
Second, potential gains in productivity from the FL
are as yet unpublished and unrealised. Several studies
investigating FLACS actually report decreased patient
turnover with FLACS.13 19 20 This is because at present
typically the operating surgeon is performing the FL
treatment as well as the subsequent lens extraction.
Table 3 Cost of femtosecond laser-assisted cataract surgery versus conventional phacoemulsification surgery
Number of operations on CPS list (%)
Number of operations on FLACS list 5 6 7 8 9
8 99.0 87.1 78.6 72.3 67.3
10 108.5 95.5 86.2 79.2 73.8
12 115.9 102.0 92.1 84.7 78.9
14 121.9 107.3 96.9 89.0 82.9
16 126.8 111.6 100.8 92.6 86.3
Bold indicates where FLACS is less expensive than CPS option.
Bivariate sensitivity analysis: demonstrating relative costs of CPS service compared with FLACS when total number of cases on each theatre
list are tested.
Table 5 Cost of femtosecond laser-assisted cataract surgery versus conventional phacoemulsification surgery
Number of operations on FLACS list (%)
Cost of PI 8 9 10 12 14 16
50 92.9 98.6 103.7 112.4 119.5 125.5
65 90.0 95.4 100.1 108.2 114.8 120.3
80 87.3 92.3 96.7 104.3 110.4 115.5
100 83.9 88.5 92.6 99.5 105.0 109.6
120 80.8 85.1 88.8 95.1 100.2 104.3
135 78.6 82.6 86.2 92.1 96.8 100.7
Bold indicates where FLACS is less expensive than CPS option.
Bivariate sensitivity analysis: demonstrating relative costs of CPS service compared with FLACS when cost of PI and number of operations on
FLACS list are tested.
Table 4 Cost of femtosecond laser-assisted cataract surgery versus conventional phacoemulsification surgery
Number of cataract operations per year (%)
Cost of PI (£) 2000 3000 4000 5000 6000
50 101.5 104.0 105.2 106.0 106.5
75 95.9 98.1 99.2 99.9 100.4
100 90.9 92.8 93.8 94.4% 94.9
125 86.4 88.1 89.0 89.6 89.9
150 82.3 83.8 84.7 85.2 85.5
Bold indicates where FLACS is less expensive than CPS option.
Bivariate sensitivity analysis: demonstrating relative costs of CPS service compared with FLACS when cost of PI and total number of cases
per year are tested.
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There are as yet no publications on the most effective
way to design a FL-centric cataract service. We chose a
‘hub and spoke’ model based on one FL in a clean
room, operated by an ophthalmic surgeon in training or
ophthalmic technician/nurse. The FL then fed patients
into two independent operating theatres, each with its
own surgeon and support staff. This model is theoretical.
It needs to be tested in the NHS setting to see if it is
viable, and further work may need to be performed to
determine a ‘best-practice’ and optimised efficiency
model for FLACS.
Third, it is likely that the costs of the PIs would be
reduced below the values quoted to us by the manufac-
turers, as a large public sector ophthalmology depart-
ment performing several thousand operations per year
could negotiate on costs and capitalise on market com-
petition. As discussed above, this would considerably
improve the financial burdens associated with imple-
menting FLACS.
Abell and Vote13 have previously designed a hypothet-
ical model to derive cost-effectiveness of FLACS. In the
absence of better evidence, conservative estimates were
used for complication rates with FLACS. Their use of
the FL resulted in reducing their theatre efficiency by
two cases per list, and subsequently, they estimated the
additional cost of FL to be AUS$1065 per case, AUS$750
of which were the direct costs from the FL and AUS$315
from lost productivity. Our model was based on using
the laser to improve, rather than impede, productivity.
We estimated the cost per case to be £158, of which
£135 is the PI. We chose to amortise the costs of the
laser over 10 years rather than only 3, but reducing the
lifetime of the laser to 3 years increased the cost of each
operation to only £180. This demonstrates yet again the
greatest cost of FLACS is the cost of the PI rather than
the laser itself.
In addition to the above, there are important limita-
tions to mention regarding this hypothetical model.
The model assumes that all patients are suitable for
a high-volume FLACS theatre list. However, some
patients may not be suited to FLACS or to a high-volume
service, although the number of contraindications for
FLACS is decreasing as experience with the technology
improves.21–23
Departmental costs used in this model were obtained
from a retrospective review of the financial records at
four NHS foundation trusts. In order to ensure that the
results were applicable to more than just one hospital
with its associated population, we selected two teaching
hospitals and two district general hospitals of varying
sizes, with annual numbers of between ∼1400 and 5000
cataract operations. These hospitals serve urban and
rural populations (range ∼275 000–823 000 served by
each hospital) with a mixture of demographics (and
include hospitals with one of the highest and one of the
lowest cataract tariffs).17
The costs of consumables were assumed to be equal
for FLACS and CPS. In reality, as the FL performs many
stages of the procedure, the cost of some consumables
may be reduced (vision blue, cystotome, etc) and some
cataracts may no longer require any phacoemulsifica-
tion.24 Our model incorporates the salary of a registrar
to operate the laser,25 26 yet if FLACS becomes widely
adopted within the UK, then technicians may be trained
to perform this duty, perhaps at a reduced cost, but no
money was saved when we modelled for the salary of a
band 6 nurse to operate the laser.
Overall, this model demonstrates that FLACS could
only be financially viable if its implementation into the
NHS allowed significant improvements in efficiency in
the number of cases treated per theatre list and/or if
the cost of the PI was considerably reduced. Further
research is required on the clinical outcomes of FLACS
compared with CPS as well as real-world evidence of the
effect to surgical efficiency afforded by this technology.
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Harry W. Roberts, MSc, FRCOphth, Vijay K. Wagh, MD, FRCOphth, Daniel L. Sullivan, MSc,
Polina Hidzheva, MCOptom, Delia I. Detesan, Bissoon S. Heemraz, MSc RGN, JohnM. Sparrow, DPhil, FRCOphth,
David P.S. O’Brart, MD, FRCS, FRCOphth, DO
Purpose: To compare the clinical results of conventional phaco-
emulsification surgery (CPS) with femtosecond laser–assisted
cataract surgery.
Setting: Guy’s & St Thomas’ NHS Foundation Trust, London,
United Kingdom.
Design: Single-center prospective randomized interventional
case-controlled trial.
Methods: Patients undergoing cataract surgery were random-
ized to receive either CPS or femtosecond laser–assisted
cataract surgery. The surgery was performed with a femtosecond
laser (Lensx), and all operations were performed with a gravity-
fluidics torsional phacoemulsification machine (Infiniti). The visual
acuity, refraction, central corneal thickness (CCT), central foveal
thickness (CFT), endothelial cell loss, and rates of intraoperative
and postoperative events were recorded. Quality of life outcomes
were measured with the EuroQOL 5 dimensions questionnaire
(EQ-5D) and patient-reported quality of vision was assessed
with a cataract surgery patient-reported outcome measures
questionnaire (Cat-PROM5).
Results: The study comprised 400 eyes of 400 patients who had
CPS (n Z 200) or femtosecond laser–assisted cataract surgery
(n Z 200). Seven patients (3.5%) in the femtosecond laser–
assisted group were not able to complete the treatment and
received CPS. The mean uncorrected distance visual acuity
(logarithm of the minimum angle of resolution [logMAR])
0.15 G 0.21 (SD) and 0.15 G 0.19 logMAR after CPS and
femtosecond laser–assisted surgery, respectively (P Z 1.0); the
pinhole-corrected visual acuity was 0.04 G 0.12 and
0.04 G 0.12, respectively (P Z 1.0); the increase in CCT was
13 G 19 mm and 15 G 25 mm, respectively (P Z .5); and the
endothelial cell loss was 9.7 G 13.7 % and 10.2% G 13.7,
respectively (P Z .76). The manifest refraction spherical
equivalent error was !0.14 G 0.60 diopters (D) after CPS and
!0.12 G 0.60 D after femtosecond laser–assisted surgery
(P Z .74); the mean change in CFT was 9 G 35 mm and
6 G 35 mm, respectively (P Z .55); and the rate of posterior
capsule rupture was 3% and 0%, respectively (P Z .03).
Conclusions: This study confirms the nonsignificant differences
between 2 treatment modalities, notwithstanding a significant
reduction in posterior capsule ruptures in the femtosecond laser–
assisted surgery group.
J Cataract Refract Surg 2019; 45:11–20 Crown Copyright Q 2018 Pub-
lished by Elsevier Inc. on behalf of ASCRS and ESCRS. All rights reserved.
Supplemental material available at www.jcrsjournal.org.
The introduction of femtosecond laser technology toallow the automation of a number of surgical stepswithin cataract extraction has been claimed to offer
potential advantages of reduced complications and better
visual outcomes through greater surgical precision and
reproducibility.1,2 However, systems to undertake femto-
second laser–assisted cataract surgery are expensive to
purchase and to use. In a previous study, we estimated
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that femtosecond laser–assisted cataract surgery adds £167
(approximately $220) to each operation within the context
of a state-funded healthcare system.3 From a public health
perspective, costs might be mitigated by improved safety
leading to increased reliability, a reduced postoperative
need for additional clinical or surgical interventions, and
better patient outcomes.4
Nine randomized controlled trials (RCTs)1,2,5–11 were
identified in a metaanalysis of femtosecond laser–assisted
cataract surgery versus conventional phacoemulsification
surgery (CPS) by Chen et al.12,13 There was a statistical
reduction in effective phacoemulsification time (EPT) in
femtosecond laser–assisted cataract surgery compared with
CPS; however, this did not translate into a difference in cen-
tral corneal thickness (CCT) or endothelial cell count (ECC)
at 1 week or beyond. The rates of surgical complications were
similar. The postoperative corrected distance visual acuity
(CDVA) was statistically superior in the femtosecond
laser–assisted surgery group at 1 week and 6 months postop-
eratively but not at the 1-month to 3-month follow-ups.
There was no statistically significant difference in uncorrect-
ed distance visual acuity (UDVA) at any timepoint.
Fortunately, the rates of cataract surgery-related events are
low. Therefore, large studies are required to be adequately
powered to investigate differences in safety. To our knowl-
edge, the largest RCT to investigate complication rates with
femtosecond laser–assisted cataract surgery compared with
CPS published to date, included 200 eyes and reported 1 ante-
rior capsule tear in the femtosecond laser–assisted surgery
group and no events of posterior capsule rupture in either
group.14 With such low rates of complications, such studies
are often underpowered to detect differences in safety. To
our knowledge, the largest case control study included more
than 7000 cataract operations (3371 femtosecond laser–
assisted and 3784 CPS) and found an increased risk for vitre-
ous loss in the CPS group (1.4% vs 0.8%).15
A recent Cochrane Review of 16 RCTs including 1638 eyes
concluded, “There is currently not enough evidence to deter-
mine the benefits and harms of laser-assisted cataract surgery
comparedwith standard ultrasound cataract surgery. The ev-
idence is uncertain because current studies have not been
large enough to provide a reliable answer to this question.”16
Our aim was to complete the largest RCT published to
date comparing femtosecond laser–assisted cataract surgery
with CPS with the intention to inform clinical practice and
health policy worldwide. Because there have been a lack of
patient-reported outcome measures (PROMs) in previous
RCTs, this study aimed to correct this by measuring quality
of life with the EQ-5D, a EuroQOL 5 dimensions question-
naire, and patient-reported quality of vision with the
Cat-PROM5, a cataract surgery PROMs questionnaire.17,18
PATIENTS AND METHODS
The study design was a prospective randomized interventional case-
controlled study at a single UniversityHospital (Guy’s & St Thomas’
Hospital NHS Foundation Trust, London, United Kingdom) to
compare femtosecond laser–assisted cataract surgery with CPS
(Clinicaltrials.gov registration number NCT02825693). The study
was approved by local Research & Development and Cambridge
South Research Ethics Committee (reference 16/EE/0180). The
study adhered to the tenets of the Declaration of Helsinki.
The patients were recruited to the study between August 2016
and June 2017. They were screened and recruited, and informed
consent was obtained, from routine cataract clinics by members
of the trial team (H.W.R., V.K.W.) as per the trial protocol (Version
2.0, 18/05/2016). Table 1 shows the inclusion and exclusion criteria.
Within the enrolment visit, patients had a complete ophthalmologic
examination. Only one eye per patient was enrolled in the study.
Patients were randomized to receive CPS or femtosecond laser–
assisted cataract surgery in equal proportions using computer-
generated random number tables (Excel software, Microsoft
Corp.) just prior to being offered a date for surgery. Excel macros
were used to perform the randomization (this was concealed from
the allocator) and then the allocation was locked with the patient’s
research information to address allocation bias. All patients’ treat-
ments in this study were delivered by the National Health Service
andwere free at the point of care.At the follow-up visit, if the patient
failed to attend, the patient was contacted and offered another
appointment within 1 week. If they failed to attend this, they were
considered lost to follow-up from the study.
Data Collection
The outcomes reported in this study are detailed in the trial pro-
tocol (version 2.0, 18/05/2016). Data collection for this study
occurred at the preoperative assessment, the day of surgery, and
the postoperative visit scheduled at 4 weeks after surgery
(Table 2). Visual acuity and any investigations performed (corneal
topography, specular microscopy, etc.) were conducted by an
optometrist or technician (D.S., P.H., D.D.) masked to the partic-
ipant’s treatment arm. Because of the nature of the intervention,
neither the surgeon, surgical team, nor the participant could be
masked to their treatment arm. All clinical technicians and nurses
were masked to the intervention received.
Visual acuities (UDVA, CDVA, and pinhole) were measured
with a Snellen chart at 6 m. Participants’ refractive errors were
collected using an autorefractor (RK-510A, Nidek Co. Ltd.). Biom-
etry was performed using partial coherence interferometry (IOL
Master 500, Carl Zeiss Meditec AG). Corneal topography and
CCT were determined using a Scheimpflug device (Pentacam,
Oculus Optikger€ate GmbH). Macular spectral-domain optical
coherence tomography was performed with amodular ophthalmic
imaging platform (Spectralis, Heidelberg Engineering GmbH).
The ECC was measured with a specular microscope (SP-3000,
Topcon Medical Systems, Inc.). Visual comorbidities and risk fac-
tors for complications of cataract surgery were recorded prospec-
tively. The risks for posterior capsule rupture were calculated for
patients using a composite risk calculation system.20
The PROMs were collected with the Cat-PROM5 tool, a
recently developed National Institute for Health Research–
funded questionnaire consisting of 5 questions that provide a
Rasch calibrated psychometrically robust measure, which is highly
responsive to cataract surgery, in which a higher score indicates
greater visual disability.17,18
The quality of life outcomes were assessed using the EuroQOL
EQ-5D questionnaire, which consists of 2 components: 5 ques-
tions about 5 dimensions of health-related quality of life (mobility,
self-care, usual activities, pain/discomfort, and anxiety/depres-
sion), which are scored as 1, 2, or 3 (1 meaning no problems
and 3 meaning extreme problems). The 5 responses are then
weighted and combined to create a summary index with values
0 to 1, where 1 indicates no problems. The visual analogue scale
is a continuous scale anchored by best imaginable and worst imag-
inable health, with values ranging from 0 to 100 (where 100 indi-
cates best possible health). The EQ-5D was chosen because it is
well recognized by public bodies (such as the National Institute
for Health and Care Excellence) for comparative health economic
analyses.19
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The femtosecond laser–assisted cataract surgery was performed
using a femtosecond laser (Lensx, Alcon Laboratories, Inc.). Two
surgeons (H.W.R., V.K.W.) received training and full accredit-
ation on the device in anticipation of this trial and performed at
least 30 laser applications each before the trial began. The femto-
second laser was used to perform capsulotomy, lens
fragmentation G astigmatic keratotomies. Default laser parame-
ters for all surgeons are detailed in Supplement 1 (available at http:
//jcrsjournal.org). When the laser treatment could not be
performed for some reason (eg, repeated inability to dock, laser
machine fault, etc.) patients underwent surgery in accordance
with conventional CPS. Astigmatic keratotomies within the
femtosecond laser–assisted group or limbal relaxing incisions
(LRIs) within the CPS group were offered to any patient with
corneal astigmatism greater than 0.9 diopters (D) based on corneal
topography. The astigmatic results are presented elsewhere.21 All
cataract operations were performed under a local anesthetic. All
operations were unilateral, and no other additional procedures
were planned, other than arcuate keratotomies for the reduction
of corneal astigmatism.
After the femtosecond laser treatment, the patient was
transferred to the operating theater for the remainder of the
cataract extraction. Phacoemulsification was performed using
the gravity-fluidics torsional phacoemulsification machine (Infin-
iti, Alcon Laboratories, Inc.) Patients undergoing CPS were pre-
pared for surgery in the same way as those in the laser arm.
Rather than receiving laser pretreatment, they were brought
straight to the operating theater. The default intraocular lens
(IOL) used for in-the-bag placement was a hydrophobic acrylic
IOL (Acrysof SA60AT, Alcon Laboratories, Inc.). All operations
were performed by surgeons who had completed at least 30 femto-
second laser–assisted cataract surgery procedures (H.W.R.,
V.K.W., D.O.B.).
Statistical Analysis
Table 3 shows the baseline characteristics for each treatment arm.
The results were analyzed primarily as per intention to treat. The
evaluators were masked to the participants’ treatment arm. For all
evaluations of visual acuity as an outcome, patients with visually
significant ocular comorbidities were excluded prospectively.
Snellen visual acuities were converted to logarithm of the mini-
mum angle of resolution (logMAR) for analysis.22 Continuous
data were reported using means G SDs if the data appeared
Gaussian. Binary data were reported as frequencies and percent-
ages and evaluated with the Fisher exact test. Student t tests
were used for parametric data. All statistical tests used a 2-sided
P value of a Z 0.05, unless otherwise specified. Intraoperative
or postoperative adverse events were defined as any event that
involved unintentional trauma to an ocular structure, requiring
additional treatment or having a negative effect on participants’
eyesight. The EQ-5D index scores were calculated using the visual
analogue score method calibrated for the U.K. The Rasch-
calibrated Cat-PROM5 scores (logits) were calculated from the
questionnaire responses in accordance with the developer’s
instructions.16
The UDVA at 4 weeks was designated as the primary outcome
with intraoperative and postoperative complications, refraction,
corneal thickness, and endothelial cell loss, with quality of life out-
comes and patient-reported quality of vision preoperatively and at
4 weeks postoperatively selected as secondary outcomes. A priori
calculations for sample size indicated a total sample size of 370 to
have an 85% chance of detecting a 0.1 difference in logMAR visual
acuity and assumption of s Z 0.32 with a Z 0.05 and a 2-tailed
analysis. This sample size was rounded to 400 to account for the
possibility of patients lost to follow-up.
RESULTS
Of the 427 patients who were recruited to the study, 27 pa-
tients withdrew from the trial before surgery. Therefore,
400 eyes of 400 patients received surgery between
November 2016 and June 2017 (200 CPS, 200 femtosecond
laser-assisted). Nine patients (2.3%) failed to attend their
follow-up appointments. Seven (3.5%) of the 200 patients
in the CPS group compared with 2 (1.0%) of the 200 pa-
tients in the femtosecond laser–assisted group were lost to
follow-up (P Z .17). Only one of the participants lost to
follow-up had an untoward clinical event (CPS arm),
requiring referral to vitreoretinal colleagues, and withdrew
from providing further information to the study team; the
remainder had uneventful clinical courses (further clinical
information on those lost to follow-up is in Supplement 2,
Table 1. Inclusion and exclusion criteria for enrolment in
the study.
Inclusion Criteria:
Patients must have reduced visual acuity or visual symptoms
attributed to the presence of cataract in 1 or both eyes by the
examining ophthalmologist or must require cataract surgery on
clinical grounds other than visual symptoms.
Patients must be willing to attend follow-ups 3 to 4 weeks after
cataract surgery.
Patients must have sufficient English language for informed consent
and completion of the patient-reported outcome questionnaires.
Exclusion Criteria:
Children below the age of 18
Already enrolled in another study
Clinical contraindications for femtosecond laser–assisted cataract
surgery, such as:
Significant corneal opacities
Small pupils (!4.0 mm) after pharmacological dilatation
Patients unable to lie sufficiently flat so as to be positioned
underneath the laser machine.











Risk factors for cataract
surgery19
X
Inclusion/exclusion criteria X X
Refractive error X X
Keratometry X
Biometry X
Corneal topography X X
ECC X X
OCT of the macula X X
EQ-5D-3L X X
Cat-PROM5 X X
Adverse event collection X X
Cat-PROM5 Z cataract surgery patient-reported outcome measures
questionnaire; CDVAZ corrected distance visual acuity; ECCZ endothe-
lial cell count; EQ-5D-3L Z EuroQOL 5 dimensions questionnaire, 3 level
version; IOP Z intraocular pressure; OCT Z optical coherence tomogra-
phy; PHVA Z pinhole visual acuity; UDVA Z uncorrected distance visual
acuity
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available at http://jcrsjournal.org). Although losses to
follow-up were unequal between the arms, the high overall
rate of follow-up of 97.8% suggests that possible biases re-
sulting from unequal follow-ups are unlikely to be
important.
One hundred eighty-two (45.5%) of the 400 study pa-
tients were men, and 330 (82.5%) of the operations were
performed in first eyes, 216 (54%) of the 400 eyes were
right-eye operations. The mean age of the patients was
70.2 G 10.4 years. The mean preoperative CDVA was
0.58 G 0.47 logMAR. Table 3 shows the patient demo-
graphics and full baseline data. Clinical and self-reported
questionnaire measures were similar between the 2 groups.
Of the 400 operations, 155 (39.0%) were performed with the
main incision within G30 degrees of the steep axis, 314
(78.5%) were performed with the main incision sited at
the corneal limbus, and 86 (21.5%) with clear corneal inci-
sions. Forty-nine (12.3%) of the 400 patients were excluded
from postoperative visual acuity analysis because of preex-
isting visually significant ocular comorbidities (28 in the
femtosecond laser–assisted group, 21 in the CPS group).
The cases were distributed evenly between the 3 surgeons
and between the 2 treatment arms (P Z .99) (Table 4).
The femtosecond laser treatmentwasdelivered successfully
to 96.5% of cases. Patients receiving femtosecond laser–
assisted cataract surgery treatment spent a mean time of
5.9 G 2.0 minutes in the laser room. Seven patients (3.5%)
were unable to receive femtosecond treatment and received
CPS. The reasons were as follows: repeated bubbles in inter-
face/flat cornea (nZ 1), administrative error (nZ 1), patient
compliance (nZ 2), and patient’s palpebral aperture too nar-
row (nZ 3). One of these patients suffered an intraoperative
suprachoroidal hemorrhage; the others experienced unevent-
ful operations. The mean number of docking attempts was
1.3 G 0.7 per patient. Supplement 1 (available at http:
//jcrsjournal.org) shows the reasons for failed attempts at
docking and details of the laser treatments delivered. The
mean duration of surgical time was 11.7 G 3.5 minutes for
femtosecond laser–assisted treatment and 14.7 G 6.8
minutes for CPS.
The mean UDVA (logMAR) after CPS was 0.15 G 0.21
and 0.15 G 0.19 after femtosecond laser–assisted cataract
surgery treatment (P Z 1.0), and the mean pinhole-
corrected visual acuity was 0.04 G 0.12 and
0.04 G 0.12, respectively (P Z 1.0) (Figures 1 to 4).
The mean increase in CCT was 13 G 19 mm after CPS
and 15 G 25 mm after femtosecond laser–assisted surgery
(P Z .5). The ECC loss was !9.7 G 13.7% after CPS and
!10.2 G 13.7% after femtosecond laser–assisted surgery
(P Z .76). The refractive mean spherical equivalent error
was !0.14 G 0.60 D after CPS and !0.12 G 0.60 D after
femtosecond laser–assisted surgery (P Z .74) (Figures 5 to
8). The mean change in the central foveal thickness was
9 G 35 mm after CPS and 6 G 35 mm after femtosecond
laser–assisted surgery (P Z .55) (Table 5). The Cat-
PROM5 demonstrated a substantial shift between
preoperative to postoperative completions, signaling a
significant self-reported reduction in visual difficulty after
surgery that was similar in the 2 intervention groups.
The EQ-5D summary index similarly reflected an
improved score that was similar in the 2 groups. The
EQ-5D visual analogue score, however, was unchanged
in the femtosecond laser–assisted surgery group but
increased in the CPS group (Table 5). There were no dif-
ferences in total rates of intraoperative or postoperative
complications (Tables 6 and 7). There was a significant





Sex, Male/female (n) 100/100 82/118
1st eye/2nd eye (n) 162/38 168/32
Right eye/left eye (n) 107/93 109/91
Mean age (y) 69.9 G 10.9 70.5 G 9.8
Mean preop CDVA (logMAR) 0.62 G 0.49 0.54 G 0.46
Mean SE refractive error (D) !0.17 G 2.99 !0.77 G 4.88
Mean AL (mm) 23.88 G 1.55 23.63 G 1.26
Mean ACD (mm) 3.25 G 0.42 3.21 G 0.44
Mean target refraction (D) !0.21 G 0.34 !0.22 G 0.4
Mean IOP (mm Hg) 13.7 G 4.1 13.9 G 3.6
Mean CCT (mm) 541 G 49 546 G 35
Mean ECD (cells/mm2) 2505 G 313 2534 G 327
Mean CFT (mm) 199 G 47 189 G 33
Mean predicted PCR risk (%)20 1.63 G 0.91 1.59 G 1.29
Mean CAT-PROM5
calibrated score
0.45 G 2.6 0.28 G 2.31
Mean EQ-5D-3L index score 0.82 G 0.19 0.80 G 0.23
Mean EQ-5D visual
analogue scale
77.84 G 16.53 75.17 G 18.63
Complicated cataracts




White cataracts (n) 7 6
Subluxated cataracts (n) 0 0
Means G SD
ACDZ anterior chamber depth; ALZ axial length; Cat-PROM5Z cataract
surgery patient-reported outcome measures questionnaire; CCTZ central
corneal thickness; CDVAZ corrected distance visual acuity; CFTZ central
foveal thickness; CPS Z conventional phacoemulsification surgery;
ECD Z Endothelial cell density; EQ-5D Z EuroQOL 5 dimensions ques-
tionnaire; EQ-5D-3L Z EuroQOL 5 dimensions questionnaire, 3 level
version; IOP Z intraocular pressure; logMAR Z logarithm of the minimum
angle of resolution; PCR Z posterior capsule rupture; SE Z spherical
equivalent
Table 4. Case distribution between the 3 surgeons and
between the 2 treatment arms (P Z .99).*








69 86 45 200
Total 137 173 90 400
*Chi-square test
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difference in the rate of posterior capsule rupture with a
higher rate occurring in the CPS group (P Z .03).
DISCUSSION
To our knowledge, this is the largest RCT published to date,
comparing the safety and effectiveness of femtosecond
laser–assisted cataract surgery versus CPS and including
400 eyes of 400 patients. All surgeries were performed at
a single center by 3 surgeons who had previously completed
their femtosecond laser–assisted surgery learning curve,
having completed at least 30 cases. Patients were reviewed
at 4 weeks postoperatively to perform clinical examination,
assess for complications, and gather postoperative data.
Overall, these results point overwhelmingly to an absence
of clinical differences between femtosecond laser–assisted
cataract surgery treatment and CPS (except for posterior
capsule rupture and the EQ-5D visual analogue scale). In
many aspects, our findings are congruous with the available
evidence and on occasion are in contrast with conventional
understanding.
Previously reported gains in visual acuity after femto-
second laser–assisted surgery tended to be early (1week post-
operatively) or late (at 6 months) but not between the 1- to
3-month timepoints.13,23 In the current study, we chose to
evaluate patients at 4 weeks when the majority of postoper-
ative edema and inflammation has settled. At this timepoint,
we found no difference in the postoperative visual acuity be-
tween the 2 groups (Figures 1 and 2, Table 5). We did not
perform an immediate postoperative evaluation, although
in accordance with our hospital protocol, all patients were
contacted by telephone to report and document any prob-
lems. It might be the case that femtosecond laser–assisted
cataract surgery is better in the early postoperative phase
because of reduced ultrasound energy and reduced corneal
edema resulting in faster visual rehabilitation, followed by
equivalence in the interim, with any late differences perhaps
Figure 1. Uncorrected distance visual acuity and CDVA at 1 month
after femtosecond laser–assisted cataract surgery (CDVA Z cor-
rected distance visual acuity, UDVA Z uncorrected distance visual
acuity).
Figure 2. Uncorrected distance visual acuity andCDVAat 1month af-
ter conventional phacoemulsification surgery (CDVAZ corrected dis-
tance visual acuity, UDVAZ uncorrected distance visual acuity).
Figure 3. Difference between UDVA and CDVA at 1 month after
femtosecond laser–assisted cataract surgery (CDVA Z corrected
distance visual acuity, UDVAZ uncorrected distance visual acuity).
Figure 4.Difference between UDVA and CDVA at 1 month after con-
ventional phacoemulsification surgery (CDVAZ corrected distance
visual acuity, UDVA Z uncorrected distance visual acuity).
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because of differences in late lens decentration or posterior
capsule opacification.24–26 It is of note that we found no dif-
ferences in CCT or endothelial cell loss at 1 month postop-
eratively, which might be expected if early corneal edema
delaying visual rehabilitation was a significant problem. At
present, we are also evaluating these patients at 12 months
postoperatively to determine late differences, and these re-
sults will be reported later.
No differences were found in the intraocular pressure
(IOP) change between the 2 groups. Because the patients
were reviewed at 4 weeks, the postoperative IOP rises might
have gone unnoticed. In the 2 patients seen with raised IOP
postoperatively, both were presumed to be attributable to a
steroid response. Furthermore, no patients with extremely
high IOPs presented to our service during the early postop-
erative phase.
To our knowledge, this is the first large-scale randomized
controlled trial to evaluate rates of cystoid macular edema
(CME) between femtosecond laser–assisted cataract sur-
gery and CPS. Our rates of CME were equivalent between
the 2 groups, and there was no overall difference in the
mean change in central foveal thickness. This is in keeping
with the available evidence.9,27 Of the 7 cases of CME in this
study, the risk factors were prospectively identified for 5
cases (previous macula off retinal detachment Z 1, previ-
ous epiretinal membrane peelZ 1, previous central retinal
vein occlusion Z 1, epiretinal membrane Z 2).
Our study found a statistically significant increase in the
rate of posterior capsule rupture in the CPS group. This is
an important finding because of the associated risks for
further complications during the postoperative phase asso-
ciated with increased morbidity and costs.4,28 The Co-
chrane review of published RCTs23 found an overall rate
of posterior capsule rupture in zero of 529 cumulative
femtosecond laser–assisted cataract surgery cases
compared with 1 (0.1%) of 547 CPS cases. We consider
the rates of posterior capsule rupture in both of those
groups to be lower than expected; perhaps reflecting patient
selection for the studies, the expertise of the surgeons, or
both. The EUREQUO case-control study, which compared
Figure 5. Spherical equivalent refractive accuracy at 1 month after
femtosecond laser–assisted cataract surgery.
Figure 6. Spherical equivalent refractive accuracy at 1 month after
conventional phacoemulsification surgery.
Figure 7. Postoperative refractive cylinder at 1 month after femto-
second laser–assisted cataract surgery.
Figure 8. Spherical equivalent refractive accuracy at 1 month after
conventional phacoemulsification surgery.
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2814 femtosecond laser–assisted cataract surgery cases with
4987 CPS cases,29 found no significant difference in the
posterior capsule rupture rates of 0.4% and 0.7%
(P Z .79), respectively. The 2 other largest studies of note
included a case series of over 7000 surgeries in the public
sector in the United States, which found a greater rate of vit-
reous loss in the CPS group,15 and a case-control study of
more than 4000 patients, which found no significant differ-
ence in posterior capsule rupture rates.30 Our study was
performed in the public sector in a hospital based within
an inner-city area of London, U.K., with the accompanying
demographics and high rates of comorbidities. Of the pa-
tients sustaining posterior capsule rupture in our cohort,
the mean composite risk calculation score was 2.04% (range
0.84% to 3.13%),20 suggesting that although on the high
side, the 3% rate in the CPS arm of our study was at least
in part a reflection of the surgical case complexity in our
patient cohort. As such, femtosecond laser–assisted cataract
surgery might carry more of an advantage in cohorts that
have an existing higher rate of posterior capsule rupture
(ie, in tertiary units performing complex cataract surgery,
surgeons in training, or in this case, both) and conversely
the benefits of femtosecond laser–assisted surgery might
be more limited in simpler case mixes. The benefits of
femtosecond laser–assisted cataract surgery for surgeons
in training have been described previously.31
All but one of the posterior capsule ruptures in the CPS
group occurred during the phacoemulsification grooving
or segment removal stages. The lower rate of posterior
capsule rupture in the femtosecond laser–assisted group
could imply that these stages of the operation are facilitated
most by the femtosecond laser. The nuclear segmentation
patterns of the femtosecond laser might produce more reg-
ular nuclear segments after cracking that might assist the
Table 5. Postoperative results in the 2 treatment arms.
Parameter
Femtosecond Laser–Assisted
Cataract Surgery CPS P Value
Mean UDVA (logMAR) 0.15 G 0.19 0.15 G 0.21 1.0
Mean PHVA (logMAR)) 0.04 G 0.12 0.04 G 0.12 1.0
Mean change in IOP (mm Hg) !1.3 G 4.5 !1.7 G 3.8 .45
Mean phacoemulsification energy (CDE) 9.6 G 7.0 11.1 G 9.8 .08
Mean change in CCT (mm) 15 G 25 13 G 19 .50
Mean ECL (%) 10.2 G 13.7 9.7 G 13.7 .76
Mean change in CFT (mm) 6 G 35 9 G 35 .55
Mean arithmetic SE refractive error from target refraction (D) !0.01 G 0.56 0.04 G 0.58 .39
Mean absolute SE refractive error from target refraction (D) 0.42 G 0.40 0.40 G 0.46 .65
SE refraction within G0.5 D of intended (%) 67.3 72.3 .32
SE refraction within G1.0 D of intended (%) 92.9 93.7 .84
Mean change in Cat-PROM5 calibrated score !2.44 G 3.13 !2.22 G 2.89 .49
Mean change in EQ-5D-3L index score 0.03 G 0.17 0.03 G 0.16 1.0
Mean change in EQ-5D visual analogue scale 0.71 G 13.61 4.18 G 13.91 .02*
Means G SD
Cat-PROM5Z cataract surgery patient-reported outcome measures questionnaire; CCTZ central corneal thickness; CDEZ cumulative dissipated energy;
CFT Z central foveal thickness; CPS Z conventional phacoemulsification surgery; ECL Z endothelial cell loss; IOP Z intraocular pressure; logMAR Z log-
arithm of the minimum angle of resolution; PHVA Z pinhole visual acuity; SE Z spherical equivalent; UDVA Z uncorrected distance visual acuity
*Statistically significant
Table 6. Intraoperative events.
Parameter




Anterior capsule tear 6 (3) 3 (1.5) .50
Descemet membrane tear 2 (1) 0 .50
IFIS/iris trauma 3 (1.5) 8 (4) .22
Residual soft lens matter 1 (0.5) 0 1.0
IOL exchange 1 (0.5) 0 1.0
Suprachoroidal hemorrhage* 1 (0.5) 0 1.0
Posterior capsule tear 0 6 (3) .03†
Vitreous loss 0 5 (2.5) .06
Dropped lens fragments 0 3 (1.5) .25
Zonular dialysis 0 1 (0.5) 1.0
Total 14 (7) 17 (8.5) .71
CPS Z conventional phacoemulsification surgery; IFIS Z intraoperative floppy-iris syndrome; IOL Z intraocular lens
*This patient was randomized to the femtosecond laser–assisted group but received CPS
†Statistically significant
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surgeon by ensuring a more reproducible stage 2. This is
certainly our anecdotal experience, and it is also reflected
by the shorter surgical time in the femtosecond laser–
assisted surgery group.
It is worth noting that the difference in posterior capsule
rupture rates was only just statistically significant. One
more posterior capsule rupture in the femtosecond laser–
assisted group or one less in the CPS group would have
rendered this result not statistically significant (and the
risk for type 2 error is increased when analyzing outcomes
with smaller numbers). However, it was possible to
compare observed rates of posterior capsule rupture with
expected rates because this study prospectively risk strati-
fied patients according to a composite risk calculation
system.20,28
Self-reported visual difficulty and quality of life outcomes
were interesting. The Cat-PROM5 scores overall shifted
significantly toward less visual difficulty with similar reduc-
tions in each group. The EQ-5D scores likewise shifted to-
ward better quality of life outcomes postoperatively, with
similar improvements in each group. There was a signifi-
cant increase in the EQ-5D visual analogue score after
CPS compared with femtosecond laser–assisted cataract
surgery (P Z .02). However, in the absence of a plausible
clinical explanation or safety issue, and because we found
no differences in the EQ-5D-3L index score (P Z 1.0) or
Cat-PROM5 calibrated score (P Z .49), we cannot suggest
any reason why this result is not a type 1 statistical error.
Furthermore, the EQ-5D visual analogue score is known
to correlate poorly with the impact of cataract surgery.32
Our anterior capsular tear rate was greater in the femto-
second laser–assisted group (3% versus 1.5%); however, this
was not statistically significant. The anterior capsule tear
rates in other RCTs were, again, exceptionally low. Howev-
er, Abell et al.30 found an increased risk for anterior capsule
tears with femtosecond laser–assisted cataract surgery
compared with CPS, reflecting the postage-stamp edge
microanatomy of the capsulotomy rim.10,11,26,33 In our
anecdotal experience, the femtosecond laser–assisted
anterior capsulotomy is indeed more likely to tear than a
manual continuous curvilinear capsulorhexis. This resulted
in each surgeon adapting their surgical technique during
each of our learning curves, that is, not to overly stretch
the capsulotomy by removing large and dense fragments.
This is in turn facilitated by predictable capsulotomy and
lens fragmentation sizes created by the femtosecond laser.
In contrast with other studies, we did not find that femto-
second laser–assisted cataract surgery resulted in more pre-
dictable refractive outcomes than CPS.1,8,26 Our overall
median absolute error (0.32 D for femtosecond laser–
assisted surgery and 0.29 D for CPS) and proportions
within G0.5 D and G1.0 D were similar between both
groups and in keeping with other studies in the literature
(Figures 5 and 6). However, in a subgroup analysis of this
same study, we have shown better outcomes with femto-
second laser astigmatic keratotomies compared with
manual limbal relaxing incisions.21
One more surprising result is that we did not realize the
reduction in phacoemulsification energy (cumulative dissi-
pated energy [CDE]) previously reported with femtosecond
laser–assisted cataract surgery (9.6 G 7.0) compared with
CPS (11.1G 9.8) (PZ .08). This was a nonsignificant result,
although perhaps our preference for segmentation of the
cataract rather than fragmentation into cubes might have
been a factor. Two studies34,35 have demonstrated reduced
ultrasound energy with femtosecond laser–assisted cataract
surgery but with using either a grid pattern or segmentation
with multiple concentric cylinders. Shajari et al.36 recently
published their findings that CDE was reduced with the
grid pattern compared with the segmentation pattern,
which was our preferred technique. It follows, therefore,
that the grid pattern softens the nucleus and permits more
phacoaspiration, reducing CDE, in comparison with a seg-
mentation pattern, which requires a nuclear disassembly
technique resembling a divide-and-conquer procedure.
Previous studies have indicated that incorporating a
femtosecond laser can have a negative impact on productiv-
ity, which can largely be attributed to transfer time between
Table 7. Postoperative events.
Parameter
Number of Events (%)
P Value
Femtosecond Laser–
Assisted Cataract Surgery CPS
Corneal edema 4 (2) 2 (1) .69
Return to OT on day 1 for suspected vitreous in AC 0 1 (0.5) 1.0
CME 4 (2) 3 (1.5) 1.0
Prolonged anterior uveitis* 2 (1) 0 .50
Steroid response/postop raised IOP 2 (1) 0 .5
Return to OT for residual soft lens matter in bag 1 (0.5) 0 1.0
Suture abscess 0 1 (0.5) 1.0
Hypotony 0 1 (0.5) 1.0
Suprachoroidal hemorrhage 0 1 (0.5) 1.0
Total 11 (6.5) 5 (2.5) .20
AC Z anterior chamber; CME Z cystoid macular edema; CPS Z conventional phacoemulsification surgery; IOP Z intraocular pressure; OT Z operating
theater
*Both patients were randomized to the femtosecond laser–assisted group but one received CPS
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the laser and the surgical bed.37–39 Although we did not
directly measure this transfer time, we have reported on
the hub-and-spoke model we used for the femtosecond
laser service and found that this resulted in marginal gains
in productivity in the femtosecond laser–assisted group.40
The limitations of this study include that many clinical
outcomes were evaluated leading to an increased risk for
type 1 statistical errors. Furthermore, RCTs are often
underpowered for safety, and complications in cataract sur-
gery are fortunately rare (making it harder to meaningfully
evaluate). For example, one patient randomized to femto-
second laser–assisted surgery sustained a suprachoroidal
hemorrhage. A case of suprachoroidal hemorrhage with
femtosecond laser–assisted cataract surgery has been re-
ported in the literature; however, at present, it is not known
whether supraphysiological vacuum applied to the globe
further increases the risk for this rare but potentially devas-
tating complication.41 The sample size required to test for
such rare complications would be unfeasibly large.
This RCT compares the clinical outcomes of femto-
second laser–assisted cataract surgery and CPS and con-
firms, in the majority, the nonsignificant differences
between the 2 treatment modalities in terms of visual,
refractive, and a range of other clinical and patient-
reported outcomes, while suggesting a higher rate of poste-
rior capsule tears after conventional phacoemulsification.
WHAT WAS KNOWN
" Metaanalyses of several small RCTs showed little overall
differences in visual and refractive outcomes between
femtosecond laser–assisted cataract surgery and CPS.
" Little was known about whether a difference existed
regarding PROMs after femtosecond laser–assisted cata-
ract surgery or CPS.
WHAT THIS PAPER ADDS
" This was the largest RCT to date to demonstrate non-
significance in clinical outcomes and PROMs between
femtosecond laser–assisted cataract surgery and CPS.
" Femtosecond laser–assisted cataract surgery might reduce
the risk for posterior capsular rupture.
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ABSTRACT
Aims To test a hypothesis that cataract operating room 
(OR) productivity can be improved with a femtosecond 
laser (FL) using a hub-and-spoke model and whether 
any increase in productivity can offset additional costs 
relating to the FL.
Methods 400 eyes of 400 patients were enrolled 
in a randomised-controlled trial comparing FL-
assisted cataract surgery (FLACS) with conventional 
phacoemulsification surgery (CPS). 299 of 400 
operations were performed on designated high-volume 
theatre lists (FLACS=134, CPS=165), where a hub-and-
spoke FLACS model (1×FL, 2×ORs=2:1) was compared 
with independent CPS theatre lists. Details of operative 
timings and OR utilisation were recorded. Differences 
in productivity between hub-and-spoke FLACS and 
CPS sessions were compared using an economic model 
including testing hypothetical 3:1 and 4:1 models.
Results The duration of the operation itself was 
12.04±4.89 min for FLACS compared with CPS of 
14.54±6.1 min (P<0.001). Total patient time in the 
OR was reduced from 23.39±6.89 min with CPS to 
20.34±5.82 min with FLACS (P<0.001)(reduction 
of 3.05 min per case). There was no difference in OR 
turnaround time between the models. Average number 
of patients treated per theatre list was 9 for FLACS 
and 8 for CPS. OR utilisation was 92.08% for FLACS 
and 95.83% for CPS (P<0.001). Using a previously 
established economic model, the FLACS service cost 
£144.60 more than CPS per case. This difference would 
be £131 and £125 for 3:1 and 4:1 models, respectively.
Conclusion The FLACS hub-and-spoke model was 
significantly faster than CPS, with patients spending 
less time in the OR. This enabled an improvement in 
productivity, but insufficient to meaningfully offset the 
additional costs relating to FLACS.
INTRODUCTION
Over the past decade, femtosecond lasers (FLs) 
have been introduced into the field of cataract 
surgery to try to automate the procedure and 
more importantly improve both efficacy and 
safety.1 Multiple prospective case series have been 
published which appear to support its potential in 
cataract surgery and more surgeons are adopting 
this new technology.1–6 A recent Cochrane review 
of 16 randomised-controlled  trials (RCTS) 
including 1638 eyes concluded, ‘There is currently 
not enough evidence to determine the benefits and 
harms of laser-assisted cataract surgery compared 
with standard ultrasound cataract surgery. The 
evidence is uncertain because current studies have 
not been large enough to provide a reliable answer 
to this question’.7 
Until good quality evidence is available describing 
better clinical outcomes, it is not possible to 
currently support the widespread introduction of 
FL-assisted cataract surgery (FLACS) within public 
healthcare organisations such as the National 
Health Service (NHS). This is especially pertinent 
as by the very nature of its complex technology, 
FLACS has significant associated financial costs, 
including initial purchase costs of the laser itself, 
servicing, depreciation and the individual patient 
interfaces (PI). These costs seriously question its 
financial viability, especially in healthcare systems 
funded by the state. In addition, current published 
studies with FLACS report increased total surgical 
time and therefore reduced patient turnover and 
productivity.8–10 This is because the operating 
surgeon in these studies is typically performing both 
the FL treatment and the subsequent lens extraction 
within the operating room (OR). This reduction in 
productivity is highly important within the public 
health sector, where high-volume surgical models 
are necessary to meet the both the increasing 
numbers of patients requiring cataract surgery and 
economic limitations. It is of note that the current 
published literature on the economics of FLACS 
mainly originates from healthcare systems within 
the private sector, where supplementary costs of 
advanced technologies may to a certain extend be 
passed onto the patient in the form of a copayment 
system.8 However, even in such healthcare models, 
the literature advocates that FLACS at this time is 
not cost-effective.8
Despite these considerations, FLACS does offer 
the promise to automate a number of the compo-
nent parts of cataract surgery so that they do not 
need to be undertaken by an appropriately trained 
ophthalmic surgeon within the OR. Surgical steps 
such as corneal incisions, arcuate keratotomies, 
capsulotomies and nuclear lens division can be 
undertaken with FL by a doctor in training or suit-
ably accredited and trained nurse/technician in a 
clean room. This has the potential to reduce the 
amount of time each individual patient spends in 
the OR with the ophthalmic surgeon. As a result, the 
efficiency of cataract surgery might be improved by 
increasing the number of surgical cases undertaken 
in a given time period. This potential efficiency is 
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increased if a ‘hub-and-spoke’ model is used, with a single FL 
treating and then feeding patients into several ORs for comple-
tion of surgery. Potentially, if the number of cases per theatre 
session can be increased sufficiently, then the additional costs 
associated with FL technology might be offset. In a previous 
publication, we have previously explored this possibility using 
a hypothetical model based on real-world financial data.11 We 
reported that in order to break even, there would need to be, for 
example, a 43% increase in the number of operations performed 
per theatre list accompanied by a need to discount the cost of the 
PIs by at least 52% by the manufacturers.2
As yet, there are no publications looking at the efficacy, 
safety and additionally the economics of FLACS compared 
with conventional phacoemulsification surgery (CPS), within 
a ‘hub-and-spoke’ model, as described above, in a real-world 
public health sector setting, where both trainee and fully 
accredited surgeons undertake surgery, with all the constraints 
that can be associated with the Public Health Sector, such as 
limited financial resources, OR space and resistance to change 
in formalised working practices. In order to investigate some of 
these issues, we undertook an RCT comparing FLACS with CPS, 
in which we delivered our FLACS service using a hub-and-spoke 
model. Surgeries were performed by three cataract surgeons of 
differing levels of experience (one fully accredited with 20 years' 
experience, one newly accredited and one specialist registrar). 
Box 1 Inclusion and exclusion criteria for enrolment into 
the study
Inclusion criteria
 ► Patients must have reduced visual acuity or visual symptoms 
attributed to the presence of cataract in one or both eyes by 
the examining ophthalmologist or else must require cataract 
surgery on clinical grounds other than visual symptoms.
 ► Patients must be willing to attend for follow-up at 3–4 weeks 
after cataract surgery.
 ► Patients must have sufficient English language for informed 
consent and completion of the patient reported outcome 
questionnaires.
Exclusion criteria
 ► Children below the age of 18 years
 ► Patients already enrolled in another study
 ► Clinical contraindications for femtosecond laser-assisted  
cataract  surgery, such as
 – Significant corneal opacities
 – Small pupils (<4 mm) following pharmacological  
dilatation
 – Patients unable to lie sufficiently flat so as to be positioned 
underneath the laser machine.
Figure 1 St Thomas’ Hospital’s ‘hub-and-spoke’ model for femtosecond laser-assisted  cataract surgery.
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Two hundred and ninety nine of the 400 cases were performed 
on designated high-volume theatre lists, where a hub-and-spoke 
FLACS model (with one FL and two ORs) was compared with 
independent CPS theatre lists. Details of operative timings and 
OR utilisation within these lists were recorded. Our aims were 
to provide the best quality evidence to date on whether FLACS 
can improve productivity in cataract surgery in the public health 
sector while maintaining safety and efficacy and what models of 
FLACS delivery might offset its associated addition costs.
METHODS
Randomised controlled trial
This analysis of relative productivity of FLACS delivered by 
hub-and-spoke model versus CPS was performed as a secondary 
outcome of a prospective randomised interventional case-con-
trolled study at a single University Hospital (Guy’s & St Thomas’ 
Hospital NHS Foundation Trust, London, UK) to compare the 
clinical outcomes of FLACS with CPS ( Clinicaltrials. gov registra-
tion number NCT02825693). This study adhered to the tenets 
of the declaration of Helsinki.
Patients were screened, recruited and consented from routine 
cataract clinics by members of the trial team (HR, VW) as per 
the trial protocol (V.2.0, 18 May 2016) (box 1).
Cataract surgery delivery models
General model, staff duties and patient flow
Cataract operations were performed during 4-hour theatre 
sessions. Patients for cataract surgery were admitted on a stag-
gered arrival basis to an ophthalmic day care unit (ODCU) which 
staffed by a receptionist and a mixture of ophthalmic technicians 
(OTs) and ophthalmic nurses (ONs) (table 4).
After electronic registration by the receptionist, the patients 
were prepared for the OR by the ON/OTs. This included a series 
of medical observations, such as blood pressure and blood sugar 
(if diabetic), and administration of mydriatic therapy. Mydri-
atic therapy used in this study included a Mydriasert implant 
(Thea Laboratories, Clermont-Ferrand, France) and two drops 
of topical diclofenac sodium 0.1% to reduce the risk of intraop-
erative miosis.12 13 The ward ON/OTs brought and collected the 
patients to and from the OR, which were adjacent to the ODCU, 
after being telephoned by one of the OR theatre nurses (TNs). 
After surgery was completed, the ON/OTs performed further 
medical observations, gave advice about aftercare, dispensed 
medication, discharged the patients and arranged follow-up.
Patients were treated on either all-FLACS or all-CPS theatre 
lists. All cataract operations were performed under local anaes-
thetic. All were unilateral and no other additional procedures 
Figure 2 CONSORT flowchart of participant numbers through the study. FLACS, femtosecond laser-assisted cataract surgery .
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planned, other than arcuate keratotomies for reduction of 
corneal astigmatism.
The duties of the ophthalmologist inside the OR included 
helping positioning the patient on the operating table, the 
scribing of patient details onto the whiteboard, the removing of 
the Mydriasert implant, the marking of the forehead above the 
eye for cataract surgery prior to the WHO checklist,14 scrub-
bing and gowning, leading the WHO checklist, preparation and 
draping of the eye for surgery, operating, writing the operation 
notes and scanning the paper WHO checklist into the hospital’s 
electronic patient record software.
FLACS hub-and spoke delivery model
FLACS theatre lists were run as a hub-and-spoke model (figure 1). 
A LenSx FL (Alcon, Fort Worth, Texas, USA) was installed in the 
anaesthetic room of one of the ORs, hereafter referred to as the 
laser suite (LS), and was used to feed patients into two adjacent 
ophthalmic ORs which were running in parallel. The FL was 
operated by an ophthalmologist (HR, VW). The model required 
an additional OT who supervised patients waiting in the corridor 
outside the LS (table 4). There was a maximum of four patients 
seated in the theatre corridor at any one time (two patients 
waiting for laser treatment, two patients waiting to enter OR). In 
the FLACS model, the ophthalmologist performing the FL treat-
ment was responsible for marking the patients’ eyes before laser, 
delivering laser treatment, removing the Mydriasert implant and 
instilling additional topical phenylephrine 10%. Performing laser 
treatment included preparing the PI, entering patient details into 
the FL, selecting the planned treatment profile, positioning the 
patient on the laser bed, instilling topical anaesthetic in to the 
operative eye, inserting the lid speculum, docking the PI to the 
eye, performing optical coherence tomography of the anterior 
segment, choosing the treatment parameters and delivering the 
laser treatment. If completion of FL treatment was not possible 
for any reason, this and the reason why was recorded and the 
patient proceeded to the OR for CPS.
The number of patients booked to each 4-hour theatre list 
was decided in advance of each theatre list. The intention was 
to attempt to always maximise the number of patients treated 
during the allotted theatre time with reference to the levels of 
nursing and paramedical staffing. Initial targets were chosen 
based on existing experience of CPS and FLACS at our institu-
tion and titrated as the trial progressed, according to whether 
theatre lists were finishing early or overrunning.
OR timings
Two hundred and ninety nine of the 400 cases were performed 
on designated high-volume theatre lists, where patients were 
randomised to either hub-and-spoke FLACS model (with one FL 
and two ORs) or CPS only theatre lists. Various timings of OR 
utilisation were undertaken by a TN and included the time taken 
for the patient to enter the OR, duration of cataract surgery, 
time taken for the patient to exit the OR after completion of 
surgery, the total individual patient time in the OR, the time 
the OR was empty between patients, overruns and underruns of 
allotted OR time, and so on.
Timings of patient entry to the OR, start of operation, end of 
operation and patient exit from the OR were recorded contem-
poraneously by TNs using the existing theatre management 
software (Galaxy Theatre Management System, iSOFT, DXC 
Technology, Virginia, USA). Accuracy of timings was ensured by 
Table 1 Demographics of patients included and excluded from the hub-and-spoke model analysis demonstrating equivalence between the two 
groups
High-volume theatre list participants
Patients not treated on designated high-
volume theatre lists P value
Male/female 140/159 41/60 0.30
First eye/second eye 243/56 87/14 0.29
Right eye/left eye 164/135 55/46 1
Age (years) 69.45±10.81 72.42±8.6 0.01
Preoperative best-corrected distance visual acuity (logMAR) 0.60±0.51 0.51±0.36 0.10
Spherical equivalent refractive error dioptrer (D) −0.50±4.32 −0.38±3.52 0.80
Axial length (mm) 23.78±1.39 23.67±1.56 0.51
Anterior chamber depth (mm) 3.27±0.38 3.10±0.55 <0.01
Average predicted PCR risk18 1.63%±1.24% 1.63%±0.71% 1
PCR, posterior capsular rupture.
Table 2 Patient demographics for the two treatment arms
FLACS CPS P value
Male/female 62/72 78/87 0.90
First eye/second eye 111/23 132/33 0.55
Right eye/left eye 70/64 94/71 0.42
Age (years) 69.07±11.55 69.78±10.14 0.57
Preoperative best-corrected distance 
visual acuity (logMAR)
0.65±0.52 0.57±0.50 0.18
Spherical equivalent refractive error 
dioptrer (D)
−0.58±5.34 −0.42±3.15 0.75
Axial length (mm) 23.99±1.44 23.60±1.33 0.02
Anterior chamber depth (mm) 3.31±0.38 3.23±0.37 0.07
Average predicted PCR risk18 1.64%±0.99% 1.62%±1.43% 0.89
CPS, conventional phacoemulsification surgery; FLACS, femtosecond laser-assisted 
cataract surgery; PCR, posterior capsular rupture.
Table 3 Staffing levels associated with delivery of hub-and-spoke 
FLACS and CPS services
FLACS (both ORs) CPS (both ORs)
ORs
Ophthalmologists 3 3
OR nurses 6.5 6.5
Ophthalmic day care unit
Ophthalmic technicians 3 2
Ophthalmic nurses 2 2
Receptionist 1 1
CPS, conventional phacoemulsification surgery; FLACS, femtosecond laser-assisted 
cataract  surgery; ORs, operating rooms.
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a trained observer (IM). Timings of patient entry and exit from 
the LS were recorded by the ophthalmologist performing the 
laser treatment. Start of operation and end of operation were 
defined as application of antiseptic solution to the eye and skin, 
and removal of eyelid speculum. Because of the nature of the 
surgery, it was not possible to mask any of the surgical team to 
the treatment arm.
Economic model
The results from this were used as inputs for a hypothetical 
economic model, reported in a previous publication, to deter-
mine an estimation of the costs of cataract surgery.11 This finan-
cial model has been described in greater detail in the previous 
publication but was based on averaged costs/values from five 
different NHS foundation trusts and four FL manufacturers. 
This model was used to provide an estimation of the difference 
in cost per case of running a FLACS service as compared with a 
traditional cataract service. Furthermore, if the results supported 
that a hub-and-spoke model could be run with more than two 
ORs, these iterations were also tested using the model.
Statistics
For the purposes of this study, the first two CPS and FLACS 
theatre lists each were excluded from analysis as they were sched-
uled with reduced patient numbers in order to allow theatre staff 
to familiarise with the models. The final four theatre sessions 
of the study were run as mixed lists in order to facilitate the 
scheduling of the remaining research participants and to avoid 
underused theatre sessions. These final mixed lists were also 
excluded from analysis.
The primary outcome as per the study protocol was the rela-
tive costs of FLACS and CPS. However, in light of inherent 
difficulties in accurate recordings of costs within a large tertiary 
ophthalmology service, it was determined that this would be 
replaced with the number of cases on FLACS and CPS lists 
and the duration of the operations. This current study of 299 
patients had a power of 99% to detect an effect size (d) of 0.5 for 
the numbers of participants included in this analysis with regard 
to duration of surgery with α=0.05 and a two-tailed analysis.
Baseline characteristics were summarised for each treatment 
arm. Results were analysed primarily as per intention to treat. 
Continuous data were reported using means and SD if data 
appear Gaussian, or medians and IQR if not. Binary data were 
reported as frequencies and percentages and evaluated with 
Fischer’s exact test. Student’s t-tests were used for parametric 
data and the Mann-Whitney U test for non-parametric. All statis-
tical tests used a two-sided P value of α=0.05 unless otherwise 
specified. Intraoperative complications were defined as any 
event that involved unintentional trauma to an ocular structure, 
requiring additional treatment or having a negative effect on 
participants' eyesight.
RESULTS
A total of 427 patients (427 eyes) were recruited for the study 
and randomised to receive FLACS or CPS. Twenty seven were 
excluded or withdrew in advance of surgery. For the purpose 
of this study comparing FLACS in a hub-and-spoke model with 
dual CPS theatre lists, 299 of 400 operations were included for 
analysis (figure 2). Excluded patients included 57 patients who 
had surgery on the first two of each theatre sessions for FLACS/
CPS and 44 patients treated on mixed (CPS and FLACS) theatre 
lists. There were no significant differences between patients 
included and excluded for this analysis other than those excluded 
were on average 3 years older (P=0.01) and had shallower ante-
rior chambers by 0.17 mm (P<0.01) (table 1). Of the 299 eyes 
included in this analysis, 134 patients had received FLACS and 
165 patients underwent CPS. Baseline demographics for the 
FLACS and CPS groups are seen in table 2. The only significant 
difference at baseline was the FLACS group had a longer axial 
length by 0.39 mm (P=0.02). Five patients due to receive FLACS 
were treated with CPS due to the following reasons: palpebral 
aperture too narrow for PI (n=3, 2.2%), patient lack of compli-
ance (n=1, 0.7%) and administrative error (n=1, 0.7%).
The 139 patients undergoing FLACS were treated during eight 
hub-and-spoke sessions, involving 16 4-hour theatre sessions. 
The 160 patients randomised to CPS were treated on 20 cata-
ract theatre lists. The average OR utilisation of a hub-and-spoke 
session was 221±21 min (92.05%±8.71) with a median of nine 
patients treated in each OR, while the average duration of a CPS 
list was 230±22 min (95.81%±9.17) (P<0.001) with a median 
of eight patients treated per list. Patients receiving FLACS spent, 
a mean time of 5.85±1.99 min in the LS. Twenty-five per cent of 
FLACS theatre sessions overran the allotted 4 hours compared 
with 30% of CPS lists. Average theatre overrun was 5±2.16 min 
for FLACS and 13.67±8.76 min for CPS (P=0.09).
Staffing levels for both models can be seen in table 3. The 
hub-and-spoke model required one additional OT to be present 
compared with the CPS. A comparison of the average times asso-
ciated with each operation can be seen in tables 4 and 5.
Complications
The overall rate of intraoperative complications was similar 
between the two groups 3.54% vs 3.76%; however, there was 
Table 4 Comparison of OR timings (in minutes) between hub-and-
spoke FLACS and CPS based on intention-to-treat analysis
FLACS (n=139) CPS (n=160) t test (P value)
Time from entering OR to 
start of operation
5.83±2.58 6.25±2.91 0.19
Duration of operation 12.04±4.89 14.54±6.19 <0.001
Time from end of operation 
to exiting OR
2.47±0.66 2.6±1.02 0.20
Total time in OR 20.34±5.82 23.39±6.89 <0.001
OR empty 5.27±3.25 5.23±3.28 0.92
CPS, conventional phacoemulsification surgery;  FLACS, femtosecond laser -assisted 
cataract  surgery; OR, operating room.
Table 5 Comparison of OR timings (in minutes) between hub-and-








Time from entering 
OR to start of 
operation
5.82±2.62 6.24±2.87 0.19 6±1.58
Duration of operation 11.73±3.53 14.71±6.76 <0.001 20.40±17.87
Time from end of 
operation to exiting 
OR
2.47±0.66 2.59±1.02 0.24 2.4±0.89
Total time in OR 20.2±4.59 23.55±7.47 <0.001 28.8±19.33
OR empty 5.79±3.9 5.27±3.25 0.21 6.4±1.95
CPS, conventional phacoemulsification surgery; FLACS, femtosecond laser-assisted 
cataract surgery;  OR,  operating room . 
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a noticeable difference in the rates of vitreous loss (0% with 
FLACS compared with 1.88% in CPS) (table 6).
Economic modelling
Based on our OR timings, using a hub-and-spoke model, we 
achieved a mean reduction of total time in the OR per patient 
of 3.05 min. This allowed us to undertake one extra FLACS 
case per 4-hour theatre list compared with our CPS only lists. 
The average number of cases on using our operative models 
was 8 for CPS and 9 for FLACS, which represented an average 
12.5% increase in productivity. We applied these results to our 
economic model. Based on these results, the average cost for 
each cataract operation was £355.42 for CPS and £500.02 for 
FLACS (figure 3).
A bivariate sensitivity analysis examining the number of cases/
week and the cost of the PI was performed, reporting the addi-
tional cost per case of a FLACS service (table 7).
3:1 and 4:1 hub-and-spoke model
Although the duration of FL application to the eye is usually 
between 25 and 45 s, patient time inside the laser room was 
5.85±1.99 min. In our model, the laser operator is an ophthal-
mologist working unassisted, and therefore the majority of time 
spent is on preparing the patient and setting up the laser. Based 
on our results, we recommend that the maximum number of 
ORs which could be run (in order to maximise the utility of an 
FL) in a hub-and-spoke model would be 4 (average total patient 
time in OR +turnaround time 25.12±5.25 min). Adding a third 
OR to our economic modelling of the costs of cataract surgery 
reduced the cost per case from £500.02 to £477.28 and adding 
a fourth reduced it to £465.91. Performing the same bivariate 
analyses on a 3:1 and 4:1 hub-and-spoke models as above shows 
that the difference in cost could be reduced further if the hospital 
was performing greater numbers of cataract surgery and received 
a significant discount in the cost of the PI from the manufacturer 
(table 8). However, in order to break even, our financial model-
ling shows the manufacturers would need to offer between 78% 
and 99% discount on the cost of the PIs (table 9).
Cases unable to undergo FLACS
Five (3.6%) patients randomised to FLACS did not receive FL 
treatment. This is consistent with reported rates of unsuccessful 
attempts at FLACS between 2.3% and 6.3%.15–17 In our experi-
ence, the most common reason was that the palpebral aperture 
was too narrow to permit the 16 mm PI to applanate with the 
cornea. Four of these patients underwent uneventful CPS, with 
one suffering a suprachoroidal haemorrhage. This patient was 
considered at increased risk for this rare complication with an 
axial length of 19.66 mm.
DISCUSSION
We have conducted a large RCT comparing FLACS with CPS 
by reporting the clinical outcomes and testing the efficiency of 
FL-centric methods of running cataract theatre lists. When FLACS 
is performed within traditional models featuring one surgeon, 
or installing the FL in the OR, productivity may be adversely 
affected, leading to incurring additional indirect costs.8–10 This is 
because the duration of the patient’s experience is increased with 
FLACS compared with CPS (time in OR+LS=26.05 for FLACS 
vs 23.55 for CPS). Evaluating new models of delivering cataract 
surgery (such as a hub-and-spoke model) within a RCT, where 
patients are prospectively randomised to CPS or FLACS, allows 
us to test the model within a rigorous framework, rather than 
performing a case–control study where bias may be inherent.
Table 6 Incidence of complications between the two treatment arms based on intention-to-treat analysis
Complications FLACS CPS RR P value
Anterior capsular tear 3 (2.16%) 3 (1.88%) 1.15 (95% CI 0.24 to 5.6) 0.86
Posterior capsule tear with vitreous loss 0 (0%) 3 (1.88%) 0.16 (95% CI 0.01 to 3.15) 0.23
DM tear 1 (0.72%) 0 (0%) 3.45 (95% CI 0.14 to 84.0) 0.45
Suprachoroidal haemorrhage 1 (0.72%)* 0 (0%) 3.45 (95% CI 0.14 to 84.0) 0.45
Abandoned-extreme zonular weakness 0 (0%) 1 (0.63%) 0.38 (95% CI 0.01 to 9.34) 0.56
Total complication rate 3.54% 3.76% 0.95 (95% CI 0.30 to 3.07) 0.94
*This patient was allocated to FLACS but was unable to undergo this procedure and the patient underwent CPS.
CPS, conventional phacoemulsification surgery; DM, Descemet's membrane; FLACS, femtosecond laser-assisted cataract surgery; RR, relative risk.
Figure 3 Comparison of weekly costs of FLACS vs CPS services. CPS, conventional phacoemulsification surgery; PES, phacoemulsification surgery; 
FLACS, femtosecond laser-assisted cataract surgery; ODCU, ophthalmic day care unit.  
group.bmj.com on February 15, 2018 - Published by http://bjo.bmj.com/Downloaded from 
7Roberts HW, et al. Br J Ophthalmol 2018;0:1–8. doi:10.1136/bjophthalmol-2017-311319
Clinical science
By deploying an FL in the anaesthetic room adjacent to the OR 
and using a hub-and-spoke model, we have found that surgical 
time and patient time in OR are shorter for FLACS than CPS. 
Transferring some of the surgical steps into the LS reduces patient 
time in OR by 3.05 min for FLACS (P<0.001) led to an average 
of one extra operation per OR operating list of FLACS (median 
nine cases per list) than CPS (median eight cases per list), resulting 
in a 12.5% improvement in productivity (overall two more oper-
ations per session). Furthermore, despite the additional cases, the 
FLACS lists were shorter than the CPS lists, and more CPS sessions 
overran. Our method of titrating the numbers of patients sched-
uled for surgery to maximise the number of operations within the 
4-hour session resulted in extremely high levels of OR utilisation. 
Our ambition resulted in a number of theatre sessions overrun-
ning (25% FLACS vs 30% CPS), especially when unforeseen 
complications had occurred. Theatre list overruns may incur finan-
cial penalty at some NHS/public hospitals; however, our greater 
concern was to test the limits of our models.
There were some differences between the 299 patients included 
for this analysis and the 101 excluded, namely that the excluded 
group were 3 years older on average, with a corresponding shal-
lower anterior chamber depth (ACD) by 0.17 mm. It is unlikely 
that these differences are clinically significant and would have had 
a material effect on the timings of the theatre list.18 Importantly, 
the prospectively calculated risk of posterior capsular rupture 
(PCR) was equivalent between the two groups.
The mean time of each patient undergoing patient preparation 
for FL and FL application was 5.85±1.99 min. Based on such 
results, it is easily possible to have a hub-and-spoke model of one FL 
feeding into three or four ORs (4:1 or 3:1) rather than two (2:1). 
We recommend that the ideal number of ORs to maximise the 
utility of an FL in a hub-and-spoke model would be 4 (average total 
time per patient in OR +turnaround 25.12±5.25 min). We predict 
that this would result in three or four more operations performed 
overall by the FLACS model per session (one for each OR).
Potential issues of having a 3:1 or 4:1 model to attempt to use an 
FL as a tool for high-volume surgery is that this requires a suitable 
and dedicated room within theatres and multiple ORs. This limits 
the use of such a model to an institution with such facilities already 
in place or a purpose-built unit (thus incurring additional costs). For 
instance, with a maximum of two eye ORs at our institution we are 
not able to evaluate adding additional ORs to our existing hub-and-
spoke model. It is important to incorporate any development costs 
in the planning process if deciding whether to adopt this technology.
In order to minimise costs of running the hub-and-spoke model, 
it is important to minimise the additional number of staff needed. 
Our model required two additional members of staff, one ophthal-
mologist to operate the laser and one OT to chaperone the patients 
between the LS and ORs. For our CPS lists, the extra OT was not 
present; however, there were three ophthalmologists between the 
two ORs. This may have improved the efficiency of the CPS lists 
in our study to a degree by allowing the surgeons to rotate. The 
cost of the third surgeon was included in the financial modelling 
for the CPS model so as not to bias the model further in favour of 
CPS. In the FLACS model, it was also possible to permit surgeon 
rotation between the ophthalmologists performing laser and oper-
ating, thus possibly reducing the risk of surgeon fatigue during 
high-volume cataract surgery.
In a previous publication we performed hypothetical financial 
modelling of hub-and-spoke delivered FLACS. Using a 2:1 model, 
we found using bivariate sensitivity analyses that a 43% improve-
ment in productivity would need to be achieved and accompanied 
by a 52% discount on the PI for the service to break even. This 
improvement in productivity was not realised by our study with a 
time saving of 3 min per patient (in the OR). The financial model 
demonstrates that the PI is the single most expensive item for the 
FLACS service. However, thus far FL platforms have tended to 
be used, and marketed as a premium product (based on reported 
improved refractive outcomes and stability).19 However, it is very 
likely that a public healthcare service may be able to negotiate 
discounts on the costs of FLACS, especially if used within a high-
volume service (which further improves affordability) (tables 7 and 
8). Further cost savings may be made by improved safety which may 
make cost savings in postoperative management.20 It is important 
to note therefore that while there was no difference in PCR and 
vitreous loss rates in this arm of this study to investigate comparative 
Table 8 Bivariate sensitivity analyses demonstrating the additional 
cost of FLACS compared with CPS within a theoretical 3:1 and 4:1 
hub-and-spoke FLACS model when the cost of the patient interface 




Number of operations performed per week
40 60 80 100
3 : 1 model 
  40 £33.40 £24.65 £20.28 £17.65
  70 £63.40 £54.65 £50.28 £47.65
  100 £93.40 £84.65 £80.28 £77.65
  130 £123.40 £114.65 £110.28 £107.65
4 : 1 model 
  40 £26.84 £18.10 £13.72 £11.10
  70 £56.84 £48.10 £43.72 £41.10
  100 £86.84 £78.10 £73.72 £71.10
  130 £116.84 £108.10 £103.72 £101.10
CPS, conventional phacoemulsification surgery; FLACS, femtosecond laser-assisted 
cataract surgery. 
Table 9 Break even points for hub-and-spoke FLACS with CPS 
services calculated for the % discount of the PI based on the number 
of ORs concurrently run and the number of operations performed per 
year
% discount on 
cost of PI 
Number of cataract operations/year
2000 3000 4000 5000 6000
4:1 model 91 84 81 79 78
3:1 model 96 89 86 84 82
2:1 model n/a 99 95 93 92
CPS, conventional phacoemulsification surgery; FLACS, femtosecond laser-assisted 
cataract surgery; OR, operating room; PI, patient interface. 
Table 7 Bivariate sensitivity analysis comparing effects of cost of 
patient interface and number of operations performed per week on 





Number of cataract operations performed per week
20 40 60 80
40 £72.75 £46.51 £37.76 £33.39
70 £102.75 £76.51 £67.76 £63.39
100 £132.75 £106.51 £97.76 £93.39
130 £162.75 £136.51 £127.76 £123.39
CPS, conventional phacoemulsification surgery; FLACS, femtosecond laser-assisted 
cataract surgery .
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high-volume hub-and-spoke FLACS and CPS theatres lists (table 6), 
the results of the overall RCT showed a statistically significant reduc-
tion in PCR with FLACS, in a public health setting with different 
grade of surgeons operating, including those in training (H. Roberts, 
D. O’Brart, personal communication, 2018). As such complications 
incur additional costs, if our findings with respect to PCR rates are 
replicated by others, then our economic modelling might be more 
favourably inclined towards a FLACS hub-and-spoke model.
A previous time and motion study (TMS) investigating the effects 
of number of allied health professionals (AHPs) assisting in cataract 
theatre lists on the overall productivity showed a marked difference 
in the number of cataract surgeries performed between different 
institutions. Furthermore, a minimum of four AHPs may be 
required to deliver high-volume cataract surgery with effective 
use of theatre time and minimum delays.21 Our cataract ORs are 
generally run with three AHPs, which precludes further increases 
in productivity, which is evident in our turnaround time compared 
with other surgical units. The average time between one operation 
finishing and the start of the next was 13.57 and 14.08 min for 
FLACS and CPS, respectively, meaning that only between 47.0% 
and 50.8% of OR time is spent engaged in surgery. Our previous 
TMS showed that patient turnover in NHS units with four AHPs 
present can be reduced to 5.4 min from one operation ending to 
the next starting. Including one additional AHP per OR to our unit 
(at a cost of £70 per session) to facilitate patient turnover could 
provide a similar overall time saving as this FL technology.
Limitations
We chose to consider the productivity difference in terms of 
number of operations per OR and found a 12.5% improvement in 
FLACS. However, other methods of assessing productivity could 
have been chosen (eg, number of cases per surgeon). However, 
there are usually an abundance of cataract surgeons in a depart-
ment compared with theatre time and space, making this more of 
a limiting factor. We did not incur any infrastructure costs in the 
installation of the laser into the anaesthetic room and so are unable 
to provide a representation of infrastructure costs into our model. 
We understand however that other surgical units have incurred 
significant costs during the installation of an FL, so this is an 
important consideration. The surgical team was not masked to the 
treatment arms and this may be associated with performance bias. 
Another potential source of bias is that we had to book patients to 
theatre lists preemptively; having a busier list may have improved 
productivity. Nevertheless, we aimed to combat this by a fair and 
transparent method of a run in period before the trial commenced 
to build experience with the model and titrating booking numbers 
depending on previous early finishes and overrunning. These 
potential biases may have been even more evident within a case–
control study, hence why an RCT methodology was preferred.
CONCLUSION
FLACS with a hub-and-spoke model was significantly faster than 
CPS, with patients spending less time in the OR. This enabled a 
slight improvement in productivity, but not sufficient to meaning-
fully offset the additional costs relating to FLACS. Further gains in 
productivity may have been achieved with a 3:1 or 4:1 hub-and-
spoke model.
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Refractive outcomes after limbal relaxing
incisions or femtosecond laser arcuate
keratotomy to manage corneal astigmatism
at the time of cataract surgery
Harry W. Roberts, MSc, FRCOphth, Vijay K. Wagh, MD, FRCOphth, Daniel L. Sullivan, MSc,
Timothy J. Archer, MA(Oxon), DipCompSci(Cantab), David P.S. O’Brart, MD, FRCS, FRCOphth, DO
Purpose: To compare the results of manual limbal relaxing
incisions (LRIs) performed during conventional phacoemulsifi-
cation surgery with those of nonpenetrating femtosecond
laser arcuate keratotomies performed during femtosecond
laser–assisted cataract surgery to manage corneal astigmatism.
Setting: Guy’s and St. Thomas’ NHS Foundation Trust, London,
United Kingdom.
Design: Randomized case-controlled trial.
Methods: This was a secondary outcome of a randomized
controlled trial comparing 400 patients treated with conventional
phacoemulsification surgery or femtosecond laser–assisted
cataract surgery. All patients with corneal astigmatism greater
than 0.9 diopter (D) were offered LRIs or femtosecond laser
arcuate keratotomy based on the original randomization.
Visual acuity, postoperative refraction, and corneal topography
were recorded 4 weeks postoperatively. Vector analysis was
performed using the Alpins method.
Results: Fifty-one eyes of 51 patients received LRIs, and 53
eyes of 53 patients received femtosecond arcuate keratoto-
mies. The mean target induced astigmatism was 1.50 D and
1.38 D, respectively, with 1.02 D and 1.23 D surgically induced
astigmatism (P Z .21), resulting in the femtosecond arcuate
keratotomy group having a smaller difference vector (1.17 D
versus 0.89 D; P Z .02) and a greater correction index (0.48
versus 0.73; P Z .02). Forty-four percent of patients in the
femtosecond arcuate keratotomy group and 20% in the LRI
group attained a postoperative cylinder of less than 0.50 D
(P Z .01).
Conclusions: The femtosecond arcuate keratotomy group
achieved a higher correction index and a smaller difference vector.
The femtosecond arcuate keratotomy patients showed less post-
operative cylinder than LRI patients.
J Cataract Refract Surg 2018; 44:955–963 Q 2018 ASCRS and ESCRS
Corneal astigmatism in patients having cataract sur-gery is common, with approximately 40% of pa-tients having more than 1.0 diopter (D) and 10%
more than 2.0 D of corneal astigmatism.1 Various tech-
niques have been introduced to decrease corneal astigma-
tism at the time of cataract surgery and thus reduce
postoperative spectacle dependence and maximize uncor-
rected distance visual acuity (UDVA). These include
on-axis incisions supplemented with opposite clear corneal
incisions if indicated, limbal relaxing incisions (LRIs),
femtosecond laser arcuate keratotomies, toric intraocular
lenses (IOLs), and refractive surgery after cataract surgery
(bioptics).2–6
Limbal relaxing incisions or femtosecond arcuate kera-
totomies have been found to be efficacious in the manage-
ment of low to moderate astigmatism (!2.5 to 3.0 D) but
are less suitable for moderate to high astigmatism, which re-
quires toric IOLs or bioptics.7,8 To our knowledge, there are
no trials comparing the effectiveness of LRIs with that of
femtosecond arcuate keratotomies in the management of
low-to-moderate corneal astigmatism at the time of cataract
surgery. The purpose of this study was to determine
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whether there are differences between laser-delivered and
manually delivered keratotomies using vector analysis.9–12
PATIENTS AND METHODS
This analysis of refractive outcomes of patients treated with LRIs
or femtosecond arcuate keratotomies was performed as a second-
ary outcome of a prospective randomized interventional
case-controlled study at Guy’s and St. Thomas’ Hospital NHS
Foundation Trust, London, United Kingdom. The study was
approved by local Research and Development and Cambridge
South Research Ethics Committee (reference 16/EE/0180). This
study adhered to the tenets of the Declaration of Helsinki.
Specific to this subgroup analysis, any patient with corneal
astigmatism greater than 0.9 D based on Scheimpflug tomography
(Pentacam, Oculus Optikger€ate GmbH) were offered LRIs or
femtosecond arcuate keratotomy as part of their cataract operation
based on the initial randomization. Eyes with previous refractive
or corneal surgery or corneal pathology were excluded. Partial
coherence interferometry (PCI) (IOLMaster 500, Carl Zeiss Med-
itec AG) was performed to obtain keratometry (K) measurements
for IOL formula calculation. Corneal astigmatism was measured
using Scheimpflug tomography, and the measurements were
used for preoperative astigmatism planning and postoperative
analysis. When biometry was not possible on PCI because of the
density of a cataract, A-scan ultrasound biometry (Carl Zeiss Med-
itec AG) was performed. All postoperative results were recorded at
the 4-week follow-up.
Surgical Technique
The methods of the study are described in the publication of the
main study findings.A Eyes were randomized to receive femto-
second laser–assisted cataract surgery or conventional phaco-
emulsification surgery. Manual limbal markings at 0 degree and
180 degrees were made on all eyes preoperatively with patients a
sitting position at the slitlamp. For the markings, a needle was
used scratch the corneal epithelium at the limbus; this was fol-
lowed by the use of a sterile marker pen.
Femtosecond laser–assisted cataract surgery was performed us-
ing the Lensx femtosecond laser (Alcon Surgical, Inc.). The femto-
second laser was used to create the capsulotomy and fragment the
lens in all patients and intrastromal femtosecond arcuate keratot-
omy was performed when appropriate. All cataract surgeries were
performed using local anesthesia. After the femtosecond laser
treatment, the patient was transferred to the operating room for
the remainder of the cataract extraction. Phacoemulsification
was performed using the Infiniti machine (Alcon Surgical, Inc.)
in both groups. Patients having conventional phacoemulsification
surgery were prepared for surgery in the same way as those in the
laser arm. Instead of receiving laser pretreatment, they were
brought straight to surgery and received LRIs at the start of the
cataract operation. All operations were performed by experienced
surgeons who had completed at least 30 femtosecond laser–
assisted cataract surgery procedures (H.W.R., V.K.W., D.P.S.O.).
Limbal Relaxing Incision Group Limbal relaxing incision param-
eters were calculated based on Donnenfeld’s nomogram via an on-
line software programB based on the K readings from the
Scheimpflug tomographer and the individual surgeon’s surgically
induced astigmatism (SIA) values. Target induced astigmatism
(TIA) was always aimed at 100% correction. Paired arcuate LRIs
were always performed; when the surgeon’s preference was to op-
erate on axis, the 2.4 mm main wound was positioned in the mid-
dle of the LRI. When anatomy or comfort dictated an off-axis
approach, the surgeon’s SIA was used to modify the LRIs.
A Mendez-style ring was used to mark the steep meridians at
the start of the surgery. The LRI incision was made before the
commencement of phacoemulsification using a 2.4 mm keratome
to incise through epithelium and Bowman layer. Next, a 600 mm
guarded diamond knife was used to incise through the stroma.
No corneal sutures were placed during the surgery.
Femtosecond Arcuate Keratometry Group Femtosecond arcuate
keratotomy parameters were determined by a nomogram previ-
ously reported by Day et al.7 The settings of the femtosecond laser
for the arcuate intrastromal incisions were also maintained.
Although this nomogram was intended to achieve up to 70%
correction only, for ease of interpretation of outcome data, the
TIA was defined as a 100% correction with no residual postoper-
ative corneal astigmatism. After the femtosecond laser was
docked, the horizontal meridian was manually adjusted in cases
of cyclorotation.13 In cases in which either of the arcuate keratot-
omies overlapped with the surgeon’s planned manual wound, the
main section was positioned more peripherally than the arcuate
keratotomy so that it would not be involved.
Statistical Analysis
Baseline characteristics were summarized for each treatment arm.
Results were analyzed primarily as per intention to treat. For all
evaluations of visual acuity as an outcome, patients with visually
significant ocular comorbidities were excluded prospectively and
those opting for a refractive target other than emmetropia were
excluded from analysis of refractive outcome. Snellen visual acu-
ities were converted to logarithm of the minimum angle of resolu-
tion notation for analysis.14 Comparative and descriptive
statistical analyses included the Fisher exact test, chi-square test,
and Student t tests. All statistical tests used a 2-sided P value of
a equal to 0.05 unless otherwise specified. Excel software (Micro-
soft Corp.) was used for data entry, analysis, and graphic represen-
tation. Intraoperative or postoperative complications were defined
as any event that involved unintentional trauma to an ocular struc-
ture, requiring additional treatment, or having a negative effect on
the patient’s eyesight.
Analysis of corneal astigmatic outcomes based on corneal
topography measurements before and after surgery was per-
formed using the Alpins method,9–11 with calculation of the 3
following vector parameters: TIA, SIA, and difference vector. Re-
sults are presented based on the standardized graphs for reporting
the outcomes of refractive surgery and IOL-based refractive sur-
gery.12,15 Additional parameters calculated included the correc-
tion index, coefficient of adjustment, magnitude of error, angle
of error, and index of success. The axis of the steep meridian
was used throughout.
RESULTS
Four hundred twenty-seven patients were recruited to the
study between August 2016 and June 2017 as per the inclu-
sion and exclusion criteria. Twenty-seven patients with-
drew from the trial before surgery. Four hundred eyes of
400 patients received surgery between November 2016
and June 2017 (200 conventional phacoemulsification sur-
gery; 200 femtosecond laser–assisted cataract surgery).
Fifty-one eyes of 51 patients in the conventional phaco-
emulsification group received LRIs, of which 8 were
excluded from the UDVA analysis because of visual comor-
bidities (6 age-related macular degeneration [AMD], 1
amblyopia, and 1 chronic central serous chorioretinop-
athy). Fifty-three eyes of 53 patients in the femtosecond
laser–assisted cataract surgery group received femtosecond
arcuate keratotomy, of which 9 were excluded for visual co-
morbidities (4 AMD, 2 amblyopia, 1 previous retinal
detachment, 1 vitreomacular traction, and 1 central retinal
vein occlusion).
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Table 1 shows the patients’ demographics and preopera-
tive values. At baseline, the corrected distance visual acuity
(CDVA) was statistically significantly worse (by 12 letters)
and axial length (AL) statistically significantly longer (by
0.7 mm) in the femtosecond group. Figures 1 and 2 show
the TIA and SIA single-angle vector plot. The SIA was
less than TIA in both groups, indicating undercorrection.
However, the femtosecond arcuate keratotomy corrected
more astigmatism than the LRI, as shown by the correction
indices (P Z .02) (Table 2). The difference vector was also
lower in the femtosecond arcuate keratotomy group
(P Z .02), indicating better correction (Table 2 and
Figures 3 and 4). Despite a greater SIA, higher correction
index, and lower difference vector in the femtosecond
group, there was not quite a statistically significant differ-
ence in the index of success (ratio of difference vector to
TIA) between the 2 groups (P Z .07). Figures 5 and 6
show the angles of error and the TIA versus SIA graphs.
Figures 7 to 10 show the 4 standard graphs for represen-
tation of refractive outcomes of cataract surgery. In both
groups, nearly 60% of patients (arcuate keratotomy 25/43;
LRI 24/41) attained their visual potential without requiring
refractive correction (Figure 8). Eight LRI patients (20%)
and 18 femtosecond arcuate keratotomy patients (44%) at-
tained a postoperative cylinder of less than 0.50 D (PZ .01)
and 18 patients (44%) versus 32 patients (74%) had less
than 1.00 D of cylinder (P Z .003) (Figure 10). The mean
corneal astigmatism was reduced from 1.38 G 0.40 D to
0.89 G 0.54 D in the femtosecond arcuate keratotomy
group and from 1.50 G 0.46 D to 1.17 G 0.69 D in the
LRI group (P Z .02). The postoperative refractive cylinder
was 0.90 G 0.50 D and 1.18 G 0.90 D, respectively
(P Z .05). The arithmetic mean of the angle of error was
very small in both groups, indicating neither group had
overall misalignment of treatment. However, the absolute
mean indicates a misalignment of 18 to 22 degrees
(P Z .28) (Table 2).
Femtosecond laser treatment was delivered successfully
in all cases. There was a complication relating to laser
delivery in 5 cases (9.4%) (corneal abrasion in 2 cases
[3.7%] and incomplete capsulotomy in 3 cases [5.6%]).
The femtosecond laser was not used to create any corneal
incision. In all cases, it was used for capsulotomy creation,
lens fragmentation, and arcuate keratotomy creation Lim-
bal relaxing incisions were performed in the conventional
phacoemulsification surgery group in all cases. None of
the femtosecond arcuate keratotomies or LRIs resulted in
complications, including posterior perforation or inadver-
tent placement. Intraoperatively, 2 patients in the femto-
second arcuate keratotomy group sustained an anterior
capsule tear and 1 patient had intraoperative floppy-iris
syndrome (IFIS). Two patients in the LRI group had IFIS
and 1 had iris prolapse/trauma. Postoperatively, no patient
in the LRI group had complications; 2 patients in the femto-
second arcuate keratotomy group had cystoid macular
edema and 1 had a steroid response leading to an intraoc-
ular pressure of 30 mm Hg at 4 weeks.
DISCUSSION
The femtosecond laser can perform, with reliability and
reproducibility, several steps of cataract surgery. These
include the creation of arcuate keratotomies, which are per-
formed to reduce corneal astigmatism at the time of sur-
gery. Although the effects of laser capsulotomy on IOL
centration and refraction as well as the effects of lens frag-
mentation on total phacoemulsification energy have been
reported, this is the first study to assess the efficacy of auto-
mated femtosecond arcuate keratotomies compared with
manual LRIs during cataract surgery. Both techniques
have been shown to be efficacious at reducing corneal astig-
matism but have not yet been directly compared.7,16
In this study, we used the femtosecond arcuate keratoto-
my nomogram originally described by Day et al.,7 notwith-
standing 2 important differences. First, we used a different
femtosecond laser platform and second, unlike the study of
Day’s group, in which the main incisions were consistently
temporal, we elected to perform our main incisions on axis
when possible (eg, accounting for surgical access). Using
Table 1. Preoperative patient demographics and baseline values.
Parameter LRI Femto AK P Value
Mean age (y) 72.5 G 10.5 69.7 G 12.0 .21
Female sex (%) 56.8 41.5 .24
Right eyes (%) 55.0 53.8 1.0
Mean CDVA (logMAR) 0.45 G 0.38 0.69 G 0.52 .01
SE refractive error (D)
Arithmetic mean 0.81 G 2.88 !1.40 G 4.51 .004
Absolute mean 2.69 G 2.48 3.25 G 3.24 .32
Cylindrical refractive error (D) !1.42 G 0.79 !1.34 G 0.99 .65
Axial length (mm) 23.56 G 1.37 24.26 G 1.69 .02
Mean corneal keratometry (D) 44.42 G 1.33 43.98 G 1.59 .13
Mean corneal astigmatism (D)* 1.50 G 0.46 1.38 G 0.40 .16
Summated vector mean 0.31 " 160 0.21 " 174 d
Means G SD
CDVA Z corrected distance visual acuity; corneal keratometry Z maximum keratometry; Femto AK Z femtosecond laser arcuate keratotomy;
logMAR Z logarithm of the minimum angle of resolution; LRI Z limbal relaxing incision; SE Z spherical equivalent
*Keratometry difference/target induced astigmatism vector
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this methodology, we found that femtosecond arcuate ker-
atotomy had a greater correction index than LRIs, indi-
cating that the SIA was 73% of the TIA (compared with
48% for LRIs). For analysis, the TIA in the femtosecond
arcuate keratotomy group was assumed to be a 100%
correction; however, the nomogram for femtosecond
arcuate keratotomy aims for a 70% correction to avoid
too many patients being overcorrected.7 Thus, the femto-
second AK was very accurate in what it aimed to deliver.
It might be assumed, therefore, that aiming for a 100%
correction with femtosecond arcuate keratotomy with on-
axis incisions might deliver better astigmatic correction
than our results and should be the subject of further clinical
studies and nomogram refinement.
Further areas for refinement include the accuracy of the
femtosecond laser incisions, a better understanding of
corneal biomechanics in the context of femtosecond
arcuate keratotomies, and the effects of the femtosecond
arcuate keratotomy on the posterior corneal curvature.
A recent optical coherence tomography study of femto-
second arcuate keratotomies17 showed that the midpoint
depth of the intrastromal incisions was significantly
more anterior than the planned parameters and that the
locations of the paired intrastromal incisions in each eye
were not correlated. In studies of biomechanical properties
and factors contributing to outcomes of femtosecond
arcuate keratotomy18,19 the type of astigmatism (against-
the-rule, with-the-rule, or oblique) were independent pre-
dictors of the efficacy of femtosecond arcuate keratotomy
and corneal hysteresis had a negative correlation with the
SIA at 1 to 6 months. L€offler et al.20 found that femto-
second arcuate keratotomies affected the anterior corneal
curvature and total corneal refractive power, but not the
posterior curvature.
In our study, there were no significant differences in the
absolute or arithmetic mean angle of error. This implies
that the femtosecond laser arcuate keratotomies were no
better aligned than what can be achieved manually. The
femtosecond arcuate keratotomy group had a significantly
smaller mean difference vector (the residual correction
required to achieve the TIA), and yet the index of success
was not quite statistically significant between the 2 groups.
The index of success is defined as the difference vector
divided by the TIA, where a number closer to zero indicates
greater success, and the value in the LRI group was 0.81
compared with 0.65 in the laser group (PZ .07). This could
Figure 1. Single-angle polar plots regarding corneal astigmatism for TIA and SIA of patients treated with LRIs (Cve cyl Z positive cylinder;
Arith. Z arithmetic; Ax Z axis; LRI Z limbal relaxing incisions; SIA Z surgically induced astigmatism; TIA Z target induced astigmatism).
Figure 2. Single-angle polar plots regarding corneal astigmatism for TIA and SIA of patients treated with femtosecond laser arcuate keratot-
omies (Cve cyl Z positive cylinder; Arith. Z arithmetic; Ax Z axis; LRI Z limbal relaxing incisions; SIA Z surgically induced astigmatism;
TIA Z target induced astigmatism).
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therefore possibly be explained by TIA in the LRI group be-
ing 0.12 D greater.
In addition to our findings that femtosecond arcuate
keratotomy had a greater correction index than LRI, we
found several possible several advantages of femtosecond
arcuate keratotomies over LRIs. First, they take a few sec-
onds to program into the laser platform and for the laser
platform to undertake them. In addition, although in this
study we marked all eyes at the slitlamp preoperatively,
several femtosecond laser–assisted cataract surgery plat-
forms now allow integration with corneal topography
and/or tomography devices and provide iris or conjunc-
tival vessel recognition. Thus, preoperative marking of
the axis is becoming redundant,13 enhancing patient and
surgeon convenience. Finally, because the incisions are
intrastromal, postoperative patient discomfort might be
less than with LRIs and the chance of posterior or full-
thickness perforation, infection, or inflammation might
be lower. However, femtosecond laser technology has sig-
nificant associated additional costs, and only limited addi-
tional cost and materials are required to perform arcuate
keratotomies.
One key limitation of this study is that follow-up was
limited to the first postoperative month and that longer
term efficacy was not evaluated. The published literature re-
ports variable results in terms of the regression of the effects
of LRIs with time, although in general such corrections
appear to be relatively stable after the first postoperative
month.21 In a series of 263 patients by Day et al.,22 of which
87 had intrastromal arcuate keratotomies, the regression in





Mean SD Mean SD
TIA vector (D)
Arithmetic mean 1.50 0.46 1.38 0.40 .16
Summated vector mean 0.31 " 160 0.21 " 174
SIA vector (D)
Arithmetic mean 1.02 0.91 1.23 0.77 .21
Summated vector mean 0.07 " 161 0.16 " 93
Correction index
Geometric mean 0.48 0.57 0.73 0.49 .02
Difference vector (D)
Arithmetic mean 1.17 0.69 0.89 0.54 .02
Summated vector mean 0.25 " 160 0.37 " 178
Index of success
Geometric mean 0.81 0.49 0.65 0.4 .07
Angle of error (degrees)
Arithmetic mean !3.35 29.90 2.35 25.95 .30
Absolute mean 22.10 20.19 17.99 18.69 .28
Femto AKZ femtosecond laser arcuate keratotomy; LRIZ limbal relaxing incision; SIAZ surgically induced astigmatism; TIAZ target induced astigmatism
Figure 3. Single-angle polar plots regarding corneal astigmatism for difference vector and correction index (SIA) of patients treated with LRIs.
One outlier is not represented on the correction index graph; the correction index of 3.38 is off the scale of the chart (at 60 degrees) (Cve
cyl Z positive cylinder; Arith. Z arithmetic; Ax Z axis; Geom. Z geometric; LRIs Z limbal relaxing incisions; SIA Z surgically induced
astigmatism).
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SIA was only 0.1 D between 1 month and 6 months and was
equivalent between groups that did or did not receive
arcuate keratotomies. Similarly, Chan et al.6 found stability
of the astigmatic correction by arcuate keratotomy between
2 months to 2 years postoperatively, and Byun et al.19 found
no significant changes between 2months and 6months and
a series of 89 eyes. This suggests that astigmatic corrections
achieved at 1 month are a good indicator of efficacy,
although we are following our patients at 12 months to
assess the longer term efficacy.
Figure 4. Single-angle polar plots regarding corneal astigmatism for difference vector and correction index (SIA) of patients treated with femto-
second laser arcuate keratotomies (Cve cylZ positive cylinder; Arith.Z arithmetic; AxZ axis; Geom.Z geometric; SIAZ surgically induced
astigmatism).
Figure 5. Astigmatism angles of error and the TIA versus SIA graphs
of patients treated with LRIs (Abs. Z absolute; Arith. Z arithmetic;
Ax Z axis; CCW Z counterclockwise; CC/Wise Z counterclock-
wise; C/Wise Z clockwise; LRIs Z limbal relaxing incisions;
SIA Z surgically induced astigmatism; TIA Z target induced
astigmatism).
Figure 6. The astigmatism angles of error and the TIA versus SIA
graphs of patients treated with femtosecond laser arcuate keratoto-
mies (Abs. Z absolute; Arith. Z arithmetic; Ax Z axis; CCW Z
counterclockwise; CC/Wise Z counterclockwise; C/Wise Z clock-
wise; SIA Z surgically induced astigmatism; TIA Z target induced
astigmatism).
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Despite randomization, there were some statistically sig-
nificant differences at baseline between the 2 groups; that is,
worse visual acuity (by 12 letters) and a longer AL (by
0.7 mm) in the femtosecond group. However, there were
no differences in the preoperative astigmatism or K values.
We believe that the differences in acuity and AL did not
play a significant role in the outcome parameters in this
current study.
In summary, we found that both manual LRIs and femto-
second laser intrastromal arcuate keratotomies were safe
Figure 7. Cumulative percentages of postoperative Snellen visual acuity (UDVA and CDVA) of LRIs (left) and femtosecond laser arcuate ker-
atotomies (right) (CDVA Z corrected distance visual acuity; LRIs Z limbal relaxing incisions; UDVA Z uncorrected distance visual acuity).
Figure 8. Number of lines difference between UDVA and CDVA of
LRIs (top) and femtosecond laser arcuate keratotomies (bottom)
(CDVAZ corrected distance visual acuity; LRIsZ limbal relaxing in-
cisions; UDVA Z uncorrected distance visual acuity).
Figure 9. Spherical equivalent refractive accuracy of LRIs (top) and
femtosecond laser arcuate keratotomies (bottom) (LRIsZ limbal re-
laxing incisions).
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and easy to perform, with both achieving a meaningful
reduction in corneal astigmatism. However, the laser group
achieved a correction of greater magnitude than the LRI
cohort 4 weeks after surgery.
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Figure 10. Preoperative and postoperative refractive astigmatism of
LRIs (top) and femtosecond laser arcuate keratotomies (bottom)
(LRIs Z limbal relaxing incisions).
WHAT WAS KNOWN
# Femtosecond laser intrastromal keratotomies and LRIs can
both be used in the management of corneal cylinder at the
time of cataract surgery
WHAT THIS PAPER ADDS
# Femtosecond laser arcuate keratotomies might offer more
efficacious and accurate correction of corneal cylinder than
LRIs.
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